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Abstract 
 
Background: Obesity is a global problem that resulted from excessive positive energy 
balance. Decreased physical activity and other dietary, environmental and genetic factors 
all contribute to its development (Han et al., 2010). On a larger scope, social, economic 
and cultural factors also predisposed to its occurrence globally (WHO, 2000). Of particular 
concern is the rise in paediatric obesity with subsequent rise in morbidity  during 
childhood, adolescence and young adulthood, and rise in morbidity in adulthood,  
including adult obesity, as well as increased risk of premature mortality in adulthood  
(Reilly and Kelly, 2011, Reilly, 2006).   
 
In Kuwait, paediatric obesity prevalence is high and may be continuing to rise in all age 
groups (Mirmiran et al., 2010, Al-Isa and Thalib, 2008, Al-Isa and Thalib, 2006). 
Affluence and rapid transformation of  Kuwaiti society after the discovery of oil is one 
theory behind the changes that took place in the dietary and physical activity patterns 
which could be the main mediators for the obesity epidemic in Kuwait (Ng et al., 2011). 
However, despite the paediatric obesity problem  in Kuwait there is not a widely available 
treatment solution or attempts to find obesity treatment solutions locally (Al-Isa et al., 
2010b). At an international level, effective treatment strategies were traditionally confined 
to the Western world, particularly the Epstein group in the USA (Epstein et al., 2012, Oude 
Luttikhuis et al., 2009, Epstein, 1996), though other successful treatment programmes have 
been published since the early pioneering work of Epstein  (Ho et al., 2012).  
 
The aim of the thesis was to: a) test the hypothesis that obesity impairs health related 
quality of life in Kuwaiti adolescents and test the differences in health related quality of 
life assessed by self-report and parent-proxy report, b) determine the prevalence of 
cardiometabolic risk factor abnormalities and metabolic syndrome in a sample of obese 
Kuwaiti adolescents, and c) test the effectiveness of a treatment intervention for adolescent 
obesity and compare it to a primary care control. 
 
Methodology: Chapter 4 describes the health related quality of life study (HRQL) that was 
conducted at baseline comparing the HRQL between obese and healthy-weight Kuwaiti 
adolescents (aged 10 to 14 years). Five hundred eligible consenting participants were 
assessed using the Peds QL™ self-reports as well as 374 parent-proxy reports. From the 
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obese group (n= 224), 82 participants agreed to participate in the National Adolescent 
Treatment Trial for obesity (NATTO) (chapter 6), an assessor-blinded randomised 
controlled trial, and were randomised to the intervention programme or primary care 
control over 6 months. The intervention programme aimed to change sedentary behaviour, 
diet and physical activity in low intensity doses through 6 hours contact over 24 weeks. At 
baseline, 80 blood samples were collected from 80 out of the 82 participants from the 
NATTO study, for the assessment of cardiometabolic risk factors namely C-reactive 
protein, intracellular adhesion molecules, interleukin-6, fasting blood glucose, fasting 
insulin, alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase, 
total cholesterol, low-density lipoprotein, high-density lipoprotein, triglycerides, and 
adiponectin. Metabolic syndrome was assessed using two criteria modified for use in 
younger individuals. 
 
Results: From the health related quality of life study, obesity was not associated with 
impaired health related quality of life in regression analysis. In a structured paired 
comparison of 98 pairs of obese adolescents vs healthy weight peers, impaired health 
related quality of life reached significance only for the physical quality of life domain  
(obese group score = 87.5, healthy weight group score = 93.7, 95% CI for quality of life 
score = -1.5, -9.4, p 0.007). In a paired comparison between parent-proxy vs self-reports 
for the obese adolescents, physical quality of life score (parent-proxy score 81.3, self-
report score 87.5, 95% CI = -3.2, -11.0, p ˂ 0.001), psychosocial score (parent-proxy score 
76.7, self-report score 85.0, 95% CI = -4.2, -10.8, p ˂ 0.001) and total score (parent-proxy 
score 78.8, self-report score 84.8, 95% CI = -4.9, -10.9, p ˂ 0.001) were all significantly 
lower in the parent reports. The cardiometabolic risk factors with highest prevalence of 
abnormal values in the sample (n = 80), described in chapter 5, were; aspartate 
aminotransferase (89% of samples abnormal), insulin resistance by homeostasis model 
assessment (HOMA) (67% abnormal ), intracellular adhesion molecule (ICAM) (67% 
abnormal), fasting insulin (43.5%), C-reactive protein (42.5%), low density lipoprotein 
(LDL) (35%), total cholesterol (34% abnormal), and systolic blood pressure (30% 
abnormal). Of all participants (n=80), 77 had at least one impaired cardiometabolic risk 
factor besides their obesity. Prevalence of Metabolic syndrome was 21.3% using the 
International Diabetes Federation definition and 30% using the Third Adult Treatment 
Panel definition. At 6 months outcome in the treatment intervention NATTO, the trial had 
acceptable retention (n =31 from the intervention group and n =32 from the control group), 
but engagement with both the intervention and control treatment (as measured by 
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attendance at treatment sessions) was poor. The intervention had no significant effect on 
BMI Z score relative to control, and no other significant effects of the intervention were 
observed. 
 
Conclusion: In a sample of obese Kuwaiti adolescents, obesity was not associated with 
marked impairment of health related quality of life; however, marked impairment in 
multiple cardiometabolic risk factors was present. Conducting the National Adolescent 
Treatment Trial for Obesity in Kuwait was feasible but not efficacious, and future obesity 
treatment trials should incorporate a qualitative assessment for better participants’ 
engagement.  
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1. Introduction and Literature Review 
 
1.1 Introduction 
This chapter is a literature review of obesity, with particular interest in childhood and 
adolescent obesity, its definition, prevalence and trends, aetiology, consequences, 
prevention and treatment options. An overview of Kuwait and paediatric obesity 
prevalence in the country is also discussed. 
 
1.2 Paediatric obesity: Definition 
Defining paediatric obesity is of great clinical importance to ensure accurate diagnosis and 
to provide the appropriate treatment option. It is also of great epidemiological importance, 
in order to monitor prevalence and trends within and/ or in between populations.  
 
Obesity is a chronic disease characterised by excess body fat which was included in the 
International Classification of Disease in 1948 (Duncan et al., 2010). It affects adults and 
children, populations of the developed and developing worlds, and is an ever growing 
public health concern worldwide. It has reached epidemic proportions, in 2010; overweight 
children under the age of 5 were estimated to be over 42 million, globally (WHO, 2012).  
 
There are direct non-reference methods to measure body fat content such as dual-energy x-
ray absorptiometry (DEXA), computer tomography (CT scans), magnetic resonance 
imaging (MRI), and bioelectrical impedance. These methods are usually informative, 
highly sensitive and specific, and reliable in terms of assessing true body fatness (Reilly et 
al., 2007). Mostly these methods are either expensive, labour intensive or not readily 
accessible in routine practice. Therefore, simpler and more practical proxy measurements 
of excess body fat are necessary for clinical as well as epidemiological purposes. In 
practice, different definitions exist for paediatric obesity using different methods of 
assessment such as waist circumference, percentage of ideal weight for height, weight for 
height Z scores, BMI percentiles and BMI Z score. These methods use either national or 
international reference data. Most of the reference data used, either nationally or 
internationally, are arbitrary and do not really reflect true correlation of specific cut off 
points with morbidity or mortality risk (Han et al., 2010). Body mass index (BMI) is a 
simple proxy of body fatness which can be obtained by the formula (weight kg/height² m²). 
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For adults, internationally agreed cut off points for BMI define underweight (˂18.5), 
normal weight (18.6-24.9), overweight (25-29.9) and obese (≥30). These cut off points 
correlate well with the risk of morbidity and mortality in adults (WHO, 2000). 
  
On the other hand, definition of paediatric obesity is more complex and still lacks 
generalisability. Effects of age, gender, ethnicity, and puberty on growth makes 
classification of paediatric obesity difficult (Reilly, 2006). Definition of a standard age-
related gender-specific growth charts with clinically significant reference points for 
overweight and obesity is of great public health importance to enable monitoring trends in 
paediatric obesity in the population and comparison with other populations internationally 
in terms of prevalence and /or trial outcomes.  
 
However, Reilly (2006) argues, in the case of BMI for age, that a unique cut off point for 
increased BMI for age would not suffice to detect the point of increased morbidity in 
paediatric populations due to the fact that these obesity-associated comorbidities are many 
and involve multiple body systems, but any method used for the definition has to be 
sensitive (identifying those who are excessively fat) and specific (identifying those who are 
not excessively fat).  
 
Gender-specific BMI for age percentile based on national representative data has been 
popular in use in the clinical and epidemiological settings (Reilly et al., 2010). In the UK, 
for example, the 1990 population-specific BMI percentile charts are used to define obesity 
at BMI ≥ 98th percentile and overweight at BMI ≥ 91th percentile (Rudolf et al., 2000). 
Also waist circumference for age, and BMI for age using internationally defined reference 
data have been in use widely clinically or in research. The latter was developed by the 
International Obesity Task Force (IOTF) Childhood obesity Working Group and published 
in 2000 where BMI percentiles involved combining data for children and adolescents aged 
2 to 18 years from six large nationally representative samples from Brazil, United 
Kingdom, Hong Kong, the Netherlands, Singapore and the United States (Cole et al., 
2000). Cole et al. (2000) developed the cut off points for overweight and obesity based on 
extrapolated adult cut off points at BMI ≥25 and BMI ≥30, respectively. One question 
remains however about the most appropriate method to be used when defining paediatric 
obesity.   
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This problem can be overcome, as Reilly et al (2010) explained in his systematic review by 
considering the accuracy of simple clinical and epidemiological definitions of childhood 
obesity. Firstly, using BMI for age with national reference data assured far more sensitivity 
and specificity in general and in between genders than using the IOTF percentiles with the 
international reference data. This is of great clinical importance in order to offer treatment 
to those who really suffer from health-threatening body fat content. Secondly, for the 
diagnosis of obesity with related cardiometabolic risk factors, high BMI for age with 
national reference data was as accurate a definition as the waist circumference for age 
method (Reilly et al., 2010). 
 
Defining paediatric obesity raises another issue of defining change of weight status or body 
fatness over time and assessing the best estimate for fat mass change in response to weight 
management. Ideally, the method used here should aim to evaluate the percentage of body 
fat loss (Hunt et al., 2007). In 2005, Cole et al. conducted an observational study on a 
sample of 135 children aged 2 to 5 years over a period of 9 months. The aim was to detect 
the best measure of adiposity change in these children from BMI, BMI%, BMI Z score, or 
BMI percentile. They have concluded that BMI is a better method to detect adiposity 
change over time (Cole et al., 2005). Hunt et al (2007) pointed out that this study, being 
observational in nature detected reproducibility of the methods tested rather than a true fat 
mass reduction over the 9 month period. Hunt et al. (2007) had tested the use of BMI Z 
score, BMI, weight, and weight Z score to detect fat mass change against actual fat mass 
measurement by Tanita Bioimpedance segmental body composition analyser. The study 
sample was of 92 children (aged 7 to 19 years) attending a weight management clinic over 
a period of 12 months. Anthropometric and bioimpedance measurements were made 3 
monthly. Hunt et al. (2007) found that BMI Z score was a better measure to predict change 
in fat mass over the other methods. Using bioelectrical impedance as the reference method 
to detect fat mass change limited the study results for being less accurate in detecting the 
body’s fat mass and differentiating subcutaneous mass from visceral mass. However, to 
detect variation in body composition, a combination of bioelectrical impedance and 
anthropometry could be of great benefit in clinical settings (Wright et al., 2008).   
 
In summary, BMI can be used as a tool to define obesity, and in paediatric populations, 
national or international age and gender specific BMI percentiles is considered a preferable 
tool to define paediatric obesity, if available. Monitoring fat mass change over time in 
paediatric population is best obtained by calculating BMI Z score at the start and end 
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points. Adding other tools to define obesity, anthropometric or direct non reference 
methods, could be of great value to detect variations of body composition.         
 
1.3 Paediatric obesity prevalence and trends 
1.3.1 Prevalence and trends – Kuwait 
Back in 1979-1980 a joint FAO/UNICEF mission visited the Gulf countries in order to 
make a first assessment of the food and nutrition situation, with particular reference to 
infant and young children, hence the development of a nutrition survey (Musaiger, 1985). 
In 1994 the Kuwait Nutritional Surveillance System (KNSS) was developed in 
collaboration with the WHO as part of the Global Database on Child Growth and 
Malnutrition. The data used were of Kuwaiti infants who had completed one year of age. It 
used anthropometric cut off points of the WHO then, where for adolescents (10 to 19 
years) overweight was defined as BMI ≥ 85th age and sex specific percentile and for 
obesity using both BMI ≥ 95th percentile and triceps skinfold thickness ≥90th percentile, 
from the US National Centre for Health Statistics/World Health Organization growth 
reference (1 to 24 years)(WHO, 1995). It is based on health clinics distributed all over the 
6 Kuwaiti governorates and selecting nationally representative samples by multistage 
random sampling methods. Data on weight, height, age and sex are collected and used to 
calculate levels of stunting, wasting, and obesity for the Kuwaiti population. Nutrition 
Surveillance is a system for consistent monitoring of the nutritional status of the population 
and its associated health, economic, demographic and food related variables. It is an 
instructive system that provides governments, on regular basis, with updated data on the 
nutrition status of their countries. It enhances the observation of nutrition-related risk 
factors and helps with the development of nutrition policy of the country (Butte et al., 
2007).   
 
The 1995 output of that surveillance showed that Kuwait was among the countries with the 
highest prevalence of overweight in all age groups (de Onis and Blossner, 2000). Yearly 
reports were sent to the Ministry of Health officials and to the WHO.  
 
At an academic level within Kuwait, several studies have been conducted by members of 
the Faculty of Medicine to determine the prevalence of adolescent obesity and develop 
body mass index reference data for Kuwaiti children and adolescents (El-Bayoumy et al., 
2009, Al-Isa and Thalib, 2008, Al-Isa and Thalib, 2006, Al-Isa, 2004). While prevalence of 
obesity in adolescence was remarkably high, the rate was relatively stable in studies done 
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on males and females aged 10 to 14 years in the year 2000 (14.7% and 13.1% respectively, 
obesity defined as BMI≥95th centile according to CDC reference charts) (Al Isa, 2004), and 
the year 2006 (14.6% and 14.2%, respectively, obesity defined as BMI ≥95th centile 
according to CDC reference charts) (El-Bayoumy et al., 2009). On the other hand, the 
comparison of BMI for age data for adolescent girls among three Middle Eastern countries 
(Egypt, Kuwait, Lebanon) showed that the highest rates of overweight and obesity were 
among the Kuwaiti girls (Jackson et al., 2007). Al Isa & Thalib (2006, 2008) collected 
anthropometric data for children aged 3-9 years old and adolescents aged 10-14 years old 
in Kuwait. Attempts were made to include all healthy, Kuwaiti kindergarten, elementary 
and intermediate school students. The aim was to establish population specific BMI 
reference data for Kuwaiti nationals and other regional countries. When compared with the 
United States National Centre for Health Statistics reference, the curves were similar 
except at the lowest percentile (5th) and higher percentiles (50th percentile onwards). The 
probable reason behind the incompatibility is that these surveys were done after the obesity 
epidemic hit Kuwait, suggesting that the national reference data might have been 
‘contaminated’ by the obesity epidemic resulting in markedly higher BMI for age than 
those obtained using US CDC reference data (El-Ghaziri et al., 2011).    
 
In 2007, the Kuwait nutritional surveillance system (KNSS) had adapted the reformed 
WHO international growth reference (de Onis et al., 2012), now called WHO child growth 
standards, for assessing overweight and obesity. These are merged data from the 1977 
National Centre for Health Statistics (NCHS)/WHO growth reference (1-24 years) and 
BMI for age growth charts designed from the WHO growth standards for 2 to 5 year old 
children, that collected reference data from Brazil, Ghana, India, Norway, Oman and USA, 
and the BMI cut offs for adults. These new BMI for age percentiles provide fitting BMI for 
age reference for 5 to 19 years old children and adolescents. Here obesity is defined using 
BMI for age ≥ +2SD corresponding to BMI =30 for adults and overweight ≥ +1SD 
corresponding to BMI = 25 for adults. Table 1.1 displays the percentages of overweight 
and obesity in Kuwaiti male and female adolescents (aged 10 to 18) from the year 1996 to 
2010, extracted from records of the KNSS-Ministry of Health-Kuwait. 
 
Prevalence of adolescent obesity in the Arabian Gulf region is among the highest in the 
world (Ng et al., 2011).  
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Prevalence of adolescent (age 12 to 18 years) obesity from a nationally representative 
sample in the Kingdom of Saudi Arabia was 12.7% in 1998 (El-Hazmi and Warsy, 2002). 
In 2008, from a sample representing 3% of the population, the prevalence of adolescent 
obesity (age 15 to 18 years) was 33.1% (Bader et al., 2008). The prevalence of adolescent 
obesity in UAE in 2005 was 24.2% (Al Matroushi and Fikry, 2005) and in Qatar in 2004 
the prevalence of adolescent obesity was 11% (Bener and Kamal, 2005). Although 
comparison is difficult to be made between all Arabian Gulf countries as different 
paediatric obesity definitions have been used (Ng et al., 2011), the prevalence in this 
region is among the highest in the world where Kuwait takes the lead.  
 
In summary, studies and national surveillance efforts show that in Kuwait obesity among 
adolescents is high and levels of overweight and obesity in that age group had stabilised 
between surveys up until the  last available survey of year 2010 (Mirmiran et al., 2010). 
From the Arabian Gulf region, prevalence of adolescent obesity is high and the highest is 
in Kuwait.                                                                            
 
1.3.2 Prevalence and trends of paediatric obesity – Worldwide 
Regardless of the definition used, it is now evident that the prevalence of childhood and 
adolescent obesity has increased dramatically over the last 3 decades in both the 
developing and developed worlds (Alwan, 2011), but might have been stabilising in the 
last few years in the western world (Rokholm et al., 2010). In the European region, studies 
show that the prevalence of overweight (defined as BMI ≥ 1SD in WHO child growth 
standards) or obese (defined as BMI ≥2 SD in WHO child growth standards) school-aged 
children is 20%, 5% of whom are obese (Branca et al., 2007). In the US, using the CDC 
definition of overweight (BMI ≥85th percentile) and obesity (BMI ≥95th percentile) these 
figures are 30% and 15%, respectively (Wang and Lobstein, 2006). Worldwide, it is 
estimated that 1 in 10 school-aged children (5 to 17 years old) are overweight or obese, 
using the WHO growth standards for definition (de Onis et al., 2012). There is a wide 
range of prevalence levels, with overweight (including obesity) prevalence in Africa, South 
East Asia and the South Pacific averaging below 10%, and in the Americas, Europe and 
the Eastern Mediterranean regions average above 20%. So the spread of obesity has been 
taking place at different speed across the world. In almost all developed countries (except 
Russia, and Poland), childhood obesity prevalence have been increasing more dramatically 
than other regions of the world. Moreover, countries that have been undergoing rapid 
economic transformation in the developing world show accelerated rate of childhood 
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obesity, particularly in urban societies, in higher socio-economic classes (Wang and Lim, 
2012, Wang and Lobstein, 2006). These countries face the double burden of over-nutrition 
and under-nutrition (Wang and Lim, 2012). One scenario for the outcome of this double 
burden is having children with low birth weights and subsequent stunting, responding to 
future availability of  food by increasing in weight disproportionately to height and 
increasing central adiposity and  subsequently increasing the risk of related chronic 
diseases (Hassan et al., 2008, Wang and Lobstein, 2006).  
 
The recent literature shows levelling off of the childhood obesity epidemic in some regions 
of the world (Rokholm et al., 2010). Recently, high quality evidence with descriptive 
datasets coming from Australia, China, England, France, the Netherlands, New Zealand, 
Sweden, Switzerland, and the USA with data from 467,294 children and adolescents aged 
2-19 years  where two measures of obesity were used to estimate the prevalence of 
paediatric obesity since 1999 suggests that the prevalence of overweight and obesity 
appears to be plateauing at different levels, however, sex, age, socioeconomic status and 
ethnicity determine the rate of change across those nations. Nonetheless, overweight and 
obesity remains at epidemic proportions (Olds et al., 2011).   
 
In summary, the prevalence of paediatric obesity has been increasing worldwide with 
probable stabilisation more recently in western countries. The rate of spread differs 
between countries, and could be slowing in some parts of the world.     
 
1.4 The aetiology of paediatric obesity  
Although the mechanism of obesity development is not fully understood, it remains an 
energy balance disorder that is caused by an excessive energy intake over energy 
requirement; this is a simplified version of a more complex subject (Reilly et al., 2007). 
Measuring energy intake or examining energy expenditure in paediatrics is limited due to 
inaccuracy of the measurements used or their high cost, respectively (Reilly, 2006).   
 
There are multiple factors for excess positive energy balance imbalance including genetics, 
environmental, lifestyle preferences and cultural factors (Kosti and Panagiotakos, 2006). 
So in other words, in order to identify aetiological factors of paediatric obesity, one could 
search for possible genetic and epidemiological risk factors (Reilly, 2006). From a review 
of systematic reviews of early-life determinants of overweight and obesity, figure 1.1 
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shows a model proposed by Monasta et al (Monasta et al., 2010) which displays the 
possible risk factors predisposing to paediatric overweight and obesity.  
 
   
Figure 1. 1 The complex web of potential determinants of overweight and obesity in children. Source Monasta et al., 
2010. 
                                                              
As discussed before, the great increase in paediatric obesity in the world over the past 
several decades suggest that environmental factors have greater influence on the aetiology 
than the genetic factors. The ‘obesogenic environment’ is a term used in the media and the 
literature to describe the current environment predisposing to chronic positive energy 
imbalance with readily available energy dense foods low in nutrients and discouraging 
physical activity(Swinburn et al., 1999). However, twin studies had shown that fat 
distribution of twins, monozygotic or dizygotic, were similar regardless of the environment 
in which they grew (Phan-Hug et al., 2012, Ramachandrappa and Farooqi, 2011, Stunkard 
et al., 1990) and so some genetic contribution exists.  
 
1.4.1 Genetic contributions to obesity 
Genetic contribution to obesity could be divided into single gene mutations in which 
obesity is the resultant abnormality, or genetic syndrome in which obesity is part of the 
identifiable signs of the specific medical syndrome along with mental retardation and 
developmental abnormality, or the result of multiple relatively common variants, each of 
which has small effect (Ramachandrappa and Farooqi, 2011).  
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Eating behaviour can be viewed as homeostatic mechanism that is controlled by hormonal 
signals from adipose tissue and the gastrointestinal tract to provide feedback to the 
hypothalamus to regulate appetite (Han et al., 2010). Gene mutations in the production, 
signalling or receptors of these hormones could contribute to the aetiology of obesity 
(Farooqi et al., 2007). Congenital leptin and leptin receptor deficiencies, and 
proopiomelanocrtin (POMC) deficiency are examples and share the phenotype of early 
onset severe obesity. The prevalence of these mutations has varied from 0.5% of obese 
adults to 6% in patients with severe childhood obesity (Farooqi et al., 2007).    
 
It has been suggested that 20 to 90% of the variation in BMI is inheritable (Maes et al., 
1997). However, studying the genetic basis of obesity susceptibility is difficult due to its 
complexity and polygenic nature. Single gene mutations are rare occurrences, with 
prevalence ranging from 0.5 to 4% of the population (Miraglia Del Giudice et al., 2002, 
Vaisse et al., 2000) 
 
There are about 30 medical syndromes in which paediatric obesity is one of their signs 
(Holgate et al., 2012). Other signs and symptoms include dysmorphic features, mental 
retardation, short stature, and developmental abnormalities. These inheritable disorders 
explain about 1 to 2% of paediatric obesity (Lobstein et al., 2004). Down syndrome, 
Prader-Willi syndrome, Duchenne muscular dystrophy, Albright hereditary 
osteodystrophy, and Fragile X syndrome are some of these conditions that can be seen in 
clinical settings.  
 
Single nucleotide polymorphism (SNP) is a variation in a single locus of DNA sequence in 
an individual which can result in impaired DNA coding resulting in a disorder or disease 
(den Hoed et al., 2009). The rs9939609 SNP in fat mass and obesity associated gene (FTO) 
is one example, contributing to 16% of obesity risk in the population (Frayling et al., 
2007).  
 
 1.4.2 Endocrine disorders 
The endocrine system is made up of glands in the body that produce hormones, which can 
act locally or at distant organs, in order to control body function, growth, sexual 
development and metabolism. There are several endocrine abnormalities that are 
associated with obesity (Nussey and Whitehead, 2001). Some of these abnormalities result 
in obesity as one of their signs; others are caused by obesity and can be corrected with 
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weight loss. Classically, these conditions include; hypothyroidism, growth hormone 
deficiency or resistance, hypopituitarism, hypogonadotrophic hypogonadism, 
hypogonadism, cortisol excess, pseudohypoparathyroidism, and craniopharyngioma 
(Nussey and Whitehead, 2001). In most of these cases, appropriate management of the 
primary cause can result in weight loss.       
 
1.4.3 Birth weight, parental factors and foetal growth 
Most obese adults were obese adolescents and most obese adolescents were overweight or 
obese children (Rooney et al., 2011).  In a birth cohort of 777 infants, followed up for 20 
years, Rooney et al. (2011) concluded that the relative risks (RRs) to predict obesity at 
early adulthood were 12.3 (95% CI 5.81, 26.1) for childhood and 45.1 (95% CI 17.24, 
117.94) at adolescence. In fact, obesity can often be traced back to early childhood 
development (Maes et al., 1997). Children who develop adiposity rebound before the age 
of 5 years have increases in mean BMI from age 3 to adolescence, but those who 
experience later adiposity rebound have decreases in BMI from age 3 to adolescence. This 
pattern is maintained into adulthood (Williams and Goulding, 2009, Rolland-Cachera et 
al., 2006). More evidence from Bjerregaard and colleagues (Bjerregaard et al., 2014) from 
the Copenhagen Perinatal Cohort where participants were followed from birth to the age of 
42 (n= 1633) showed that higher weight gain during the first 12 months of life was 
associated with higher adult BMI.     
 
High birth weight is associated with increased fat and lean mass in infancy and childhood 
(Monasta et al., 2010). Small-for-gestational-age babies who show early catch-up growth 
might be at risk of childhood obesity and insulin resistance (Monasta et al., 2010).   
 
Gestational diabetes produces macrosomia (large babies), and could be associated with 
childhood obesity later in life. A similar association is also found between prenatal 
maternal smoking and later childhood obesity (Monasta et al., 2010).  
 
There are certain environmental settings that could predispose children to obesity. Growing 
up with an obese parent is a risk factor for subsequent obesity, especially if both parents 
were obese (Lobstein et al., 2004). There could be genetic as well as shared environmental 
factors in this picture. This relationship maybe stronger if the mother is obese (Nader et al., 
2006).  
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Evidence from systematic reviews suggests that breastfeeding is likely to be causally 
protective against childhood obesity (Yang and Huffman, 2013).   
 
1.4.4 Diet 
 Energy intake is one input of the energy balance equation, thus high energy intake is 
considered a risk factor for obesity development. Food preferences and eating habits that 
lead to obesity are gained during childhood from infancy onwards (Pearce and Langley-
Evans, 2013). A recent review by Pearce and Langley-Evans (2013) on the relationship 
between foods consumed during infancy complementary feeding and overweight or obesity 
during childhood, found that only one study out of five showed that high energy intake in 
early infancy could be associated with high BMI and percentage body fat, so considered 
the results as inconclusive and further research is needed to establish the nature of the 
relationship between food consumed and eating habits acquired during infancy and obesity 
during childhood.  
 
The source of the high energy intake is often from high fat content of food (Lobstein et al., 
2004). Evidence from the past 50 years show that fat content of the modern diet has 
increased markedly, coupled with higher consumption rate and larger portion size 
especially for foods eaten outside the home (French et al., 2001). This pattern obviously 
can provide larger sum of energy to the child’s actual need. In children who ate meals with 
high fat content from fast food consumed poorer quality diet than those who did not, and 
could increase their risk of obesity if this was allowed to be part of their lifestyle (Bowman 
et al., 2004). However, carbohydrate content of children diet has received little attention 
with the exception of sweetened soft drinks that show a positive association with the 
development of obesity in childhood (Lobstein et al., 2004, BMJ, 2012). This was also 
supported by a recent systematic review (Monasta et al., 2010). 
 
1.4.5 Sleep deprivation 
Monasta et al. (2010) in their review of systematic reviews on the association between 
sleep duration during infancy and the risk of future childhood obesity concluded that the 
shorter the period of sleep during infancy (˂ 12 hours of sleep) the more likely to 
encounter obesity later on in life (at the age of 7 to 10 years of age). This association was 
stronger for boys and for younger age children (˂10 years of age).  
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1.4.6 Physical activity and sedentary behaviour 
Systematic reviews have concluded that prolonged screen time and decreased level of 
physical activity was associated with increased body fatness (Monasta et al., 2010). 
Sedentary behaviour could also result from obesity as play and other physical activities are 
less attractive to the obese child (Tsang et al., 2013, Bauman et al., 2012). However, a 
longitudinal study of 871 children from the Auckland Birthweight Collaborative Study in 
New Zealand with a 7 year follow up confirmed that sedentary behaviour predicts 
overweight and obesity in children (Blair et al., 2007). This may work by displacing the 
amount of time a child would normally spend on play with inactivity and in doing so, the 
likelihood of consuming sugary drinks and energy dense foods could increase (Lobstein et 
al., 2004).  
 
In summary, there are multiple risk factors that could predispose to the development of 
paediatric obesity. Some factors are at least potentially modifiable and others are not. In 
clinical settings, proper assessment of the obese child or adolescent and their family is 
essential in order to pinpoint the factor or factors that might have led to the development of 
obesity and offer the best possible treatment options and support (SIGN, 2010). 
 
1.5 Complications of paediatric obesity 
With the relatively recent and fast increase in paediatric obesity prevalence emerged 
multiple and dire health consequences both physical and psychological. These 
consequences could represent the roots of multiple diseases and disorders that can emerge 
in early adulthood, or can present in their full-blown picture in childhood and adolescence 
(Juonala et al., 2011, Reilly and Kelly, 2011, Lobstein et al., 2004). There are immediate 
health consequences of paediatric obesity and there are long-term health risks. All of these 
complications can be divided into either physical complications which can affect every 
organ system in the body, or psychological complications. The evidence for these 
associations from the literature is multiple and extensive.  
 
Identifying children and adolescents with obesity in turn identifies a group of the 
population who suffer from cardiovascular disease risk factors, and inflammatory and 
metabolic risk factors, and who might also suffer from multiple psychosocial impairments 
(Reilly et al., 2003). However, as discussed in section 1.1 Definition of paediatric obesity 
above, an ideal definition of paediatric obesity is still not available due to a number of 
reasons; lack of agreement on a universal anthropometric tool to classify healthy weight, 
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overweight and obesity ranges, lack of agreement on a reference population being national 
or international, and lack of agreement on the most appropriate cut off points that best 
mark the individuals who are at a higher risk of obesity-related complications (de Onis and 
Lobstein, 2010). 
Figure 1.2 outlines the physical and psychological complications of childhood obesity. Out 
of the vast number of complications, the psychological complications are probably the 
most common (Reilly, 2006). These include depression, anxiety disorders, low self-esteem 
and low health related quality of life (HRQL).   
 
One important consideration made by Ebbeling and colleagues (2002) is that the 
occurrence of  these obesity-related complications can be affected by ethnicity as a result 
of cultural factors, one example being that psychological consequences are higher in 
whites than other ethnic groups in a study done with regards to self-esteem in girls in the 
USA (Kimm et al., 1997). Ethnic minorities and socioeconomic disparities have been 
linked to childhood and adolescent obesity in several parts of the world (Singh et al., 
2008b, Stamatakis et al., 2005, Willms et al., 2003). However, in Kuwait there is no 
official socioeconomic categorisation of the population (Shah et al., 1998) and questions 
pertaining inequalities in the society have not been answered in a systematic manner. 
Moreover, published census data from the Public Authority for Civil Information (PACI) 
has no reference to ethnic categorisation for the population, related to the fact that the 
Kuwaiti population is homogenous of Arabic origins.   
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Figure 1. 2 Complications of childhood obesity. Source Ebbeling et al., 2002. 
 
1.5.1 Psychological complications 
Some researchers argue that obesity should be regarded as mental or behavioural disorder, 
and that research should be directed towards identifying the psychological factors 
associated with its development rather than identifying medical strategies for prevention 
and treatment (Russell-Mayhew et al., 2012). However, not all obese children and 
adolescents suffer from psychosocial problems, and the lack of longitudinal studies in this 
area hinders the recognition of the direction of the relationship between obesity and 
psychosocial issues and also the magnitude of such relationship (Vila et al., 2004).  
 In a cross-sectional study done by Vila and colleagues (2004) on 155 obese children and 
adolescents attending obesity treatment in Paris (aged 5 to 17 years) to explore the 
relationship between paediatric obesity and psychopathological disorders, the researchers 
showed that obesity is a significant factor in the development of psychological disorders 
namely separation anxiety and social phobia and incompetence, which all may contribute 
to the maintenance of obesity. When this sample was compared with diabetic controls 
(Type 1 diabetes which a major part of their management relies on dietetic control), they 
had significantly more psychological disorders in number and severity. In another study 
that supports the view that obesity could involve greater potential for psychosocial distress 
16 
 
than some chronic somatic disorders, Schwimmer et al. (2003) recruited 106 children and 
adolescents aged 5 to 18 years, and studied HRQL of this sample using the PedsQL™ 
questionnaire, which is a valid and reliable age specific health related quality of life 
questionnaire (Varni et al., 2001),  and compared it with the results from cancer paediatric 
patients. The researchers found that HRQL levels were worse for the obese group. For 
obese children and adolescents, psychosocial development is usually impaired to a varying 
extent ranging from dissatisfaction with weight status and shape to low self-esteem, 
depression and other psychosocial disorders (Griffiths et al., 2010) (discussed in more 
details in chapter 4).  
 
1.5.2 Cardiometabolic complications  
The major cardiovascular disease risk factors that can be found in children and adolescents 
are hypertension, dyslipidaemia, left ventricular hypertrophy or dysfunction, 
hyperinsulinaemia and /or insulin resistance (Reilly et al., 2003). The Bogalusa Heart 
Study in Louisiana (Freedman et al., 2007) had provided detailed profile of cardiovascular 
risk factors in children and adolescents and their persistence into adulthood. In the study, 
obese adolescents (BMI ≥ 99th percentile, Centre for Disease Control (CDC) growth 
charts) had the prevalence of hypertension increased 8.5 fold, the prevalence of total serum 
cholesterol increased by 2.4 fold, and a 3 fold increase in LDL cholesterol, as adults aged 
27-31 years.  
 
The metabolic syndrome (insulin resistance syndrome or syndrome X) is a combination of 
medical disorders that, when present, increase the risk of cardiovascular disease, stroke and 
diabetes. There have been debate on the proper definition of metabolic syndrome in adults 
and whether all the features of the syndrome should be obligatory for the definition, 
however, in 2009 the International Diabetes Federation Task Force on Epidemiology and 
Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World 
Heart Federation; International Atherosclerosis Society; and International Association for 
the Study of Obesity reached a Joint Interim Statement to harmonise the definition of the 
syndrome. There are 5 criteria in use, and if 3 out of these 5 are present, that would qualify 
for the definition (Alberti et al., 2009). These criteria include; elevation of waist 
circumference (population-specific definitions), triglycerides ≥ 1.7 mmol/L or drug 
treatment for elevated triglycerides, reduced HDL ˂ 1.0 mmol/L in males or ˂ 1.3 mmol/L 
in females or drug treatment for reduced HDL, elevated systolic blood pressure ≥130 
mmHg and/or diastolic blood pressure ≥ 85 mmHg or treatment for hypertension and 
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elevated fasting blood glucose ≥ 5.6 mmol/L or drug treatment for diabetes mellitus 
(Alberti et al., 2009).      
   
The diagnostic criteria for childhood and adolescent metabolic syndrome are not 
unanimously agreed upon (Goodman et al., 2007) due to the fact that the paediatric risk 
profile is unstable in the short (60 days) and long (1.5 year) term based on the adult criteria 
(Gustafson et al., 2009). Applying absolute cut off points to continuous variables without 
considering the impact of aging, pubertal stages, and ethnicity are also factors in failure to 
reach a consensus. Nevertheless, identifying children and adolescents with increased risk 
of developing cardiovascular disease later on is extremely important and one of the 
available clinical definitions for paediatric metabolic syndrome is the IDF definition of 
metabolic syndrome in children and adolescents which consist of five criteria (Zimmet et 
al., 2007). These guidelines are age-specific to encompass the different stages of paediatric 
development. They start from 6 years of age to older than 16 years of age as shown in box 
1.1. However, the IDF recommend that the syndrome should not be diagnosed at age 10 
and younger, and such patients with identified criteria should be directed towards obesity 
treatment instead as appropriate. To be diagnosed with MS using the IDF definition, high 
waist circumference (population specific percentile) and two other criteria need to be 
present. 
 
Al Isa and colleagues assessed the prevalence of metabolic syndrome in a random sample 
(n=431) of female Kuwaiti adolescents aged 10 to 14 years using IDF criteria (Al-Isa et al., 
2010a). The results showed a high prevalence of metabolic syndrome in that age group 
(14.8%) compared to general population.   
Internationally, a recent review by Tailor et al (2010) concluded that prevalence of MS 
among in the paediatric population ranges from 1.2 and 22.6%, where obesity is the most 
important risk factor (up to 60% of the obese children or adolescents maybe affected 
according to Tailor et al., 2010). 
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Box 1.1  IDF definition of at risk group and of metabolic 
syndrome (MS) in children and adolescents 
 
Age 6 to ˂ 10 years 
· Obesity ≥ 90th centile defined by waist circumference 
· MS should not be diagnosed, further measurements should be made if family history of 
MS, type 2 DM, dyslipidaemia, 
cardiovascular disease, hypertension or obesity. 
 
 
Age 10 to ˂ 16 years 
· Obesity ≥ 90th centile or adult cut off if lower assessed by 
waist circumference 
· Triglycerides ≥ 1.7 mmol/L 
· HDL-C ˂ 1.3 mmol/L 
· Blood pressure ≥ 130mmHg systolic or ≥ 85mmHg diastolic 
· Glucose ≥ 5.6 mmol/L (oral glucose tolerance test) or known 
type 2 diabetic 
 
Age > 16 years 
· Use existing criteria for adults 
Source Zimmet et al. 2007. 
 
1.5.3 Orthopaedic complications 
Excess weight is a continuous stress on the musculoskeletal system. The presence of 
unfused growth plates and softer cartilaginous bones of children contribute to the 
development of a number of abnormalities including; slipped femoral capital epiphyses, 
Blount’s disease (Bowing of legs and tibial torsion) and osteoarthritis in older children and 
adolescents (Wills, 2004).  Moreover, extreme paediatric obesity is associated with 
increased chances of lower extremities fractures (Kessler et al., 2013). 
 
1.5.4 Endocrine complications 
Childhood and adolescent obesity is associated with increased incidence of insulin 
resistance and type 2 diabetes mellitus. In some populations, type 2 diabetes mellitus in 
adolescents account for 50% of the newly diagnosed cases (Fagot-Campagna, 2000). 
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Moreover, the pre-diabetic state i.e. glucose intolerance and insulin resistance, seems to be 
more prevalent in the severely obese children and adolescents, irrespective of ethnic origin 
(Sinha et al., 2002). In view of the subsequent increase in blood glucose, emerges the 
possibility of the macro-vascular and micro-vascular impairments of type 2 diabetes 
mellitus that include complications like stroke and kidney failure, respectively.        
 
Menstrual abnormalities are often diagnosed in obese female children and adolescents, one 
of which is the decreasing age of menarche (before 11 years of age) (Currie et al., 2012, 
Must and Strauss, 1999). In Kuwait, Al Awadhi et al. (Al-Awadhi et al., 2013), had 
investigated the age at menarche for 1250 contemporary girls and found a significant 
inverse relationship between the age at menarche and obesity or overweight before and 
after adjusting for potential confounders. In males however, the evidence is not clear 
whether obesity reduces or increases the age of puberty (De Leonibus et al., 2012). 
 
Oligo- or amenorrhoea, hirsuitism, obesity, acne, acanthosis nigricans, and insulin 
resistance are all part of the polycystic ovarian syndrome (PCOS) formally known as 
Stein-Leventhal syndrome (Ojaniemi et al., 2010). Pre- and peripubertal obesity could be a 
contributing factor in the development of PCOS in adolescents through insulin-resistant 
hyperinsulinism (Rosenfield, 2007). The mechanism of this process is yet unknown, 
however, studies showed that using insulin-lowering agents such as metformin 
administered to obese girls at risk of developing PCOS, improved insulin resistance, 
adiposity and androgen levels (Ibanez et al., 2004).  
 
1.5.5 Respiratory complications 
In a recent review by Pulgaron (2013) examining the relationship between obesity and 
other comorbidities, the prevalence of asthma has been increasing in parallel with obesity 
epidemic in recent years. Obesity seems to increase the incidence of asthma or worsen 
existing asthma. There are some suggestions of gender differences in the relationship 
between obesity and asthma but the evidence is not yet consistent.  
 
Sleep-associated breathing disorders ranging from heavy snoring to obstructive sleep 
apnoea have also been associated with paediatric obesity. The resultant hypoxaemia of 
sleep-disordered breathing can predispose to increase in inflammatory risk factors 
(Tauman et al., 2007, Tauman and Gozal, 2006). It has been estimated that 94% of children 
with severe obesity have abnormal sleep pattern (Silvestri et al., 1993). The state of 
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hypoxia and hypercapnia that results from obstructive sleep apnoea can potentiate the 
development of cardiovascular abnormalities (Daniels et al., 2005). 
 
1.5.6 Gastrointestinal complications 
 Gastroeosophogeal reflux disease (GERD) is a common complication of obesity in adults 
affecting almost 40% of the population (Anand and Katz, 2010). With the rising of 
paediatric obesity and extreme obesity, GERD has been diagnosed more frequently in 
obese children and adolescents (Koebnick et al., 2011). In addition, gallstone disease is 
found to be high in prevalence in extremely obese children and adolescents, especially girls 
(Koebnick et al., 2012). Non-alcoholic fatty liver disease (NAFLD) is the most prevalent 
chronic liver disease in obese children and adolescents (Giorgio et al., 2013). It is 
associated with the development of insulin resistance and type 2 diabetes mellitus, 
metabolic syndrome, hypertension and cardiovascular disease (Koebnick et al., 2009). 
Early recognition is needed to avoid future morbidity and mortality (chapter 5). 
 
 1.6 Paediatric obesity prevention 
The ultimate goal of any health promotion strategies is to modify human behaviour that is 
causing ill health into more health-enhancing behaviour to reduce the risk of disease. 
However, behaviour modification goes beyond individual level to include more societal 
and broader community levels and any health promotion plan should be injected at these 
levels for potential change (Lawlor and Pearce, 2013). There is a wealth of trials on 
interventions to prevent childhood obesity in school settings, with successful outcomes 
(Martin et al., 2013, Katz et al., 2008, Sahota et al., 2001b). The rationale behind this is 
that schools are well circumscribed areas, where children spend substantial proportion of 
their lives and in most countries of the world education is compulsory (Nixon et al., 2012, 
Katz et al., 2008).  
It is beyond the scope of this thesis to examine the prevention interventions as our main 
theme is paediatric obesity treatment. The most recent Cochrane review on the prevention 
of child and adolescent obesity was that of Waters et al (2011).  
 
1.7 Paediatric obesity treatment 
Management of paediatric obesity and its related health risks consume more and more time 
of health professionals, presenting a health care challenge (Avis et al., 2014, Story et al., 
2002). However, the need for evidence-based interventions for obesity treatment is 
important in order to counteract the current paediatric obesity epidemic and its related 
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health consequences. The current knowledge, belief and practices of physicians at 
secondary health care in the western world lacks the proper training in lifestyle 
modification required to deal with behavioural problems which maintain paediatric obesity 
(Avis et al., 2014, Klein et al., 2010, O'Brien et al., 2004, Foster et al., 2003, Story et al., 
2002).  
 
1.7.1 Why treat paediatric obesity?  
There are a number of high priority reasons to treat childhood and adolescent obesity some 
of which are as follows: 
• Childhood and adolescent obesity does not spontaneously resolve. Strong evidence 
from various prospective studies show that childhood and adolescent obesity tracks 
into adulthood and the evidence is strongest with increasing age; over 50% of obese 
adolescents become obese adults (Singh et al., 2008a, Guo et al., 2000, Whitaker et 
al., 1997).  
• Obese children and adolescents already experience multiple physical and 
psychological consequences as a result of their obesity as explained in section 1.5 
Complications of paediatric obesity above. 
• Adverse cardiovascular risk factors encountered during childhood and adolescence 
increases the risk of adult cardiovascular disease morbidity and mortality (Reilly 
and Kelly, 2011, Reilly et al., 2003). 
• Management of childhood and adolescent obesity can improve the cardiovascular 
risk factor profile. Decreasing one’s weight by 6.5% leads to a decrease in health 
risks in adolescents as well as adults (Shapiro et al., 2006). Furthermore, the 
atherogenic profile and insulin sensitivity in obese children improves with a 0.5 
reduction in BMI SDS over 1 year period (Reinehr and Andler, 2004, Reinehr et 
al., 2004).  
• Improvement in psychosocial functioning can also be attained with proper weight 
management of childhood obesity (Hofsteenge et al., 2013, Harris-Glocker et al., 
2010, Lofrano-Prado et al., 2009, Myers et al., 1998). 
• With the current prevalence and severity of childhood and adolescent obesity, the 
economic cost has increased dramatically, and the costs are likely to increase even 
more (Wang and Dietz, 2002) and weight management programmes could be 
designed to be cost effective or even cost saving (John et al., 2012).  
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1.7.2 Current recommendations for paediatric obesity treatment 
The current recommendation for paediatric obesity treatment derived from systematic 
reviews, notably from the most recent Cochran review (Oude Luttikhuis et al., 2009). The 
review included 64 studies; 54 lifestyle intervention studies and 10 on drug treatment. 
However, long-term outcomes (follow up period of ≥ 6 months following the intervention) 
of obesity treatment was limited, hence the recommendation in the Cochrane review to 
extend the trial period in order to examine the efficacy of the proposed interventions in the 
longer-term. 
The expert committee on the treatment of overweight and obesity in children and 
adolescents in the USA recommends that the treatment of obesity should start at younger 
age (Spear et al., 2007). Age is an important predictor of weight management success in 
children and adolescents; younger children seem to achieve more weight loss (Danielsson 
et al., 2012, Pott et al., 2009, Goossens et al., 2009, Sabin et al., 2007).  
 
1.7.3 Who should be offered treatment? 
Ideally, all children and adolescents who suffer from obesity, as defined by local protocols, 
should have a weight management plan (Spear et al., 2007). Identification of obese 
children and adolescents should be made at primary care level, and special attention should 
be directed towards assessing the health risks associated with the condition as well as 
assessing unhealthy lifestyle habits that could have led to the child’s or adolescent’s 
obesity (Barlow, 2007). The focus should be on the family as a whole and not just the child 
or the adolescent. Suggestions for obesity management plan through lifestyle modification 
can be made at this primary setting.  
 
1.7.4 Obesity treatment goals 
The primary treatment goal is to improve the long-term physical health through permanent 
healthy lifestyle habits. In children and young adolescents who have growth potential and 
do not suffer from co-morbid conditions associated with their obesity, weight maintenance 
is the goal of the treatment plan which in turn allows for normal growth in height to take 
place and “cure” the child as he/she grows (SIGN, 2010).  
In children and adolescents where faster weight reduction is needed due to the presence of 
obesity-related co-morbid conditions including psychosocial functioning, weight loss is the 
goal (SIGN, 2010). Therapeutic goals are also considered such as correcting metabolic 
abnormalities, improving psychosocial health and family functioning.  
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1.7.5 How strong is the evidence on the effectiveness of obesity treatment? 
In general, poor dietary habits, decreased physical activity and sedentary lifestyles play a 
fundamental role in the onset of overweight and obesity (Lobstein et al., 2004). Therefore 
most behavioural interventions for obese children and adolescents are aimed at improving 
lifestyle behaviours and there is evidence of efficacy of lifestyle modification in the 
Cochrane review (Oude Luttikhuis et al., 2009). Accordingly, lifestyle modifications 
usually include three components: dietary intake, physical activity and sedentary behaviour 
reduction. Changing human behaviour is very challenging task especially in an 
environment that favours sedentary behaviour and fat and sugar loaded fast foods (Spruijt-
Metz, 2011).   
Four recent reviews on interventions to treat childhood and adolescent obesity (Ho et al., 
2012, Oude Luttikhuis et al., 2009, McGovern et al., 2008, Atlantis et al., 2006) had 
reviewed very diverse studies comprehensively (Table 1.2). Ho et al (2012) performed a 
systematic review and meta-analysis on the effectiveness of lifestyle interventions (dietary 
and physical activity modifications) on weight change (BMI or BMI Z score) in children 
and adolescents ≤ 18 years of age. Other outcomes included lipid profile, serum insulin and 
blood pressure. A total of 33 studies included, mostly from the USA, and the rest were 
from Australia, Israel, Germany, the UK, Belgium, China, Finland, Iran, Korea, Mexico, 
Taiwan and Tunisia. Ho and colleagues concluded that lifestyle interventions had direct 
effect on weight loss, improvement in the lipid profile, fasting insulin and blood pressure 
as compared to no treatment control. However, more research is needed to determine the 
optimal duration, frequency and long term benefits of lifestyle intervention in the treatment 
of paediatric obesity (Ho et al., 2012).  
The 2009 Cochrane review of interventions to treat obesity in children and adolescents 
showed that family-based programmes achieve the best results in relation to weight 
reduction, as mentioned above (Oude Luttikhuis et al., 2009).  
McGovern et al. (2008) reviewed 61 trials that were designed for treating childhood and 
adolescent obesity non-surgically including pharmacological trials, dietary interventions, 
physical activity interventions and combination of dietary and physical activity 
modifications. The efficacies of these interventions were short-term with no or limited 
subsequent follow up; however, non-significant trends favoured combined lifestyle 
interventions with parental involvement.  
Atlantis and colleagues (2006) studied the effects of 14 exercise trials in the treatment of 
childhood and adolescent obesity. They recommended between 155 to 180 mins/week of 
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moderate to vigorous aerobic exercise to reduce adiposity in obese children and 
adolescents.  
All four reviews call for future larger scale trials with long-term follow up and broader 
health and psychosocial benefits.  
However, data on the effectiveness of comprehensive weight management programmes for 
the treatment of adolescent obesity are limited (Danielsson et al., 2012), Community and 
school programmes often have dual goals of prevention and treatment, so the data are 
difficult to evaluate (Zitsman et al., 2014, Brei and Mudd, 2013).   
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The expert committee on the treatment of overweight and obesity in children and 
adolescents from the USA (Barlow, 2007) suggests one possible scenario with four-staged 
approach, depending on the severity of the condition and the willingness of the family to 
commit. The first stage called prevention-plus where the health professional, at primary 
care level, analyse the eating and lifestyle habit and offer healthy eating habit and to 
increase the level of physical activity of the individual while reducing sedentary behaviour. 
The second stage could be started first if obesity was severe or was associated with co-
morbid conditions. It is a structured weight management plan that could involve more than 
one heath professional usually a dietician and physical therapist, with hospital OPD 
referral to a qualified physician.   
The third stage is a comprehensive multidisciplinary intervention approach with more 
frequent hospital OPD visits and intensive monitoring for behavioural change and 
setbacks. The multidisciplinary team include a qualified physician, a dietician, a physical 
therapist, and a psychologist. Hospital appointments are frequent to ensure better 
compliance and health improvement.  
The last stage is a tertiary care intervention and should not be started unless the patient had 
failed in the third stage and it only concerns those with morbid obesity and associated co-
morbid conditions because it involves the use of medications and/or surgery and/or 
hospital admission. 
 
1.7.6 Dietary component 
There is no straight forward guideline as to what dietary regimen works best in children 
and adolescents to treat obesity (Spruijt-Metz, 2011). The aim is to replace energy-dense 
foods of low nutritious value with low-energy foods with high nutritious value (Steinbeck, 
2005). The dietary interventions that have been reported in recent reviews include low-
glycaemic index diets, protein-sparing modified diets, low-carbohydrate diet, high-protein 
diet and hypocaloric diets (McGovern et al., 2008).  
The Epstein group from the USA reports the majority of studies and are the most 
frequently cited in the literature (Epstein et al., 2012, Epstein et al., 2001, Epstein, 1996, 
Epstein et al., 1995a, Epstein et al., 1985). Their interventions are resource intensive and 
characterised by long-term follow-up, include a traffic light diet scheme, increase in 
physical activity and decrease in sedentary behaviour, and usually involve a family 
member (Epstein, 1996). Stewart and colleagues (2005) simplified the traffic light scheme 
developed by Epstein et al (1985) and this was used in the Scottish Childhood Obesity 
Treatment Trial (SCOTT) in 2008 (Hughes et al., 2008, Stewart et al., 2005, Epstein et al., 
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1985). This modified version of the traffic light diet used basic divisions of foods into 3 
categories without residing to the concept of calorie counting, therefore, the concept 
seemed simpler and easier to follow by parents and their children. Figure 1.4 displays the 
food categories of the modified traffic light diet where “red” refers to bad foods namely 
energy-dense high fat high sugar foods, “green” refers to good foods namely fruits and 
vegetables and “amber” is for foods restricted to meal times.  
 
 
Figure 1. 3 Summary of the traffic light diet. Source Stewart et al., 2005. 
 
1.7.7 Physical activity and sedentary behaviour  
Increasing physical activity deals with the “energy out” part of the energy equations for 
weight balance. Hence, lifestyle interventions that incorporate increase in physical activity 
level as well as healthier dietary modifications reach far better results than interventions that 
focus on physical activity or diet alone (Oude Luttikhuis et al., 2009). On the other hand, 
although it may not have a dramatic impact on weight reduction, increasing physical activity 
alone will reduce obesity-related co-morbidities (O'Donovan et al., 2010, Ortega et al., 2008). 
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There is a general consensus that physical activity should be increased to 60 minutes per day 
of moderate to vigorous intensity activity and to decrease sedentary behaviour, often referred 
to as screen time, to less than 120 minutes per day (Health, 2011, O'Donovan et al., 2010, 
SIGN, 2010, Barlow, 2007, NICE, 2013).  
Evidence also suggests that decreasing sedentary time is associated with decreased physical 
and psychological health risks and could lead to reduction in weight (Tremblay et al., 2011, 
Salmon et al., 2011). 
  
1.7.8 Behavioural modification 
The treatment of obesity requires lifestyle change, and this is done through change in 
behaviour, i.e. replacing obesity-enhancing sedentary and unhealthy dietary behaviours with 
health promoting behaviour. Robinson’s review on behavioural treatment of childhood and 
adolescent obesity (Robinson, 1999) describes several components of behaviour change 
approach for the treatment that includes: 
 
• Self-monitoring. 
This includes monitoring body weight, behaviour related to eating and physical 
activity, which in turn enhances self-awareness and control (Stewart et al., 2009, 
Robinson, 1999). 
 
• Goal setting and contractual agreement, with rewards for reaching goals. 
Choosing an appropriate goal is determined by the child or adolescent in parallel with 
his or her ability to commit. The goal should be small, measurable, attainable, 
recorded and timed (Robinson, 1999). In line with this plan, a contract should be 
signed between the caregiver and the child or adolescent regarding this chosen goal, 
and if it is achieved within the time frame that was agreed upon, then a reward should 
be presented to the “winner” and that should not involve food or money. The reward 
technique represents a positive reinforcement method for the achievement and 
maintenance of goals (Stewart et al., 2009, Robinson, 1999). 
 
• Skills to deal with high risk situations and relapses. 
There are a number of situations where commitment to goals could prove to be very 
difficult and requires skills in order to prevent relapse. These include parties, holidays, 
eating out and others (Stewart et al., 2009, Robinson, 1999)  
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• Stimulus control 
This involves controlling stimuli that can bring about the unhealthy behaviour. 
Establishing new routines that promote healthy eating and physical activity should 
replace old routines that promote unhealthy eating and sedentary behaviour (Stewart et 
al., 2009, Robinson, 1999). 
 
Parental involvement with positive impact on the behavioural change approach is an 
important management aspect in all international guidelines (SIGN, 2010, Barlow, 2007, 
NICE, 2013). In fact, targeting parents as the agents of change in a weight management 
programme  by Golan et al (1998) had a greater positive effect on the weight change of their 
primary school aged children than did the control who received group intervention. In this age 
group particularly, having a parent-only approach overcome the possibility of causing anxiety 
and stigmatisation to the child as a result of their weight management plan (Golan et al., 
1998b). 
 
1.7.9 More intensive treatment options 
Morbidly obese adults are usually offered more intensive treatment options which would 
include pharmacotherapy, surgery or very low-energy diets (VLEDs). Some of these 
treatments have been recommended recently for morbidly obese adolescents (SIGN, 2010, 
NICE, 2013).  
 
1.7.9.1 Pharmacotherapy 
It is always recommended to start drug therapy in conjunction with dietary, lifestyle and 
behavioural modification (SIGN, 2010, NICE, 2013).  
 
Orlistat (Genentech USA) is a reversible gastric and pancreatic lipase inhibitor that limits the 
gastrointestinal absorption of dietary cholesterols by about 30% (FDA, 2010b). It also causes 
a reduction in plasma fat-soluble vitamins hence concomitant administration of multivitamin 
supplement is recommended (FDA, 2010b). Orlistat should be part of low fat diet in order to 
have the desired caloric deficit to cause weight reduction. A number of studies have shown 
that orlistat can be effective in the treatment of adolescent obesity with significant decrease of 
BMI from baseline ranging from 0.5 to 4.1 kg/m² (Matson and Fallon, 2012). It is currently 
approved in USA for use in children > 12 years of age.  
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Sibutramine was formerly considered as a potential agent for weight management in morbidly 
obese adolescents through its satiety and thermogenic effects (Reisler et al., 2006, Godoy-
Matos et al., 2005). However, in 2008 the FDA recommended that Abbott Laboratories 
withdraw Sibutramine from the market in light of the increased risk of adverse cardiovascular 
events that accompanied the sirbutamine Cardiovascular Outcome (SCOUT) trial (James et 
al., 2010, FDA, 2010a).  
 
Metformin is an oral hypoglycaemic agent. Its use for weight management in children and 
adolescent has limited evidence from the literature (Matson and Fallon, 2012). However, it 
would be the first drug of choice for obese adolescents with type 2 diabetes, or the risk of type 
2 diabetes , or with polycystic ovarian syndrome or even to reduce the weight gaining effect 
of psychotropic medication (Matson and Fallon, 2012). For adolescents, the use of metformin 
as adjuvant therapy with lifestyle modification has been recommended for its associated 
improvement in weight status and insulin sensitivity (Kendall et al., 2014). 
 
1.7.9.2 Surgery 
The NICE (2006) obesity management guidelines recommended bariatric surgery in children 
and adolescents only in exceptional circumstances with full psychological pre-operative 
evaluation and only if the candidate was close to physiological maturity (NICE, 2013). 
Moreover, the International Pediatric Endosurgery Group has published guidelines for pre-, 
intra- and post-operative surgical management of adolescent obesity (IPEG, 2003). They 
recommend preoperative education on the post-operative nutritional and exercise programmes 
that the patient should follow to maximize long-term success, as well as a life-long medical 
supervision with a team that includes the surgeon, a dietician, a psychologist and exercise 
therapist. A number of case series have been reported on bariatric surgery for adolescent 
obesity utilizing gastric bypass, vertical-banded gastroplasty and laparoscopic banding (Inge 
et al., 2004). A recent review and meta-analysis by Black and colleagues (2013) selected 
studies done on children and adolescents from 1955 to 2013 and showed that the 23 studies 
included in the meta-analysis had inconclusive reports on post-operative complications, 
however, BMI reduction after 1 year post surgery was significant (Black et al., 2013). 
Improvement in metabolic and psychological outcomes was also significant. As the current 
NICE guidelines provide general suggestions for the medical care plan, Black and colleagues 
urges the need for more specific, patient tailored plan with the appropriate choice of the 
surgical method according to physiological and psychological maturity of the patient.      
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1.7.9.3 Very Low Energy Diets (VLEDs) 
Being liquid meal replacement or a protein-sparing modified fast (PSMF), VLEDs have been 
used in the treatment of adolescent obesity (Stallings et al., 1988, Brown et al., 1983). In 
PSMF, protein is the major component with 1.5 and 2.5 g/kg BW/day with the addition of 
vitamins and minerals, vegetables and water. Minimal carbohydrates may be added to avoid 
the possible negative nitrogen balance. The National Health and Medical Research Council 
for Australia (2003) advised that VLEDs be restricted to use in adolescents with significant 
morbid obesity (NHMRC, 2003).  
 
1.7.10 Group versus individual treatment for childhood and adolescent obesity 
One can argue that group therapy can be more efficient and less expensive to administer, as 
well as fostering more beneficial interactions between group members. Unfortunately, there is 
not much data directly comparing the results of group versus individual therapy. One RCT by 
Kalavainen et al. (2007) examined the effect of group based treatment for childhood obesity 
compared to the effects observed from receiving routine individual counseling. They recruited 
seventy 7 to 9 year old children, 35 of which received the routine treatment and the other 35 
received the group treatment. The group treatment was composed of 15 sessions held 
separately for parents and children. Each session was given a special theme and carried health 
promotion messages related to diet, physical activity and behaviour modification techniques. 
One limitation to this study was the duration of the intervention, as the sessions extended for a 
period of 3 months and follow up only occurred after 6 months from baseline. The drop-out 
rate was low (n=2). The most important finding was that there was a significant drop in 
weight for height, BMI and BMI Z score in the intervention group compared to the control 
group (Kalavainen et al., 2007). Joined with this optimism is another high quality RCT by 
Savoye and colleagues (2007) which examined the effects of a group-based weight 
management programme (Bright Bodies) on weight, BMI and insulin resistance. The results 
for the intervention group were superior to the control group who received traditional weight 
management counselling. Their intervention was based on group therapy delivering exercise, 
nutrition and behaviour modification techniques. At 12 months follow up, these results 
persisted although drop-out rate was high (29%). There is still however an unanswered 
question in group therapy sessions which is related to an important and marked psychosocial 
morbidity associated with childhood and adolescence obesity which is whether group therapy 
programmes alleviate some of these morbidities by improving and developing the social skills 
among individuals in the group (Savoye et al., 2007). 
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In summary, treatment of paediatric obesity is important. The management plan involves 
lifestyle modification with dietary and physical activity interventions and should involve 
behavioural modification techniques. It probably requires some participation of the entire 
family. More intensive measures could be required in the case of severe obesity with co-
morbid conditions. More research is still needed to establish a general protocol for the 
management of paediatric obesity and more training is required to update health professionals 
on the latest advances and guidelines for the treatment of paediatric obesity.    
 
1.8 Kuwait in context 
Kuwait is a small Middle Eastern country located at the North Western tip of the Arabian 
Gulf. It shares borders with Iraq on the North and West, Saudi Arabia on the South and West 
and the Arabian Gulf on the East. Its land of 17,818 km² consists mainly of parched desert, 
and over 90% of the country’s population lives within the 500 km² area surrounding Kuwait 
City and its harbour (MOI, 2009). 
The climate is extremely hot during the summer which extends from April to September, with 
temperatures exceeding 50°C during the day. The months of August and September 
experience moderate humidity. The highest temperature in January, the coldest month in the 
year, is typically 13.5°C. Annual rainfall is usually less than 160 mm per year, mostly falling 
in the winter season (FAO, 2008). 
Administratively, Kuwait is divided into six governorates; Al Ahmadi, Al Farwania, Capital, 
Al Jahra, Hawalli and Mubarak Al Kabeer. 
Kuwait’s economy is dominated by the oil industry and its revenues. It has limited fresh water 
resources, thus desalination facilities provide most of the water for human consumption. 
Agriculture is limited by the lack of water and arable land. Aquatic resources, fish and 
crustaceans are plentiful in the Gulf. 
 
1.8.1 Population: 
On 31st December 2008 the population of Kuwait was 3,441,813, of which 32% were 
Kuwaiti nationals. Among the non-Kuwaiti population, 28% are Arabs, 65% are non-Arabs 
(mainly Asians) and 7% are stateless. The ratio of males to females among the total 
population was 1.5: 1 due to the large proportion of single men among the immigrant work 
force in the country (Table 1.3) (PACI, 2008). 
The Kuwaiti population is a young population with approximately 40% below 20 years of 
age. The crude birth rate of Kuwaitis is high. Of note, Kuwait is an urban country with almost 
90% of the population living in urban areas (MOP, 2007). 
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1.8.2 Economy 
Kuwait is a small, rich, relatively open economy with 10% of the world reserves of crude oil. 
Petroleum accounts for nearly half of Gross domestic product (GDP), approximately 95% of 
export revenue and 80% of the government income. In 2005, GDP was 53.31 billion, giving 
Kuwait a pre-capita GDP of $22,800. The main imported items are food products, 
construction materials, vehicles and clothing (MOP, 2007). 
Industry in Kuwait consists of several export-oriented petrochemical units, oil refineries, 
ammonia, fertilizers and cement. The labour force in Kuwait is about 2.2 million people, 1.87 
million of which are non-Kuwaitis. Unemployment is relatively low compared with other 
Arab countries (MOP, 2007). There is no socioeconomic status hierarchy in Kuwait, which is 
a factor that is inversely related to the development of obesity (Coombs et al., 2013, Arauz 
Boudreau et al., 2013). Therefore, the development of obesity treatment intervention could 
potentially be affected by the lack of SES system where adherence to the intervention could 
be varied between participants as a result.   
 
1.8.3 Education 
Education is free and compulsory for all Kuwaitis until the age of 15 years. The system offers 
a number of different pathways to cater the varied needs of young people. From 2004-05 
onwards, General education begins with Kindergarten (2 grades), progresses through Primary 
school (4 grades), Intermediate school (4 grades), and Secondary school (3grades); prior to 
2004-05 each Primary, intermediate and secondary levels included 4 grades. The education 
system in Kuwait can be categorized between general education, vocational education, and 
other programmes of education. School canteens are present in all the government and private 
schools and are controlled by high committee and representatives from Ministries of 
Education, Health and Municipality. These bodies monitor the standards of foods sold and 
distributed yearly; however, what is allowed does not always represent healthy choices in 
terms of nutritious value (MOE, 2007).  
 
1.8.4 Childhood obesity treatment initiatives in Kuwait 
Although obesity screening and surveillance programmes have been taking place since the 
1980’s at local and international levels as previously mentioned, with complete understanding 
of the growing problem of paediatric obesity, there has been no standard childhood obesity 
treatment manual or policy available in Kuwait to date. Furthermore, no clinical trials which 
attempted to treat paediatric obesity in Kuwait: it remains low priority in the public health 
agenda. The available regulations however encompass reception of motivated patients, of 
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varying age range, to the nutrition clinic in the Food and Nutrition Administration, taking the 
weight and height and using adult WHO cut off points for diagnosing obesity, taking a 24 
hour food recall to estimate energy intake, and then finally using a set of 1200 kcal menus for 
each patient as a dietary plan. Furthermore, since the establishment of nutrition clinic in 1976, 
there has been no record of any audit carried out to evaluate the level of efficacy of the clinic. 
The filing system is collapsing with many patients having more than on file under their 
names, which adds more deficiencies for attempts of patients’ follow up.  Paediatric obesity 
epidemic in Kuwait has economic, educational, political and research dimensions which 
necessitate urgent detection and correction in order to avoid profound public health 
consequences. 
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Table 1.3 Population indicators  
Indicator Estimate Unit Reference period Source 
Kuwaitis  Non-Kuwaitis     
Total population 1.1 2.5 million 2008 PACI 
Annual population growth rate 2.7 3.8 % 2005 MOP 
Crude Birth rate 33.9 15.1 % 2006 MOP 
Population distribution by age: 2008 MOP 
0-4 years 4 3 % 
5-14 years 7 5 % 
15-24 years 6 8 % 
25-59 years 11 50 % 
60+ years 1.5 1.5 % 
Population density 130.5 per Km² 2003 MOP 
Median age 30 years 2005 UNPD 
Life expectancy at birth 78 n.a. years 2003 MOP 
n.a. : not available, Sources: Public Authority for Civil Information 2008 (PACI); Ministry of Planning, Central Statistical Office 2003, 2005, 2006 and 2008; and
 
United Nations Population Development report 2005.
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1.9 Thesis aims and research hypothesis 
Choosing a treatment method for any disease in the population should firstly undergo the trial 
stage to assess its feasibility, efficacy for the short and long term, and whether or not this 
method is socially, culturally and gender appropriate. The available paediatric obesity 
treatment guidelines differ greatly between countries depending on the local health services 
structure, the available resources, culture and behaviours of the population. In the scope 
highlighted by the consensus from systematic reviews and guidelines, obesity treatment 
should aim at the entire family with the objective of changing dietary and physical activity 
and sedentary behaviour through resorting to intensive  behavioural change and motivational 
techniques (NICE, 2013, SIGN, 2010, Oude Luttikhuis et al., 2009, McGovern et al., 2008). 
However, the style of delivering such treatment differs greatly in the literature and this could 
be divided into individual outpatient care or group-based programmes (de Mello et al., 2004). 
Medical literature reports only few studies on the treatment of paediatric obesity in group 
discussion fashion without the prescription of a diet and the results had been promising 
(Watson-Jarvis et al., 2011, Golan et al., 1998a, Braet et al., 1997b, Epstein et al., 1995b).  
 
At baseline, at the recruitment stage we analysed the Health Related Quality of Life (HRQL) 
in a group of obese Kuwaiti adolescents and compared the results with healthy-weight peers 
(chapter 4). This was done using the Peds QL™ 4.0 generic questionnaire (Varni et al., 2001). 
It is now well established, from systematic review and meta-analysis, that obesity has a 
deleterious effect on the HRQL of children and adolescents from western societies (Ul-Haq et 
al., 2012, Griffiths et al., 2010).  There is much less evidence on the extent to which obesity 
might impair HRQL in adolescents from other parts of the world: some degree of obesity-
associated impairment of HRQL has emerged from studies of children or adolescents in 
Malaysia, Taiwan, and Lebanon (Lin et al., 2013, Lin et al., 2012, Hamzaid et al., 2011, 
Fazah et al., 2010). The primary purpose of the HRQL study was therefore to test the 
hypothesis that obesity is associated with impaired HRQL in Kuwaiti adolescents, as in 
western societies. A secondary aim was to test whether HRQL differed between self-reports 
and parent-proxy reports for the obese adolescents.  
 
Chapter 5 describes the study on the prevalence of cardiometabolic risk factors in a sample of 
obese Kuwaiti adolescents (aged 10 to 14). We carried out assessments of obesity-related 
cardiometabolic risk factors that could impair vascular health and liver function. These 
included lipid profile (Cholesterol, LDL, VLDL, HDL, TG), IL-6, ICAM, CRP, adiponectin, 
liver function tests (ALT, AST, gGT) and insulin resistance by homeostasis model assessment 
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(HOMA-IR). The purpose of the study was to determine the prevalence of cardiometabolic 
risk factors and metabolic syndrome in a sample of obese Kuwaiti adolescents, as prevalence 
data might be helpful in improving engagement with obesity treatment in future.  
 
Chapter 6 examines the feasibility of conducting a group therapy model in treating adolescent 
obesity in Kuwait (chapter 6). The National Adolescent Treatment Trial for Obesity (NATTO 
www.controlled-trials.com/ISRCTN37457227, Dec 1st 2009) is an RCT set out to compare a 
family-based behavioural treatment of paediatric obesity delivered in group discussion 
fashion with a primary care control.    
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2. General Methods 
 
2.1 Introduction 
This chapter outlines the design and methodology for chapters 4, 5 and 6. The National 
Adolescent Treatment Trial for Obesity (NATTO) intervention study (chapter 6) examined 
the feasibility and efficacy of family based behavioural treatment intervention for obese 
adolescents (intervention group) in Kuwait relative to a standard care (primary care control 
group, see chapter 1). NATTO was a single blinded randomised controlled trial aimed at 
adolescents aged 10 to 14 years. The methods and the treatment manual were based largely 
on systematic reviews, evidence-based guidelines and the Scotish Childhood Obesity 
Treatment Trial (SCOTT) (NICE, 2013, Hughes et al., 2008, Oude Luttikhuis et al., 2009, 
SIGN, 2010) (chapter 1). A full description of the treatment intervention and primary care 
control is described in chapter three. The intervention was delivered over a period of six 
months and the outcome measures were taken at baseline and six months. The trial used an 
intention to treat analysis and followed the CONSORT statement on the conduct and 
reporting of  RCT (Boutron et al., 2008).   
 
The research team wanted to answer the research question of whether a family based 
behavioural treatment programme for obese adolescents in Kuwait would be feasible and 
effective to treat obesity compared to primary care. The study’s primary outcome was 
change in BMI Z score at 6 months. The study also aimed to investigate a number of 
secondary outcomes namely change in body fat, waist circumference and blood pressure. 
Beside these secondary outcomes, NATTO had two other outcomes for which only 
baseline assessments could be obtained (see chapter 7). These two outcomes were heallth 
related quality of life (chapter 4) and cardiometabolic risk factors (chapter 5). Therefore, 
these two studies are considered as separate studies and their  methodologies are also 
described. 
 
2.2 Health related quality of life study 
The first phase of our research in Kuwait was to evaluate the association between health 
related quality of life (HRQL) and obesity in Kuwaiti adolescents aged 10 to 14 years. We 
wanted to test the hypothesis that with increasing body mass index (BMI), HRQL 
decreases. We compared HRQL of obese Kuwaiti adolescents with HRQL of healthy 
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weight Kuwaiti adolescents matched for age and sex. We also compared self-report HRQL  
of obese adolescents to their parent-proxy report. 
 
2.2.1 Measurement of HRQL 
The Pediatric Quality of Life Inventory (PedsQL ™ 4.0, MAPI Research Institute, Lyon, 
France) was used in the present study, with the Arabic Generic Version. The PedsQLTM is 
a generic HRQL questionnaire that has both self- and parent-proxy report forms (Varni et 
al., 2003). The forms are available in age-appropriate versions (5-7 years, 8-12 years and 
13-18 years), and we used the version appropriate to the age of each study participant in 
the present study. The PedsQL ™ 4.0 is well-established, has been used most commonly in 
studies of child and adolescent obesity (Ul-Haq et al., 2012), and is a valid and reliable tool 
which is responsive to clinical change over time (Palermo et al., 2008, Varni et al., 2003). 
The Arabic Generic version of the PedsQLTM used in the present study is valid and 
reliable, e.g. with internal consistency for the different scales of 0.88-0.92 (Arabiat et al., 
2011). The PedsQLTM measures a multidimensional construct that includes 23 items 
consisting of physical, emotional, social and school performance domains from which a 
total score, psychosocial score (composite of the emotional function, social function, and 
school function domains), and physical score  are derived. Items are linearly transformed 
to a 0 to 100 scale, so that the higher the score, the better the HRQL. 
 
2.2.2 Study participants 
The sample was recruited from public (state) schools in Kuwait city, the capital of Kuwait. 
The original intention was to recruit adolescents from a random sample of public schools, 
but this proved not to be possible due to limited consent to participate from school 
headteachers. The Ministry of Education granted approval to the research team to invite all 
80 intermediate schools in Kuwait City to participate in the study. Kuwait City has 41 male 
public intermediate schools and 39 female public intermediate schools. Only 10/80 
intermediate school headteachers responded, from 3 girls schools and 7 boys schools, and 
of these 10, permission to conduct the study at school was granted by only three schools; 
two male and one female school. Participants and their families provided informed written 
consent. The PedsQL™4.0 Arabic version was completed independently by the 
adolescents at school and by their parents at home. The study was approved by the Medical 
Research Committee of the Ministry of Health and the Ethical Committee of the Ministry 
of Education in Kuwait. 
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Study participants were included if within the eligible age range (within grades 5-9, the 
grade range for intermediate schools, age 10 to 14y), and were either obese or healthy 
weight as defined below. Overweight pupils were excluded from the study sample in order 
to provide a marked contrast in weight status between the two groups of interest, and to 
minimize the impact of any mis-classification arising from use of the body mass index. 
Other exclusions were based on a brief medical history/checklist aimed at including only 
apparently healthy adolescents, and excluding participants with serious chronic or acute 
illness which might affect their HRQL. 
 
2.2.3 Assessment of weight status and formation of obese-healthy weight matched 
pairs 
A pre-planned paired analysis of HRQL between obese and healthy weight participants, 
with pair matching for same sex, same school, same school year, and same ethnic group 
(all participants were Kuwaiti nationals) yielded 98 pairs with 57 paired comparisons in 
boys and 41 paired comparisons in girls. More details in chapter 4. 
 
2.2.4 Statistical analysis 
All statistical analyses were performed using Minitab 16.0. Data were checked for 
normality. A full description of the study statistical analysis is given in chapter 4. 
 
2.3 Cardiometabolic risk factors study 
The main original intention of this present study was to measure cardiometabolic risk 
factors before and after initiation of a family-based obesity treatment intervention 
(NATTO) and to see if the treatment intervention had any positive impact on the measured 
cardiometabolic risk factors as clinical outcome. This original plan had to be altered and 
only baseline measures were taken (see chapter 7). The ethical approval for the thesis 
studies stated very clearly that permission was granted for baseline and end of trial blood 
collection. The head of the Laboratory Department at the Ministry of Health-Kuwait 
refused to grant the author permission to collect blood samples at 6 months (end of 
intervention) with the given reason that collection at that stage would require a new ethical 
approval from the Medical Research Committee-Ministry of Health-Kuwait, and the study 
supervisor (Professor John Reilly) would have to appeal directly to the head of the 
Laboratory Department in order to be granted permission to collect end of intervention 
blood samples. 
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In this study we carried out assessments of obesity-related cardiometabolic risk factors that 
could impair vascular health and liver function in obese adolescents. These included lipid 
profile (Cholesterol, LDL, VLDL, HDL, TG), IL-6, ICAM, CRP, adiponectin, liver 
function tests (ALT, AST, gGT) and insulin resistance (described in detail in the next 
section). To date, there are no published studies on the prevalence of these risk factors 
among Kuwaiti adolescents. The main aim of the study was to establish the prevalence of 
cardiometabolic risk factors in obese Kuwaiti adolescents, in order to establish whether 
such measures might be useful to encourage greater engagement with obesity treatment in 
future adolescent obesity treatment trials in Kuwait (chapter 5). 
 
2.3.1 Study participants 
Participants in the study were invited from among participants in the NATTO study 
(n=82). Eighty participants aged 10 to 14 years (40 males) consented and underwent a 
baseline clinical examination in 2009 and were diagnosed with obesity (BMI ≥ 95th 
percentile for age and sex according to US CDC reference data). The participants had no 
other morbidities and were willing to provide blood samples for the current study. 
Participants and their parents signed an informed consent form. The study was approved by 
the Ethics Committee for Medical Research-Ministry of Health-Kuwait.  
 
2.3.2 Blood sample collection and analysis 
Participants underwent clinical examination including anthropometric assessment by the 
author. Blood sample collection was carried out by the author and it took place at 8 am in 
the outpatient clinic after an overnight fast (8-12 hours). Blood sample analysis was carried 
out by Dr Lynne Cherry of the Metabolic Medicine Group of the Cardiovascular and 
Medical Sciences division based at the BHF-GCRC Building at University of Glasgow. A 
full description of the study methodology is given in chapter 5. 
 
2.4 The National Adolescent Treatment Trial for Obesity 
The National Adolescent Treatment Trial for Obesity is an RCT set out to compare a 
family-based behavioural treatment of paediatric obesity delivered in group discussion 
fashion with a primary care control.    
 
2.4.1 Ethical approval 
NATTO study was granted ethical approval by the Ethics Committee for Medical 
Research-Ministry of Health-Kuwait. The research team in Kuwait consisted of a physician 
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(the author), a dietician, two assistant dieticians, and a waitress. All procedures were 
supervised by Professor John Reilly in Glasgow.  
 
2.4.2 Study design 
The trial was registered, conducted and reported in accordance with CONSORT guidelines 
(RCT Registered as National Adolescent Treatment Trial for Obesity in Kuwait (NATTO): 
www.controlled-trials.com/ISRCTN37457227, Dec 1st 2009) (Boutron et al., 2008).       
 
2.4.3 Power calculation 
No local data were available upon which to base a power calculation. The present study 
was therefore powered using BMI data from the Scottish SCOTT RCT (Hughes et al., 
2008) which was used to develop the treatment intervention. NATTO treatment manual in 
essence was based on SCOTT treatment manual, with some modifications made to 
accommodate for group sessions.   
Professor J H McColl (University of Glasgow-Department of Statistics) confirmed that 
with a between-group difference in the change in BMI Z-score of -0.25 at six months 
(which is a small change in BMI Z score) and a SD of change in BMI Z score of 0.21, 
giving a delta of 1.15, a sample size of around 30 adolescents per arm at 6 months would 
give 90% power at the 0.05 significance level. Dropout from the trial could not be 
predicted, but it was hoped that entering around 90 adolescents would make sufficient 
allowance for attrition during the 6-month study to leave around 30 participants per arm at 
the end of the trial. Of note, the MASCOT study which was and adaptation of SCOTT in 
Malaysia and was conducted at the same time of NATTO study in Kuwait, had a drop out 
rate of 26% at six months. 
 
2.4.4 Delivery of treatment 
The author and dietician delivered the treatment programme (chapter 3) to the intervention 
group. The sessions were carried out in the lecture theatre of Al Faiha polyclinic situated in 
Al Faiha area in the capital of Kuwait. The standard care was supposed to be delivered by 
the dieticians in the Central Nutrition Clinic of the Food and Nutrition Administration 
(FNA), Al Sabah Hospital in the capital, which was considered a primary care level for the 
treatment of obesity. Care was taken to avoid contamination between the two treatment 
groups. Both the author and dietician worked solely with the intervention group and did 
not attend the FNA at any stage during the conduct of the trial. The author and dietician 
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were also aware of the importance of not discussing any aspect of the intervention 
programme with the standard care dieticians.   
The schools and residences of all participants were located in the capital, and both the 
venue for the intervention (Al Faiha polyclinic) and the venue for the control primary care 
clinic were also in the capital, just to ensure that distance was not an issue hindering 
attendance 
 
2.4.4.1 Intervention  
The intervention was originally intended as a relatively moderate intensity (12 sessions 
biweekly with 12 hours contact time, delivered in group discussion fashion) programme, 
delivered over 6 months period largely by the author who led every session (more details 
in chapter 3). However, attendance at the second and third sessions was poor and 
modification to the sessions’ scheduling had to be made to ensure better attendance, 
therefore, the intervention was altered to low intensity programme by having one session 
every month for 6 months. 
There were 2 groups, one for girls and one for boys, each consisting of the parents (at least 
one parent) and their adolescents. 
The primary aim of the intervention was modification of lifestyle which would slightly 
reduce BMI Z score (Danielsson et al., 2012, Weigel et al., 2008).  
 
2.4.4.2 Control 
The control group agreed to seek the available standard care from the Food and Nutrition 
Administration clinic and was given the clinic phone numbers to arrange for appointments. 
This was considered a primary care level for the treatment of paediatric obesity in Kuwait. 
It is based on clinical assessment by the clinic physician, then  a referral to the clinic 
dietician where the patient would be given a set menu of 1200 Kcal diet and an 
appointment in two weeks for follow up. None of the families attended primary care 
(chapter 6). 
 
2.4.5 Inclusion and exclusion criteria 
The study enrolled adolescents of intermediate school age, 10 to 14 years old, who were 
clinically obese as defined by the US CDC 2000 definition of BMI  ≥ 95centile 
(Kuczmarski et al., 2000) and whose parents were willing to participate in the study. 
Diagnosing obesity was based on BMI CDC reference data and cut off points in the current 
thesis as the local reference data were proved to be rather inaccurate (El-Ghaziri et al., 
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2011). Moreover, BMI as an index of obesity correlates well with body fatness, morbidity 
and mortality (Cole et al., 2005).  
 At least one parent was required to attend the treatment sessions. Adolescents were 
eligible for inclusion if they satisfied the inclusion criteria; 
• Aged between 10 to 14 years old. 
• Had BMI ≥95th centile (US CDC reference). 
• Had no obvious underlying medical cause of obesity. 
• Had no serious co-morbid conditions requiring medical or surgical 
attention. 
• Were attending main stream schools (public schools). 
• Had not received any weight loss management in the past 12 months. 
• Were of Kuwaiti nationality. 
 
Participants were excluded if they: 
• Were diagnosed with obesity as part of a medical condition or due to 
drug therapy. 
• Had serious medical or surgical co-morbidities. 
• Were receiving weight management therapy.  
• Were not Kuwaiti nationals. 
 
2.4.6 Recruitment 
The recruitment process took place from September until November 2009. A list of public 
intermediate schools in the capital of Kuwait was obtained from the Ministry of Health, 
updated for the year 2009. There were a total of 41 male and 39 female public schools in 
the capital of Kuwait. The author made phone calls to these 80 schools explaining the 
nature of research and the likelihood of their participation after random selection. Only 10 
schools agreed to grant the research team access to their premises. The research team 
consisting of the author and the two assistant dieticians visited these 10 schools and only 3 
(2 male and 1 female schools) were willing to take part in the study. Therefore random 
school sampling as intended originally was not possible under the circumstances.  
The first phase of the study was in the form of BMI screening to identify for eligibility;  
obese, overweight and healthy weight adolescents (aged 10 to 14 years old).  
Screening started by the assistant dieticians visiting every classroom from grade 5 to grade 
9 in every school, taking the weight and height measurements as described in section 
2.2.11 Outcome measures, and assessing students for eligibility using a check list present 
in all forms used for recording the results (appendix1). Potentially suitable subjects’ 
measurements were plotted by the author using age appropriate gender specific BMI charts 
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(Kuczmarski et al., 2000). Participants were categorised into healthy weight (BMI ≥5rd 
centile and ˂85th centile of US CDC reference population), obese (BMI ≥95th centile of US 
CDC reference population) and ineligible group (where overweight was defined as BMI 
≥85th centile and ˂95th centile of US CDC reference population, or those who were obese 
but did not fit the inclusion criteria). This yielded 224 potentially eligible obese students 
(142 males or 63%) and 276 healthy weight pupils (176males or 63%). The total number of 
excluded students was 542 which included overweight students (n=536) and 6 obese 
students who did not meet the inclusion criteria. At this stage, all obese and healthy weight 
students were assigned a unique study code  and participated in health related quality of 
life study comparing health related quality of life between obese and healthy weight 
Kuwaiti adolescents (see section 2.3).  
 
2.4.7 Consent 
The entire obese group was given consent forms explaining the nature of the trial in details, 
as directed by the Ethical Committee of the Ministry of Health in Kuwait. Any willing 
family had to sign the consent forms attached to each information sheet (appendix 1), one 
for the participating parent and one for the participating adolescent. Collection of the 
information and consent package was done by the author from the adolescents in the 
schools. We aimed to collect more than 100 consent forms of families agreeing to 
participate in the study; however, we got 91 forms back of families willing to participate, 
44 of adolescent boys and 47 of adolescent girls.   
Each eligible and willing adolescent was invited with at least one parent to come to the 
nutrition clinic where the author carried out a thorough history and clinical examination, 
and baseline measurements were taken including weight, height, and waist circumference. 
At this point, the study was explained in detail to the parent and the adolescent.  
If families were allocated to the intervention group, the author then sent them the 
intervention programme timetable and made phone calls two days prior to each session to 
confirm attendance. In addition, all parents and adolescents were assured that withdrawal 
at any stage of the programme is permissible without any consequences.  
 
2.4.8 Randomisation and concealment 
Prior to random allocation, all obese adolescents were assigned a unique study code at the 
baseline assessment stage (section 2.2.6 Recruitment). The 91 eligible and consented 
adolescents and their parents were invited to the nutrition clinic for full physical 
examination, blood sampling, and basic anthropometric measurements. Nine of the invited 
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families failed to show up for their appointments after repeated rearrangements of their 
appointments. The remaining 82 participating adolescents consisted of 42 boys and 40 
girls. Their study codes were sent electronically to the team’s statistician Professor John 
McColl at University of Glasgow who then produced a computer generated stratified 
randomisation list assigning the participants to either the intervention group (n=41) or to 
the control group (n=41). The list was sent electronically to the author who in turn 
informed the participants of their assignment by phone calls. The study timetable was 
delivered by the author to the adolescents of the intervention group in their schools.  
 
2.4.9 Blinding 
All the baseline anthropometric measurements were taken before group allocation by the 
assistant dieticians. At six months, all anthropometric measurements were taken by the 
same assistant dieticians who were not involved in the delivery of either the intervention or 
the standard care. They work in a different sector of the FNA and hence had no contact 
with the author, the participants or their families throughout the study. 
 
2.4.10 Retention 
Participants’ retention in paediatric weight management studies ranged from 0 to 41% as 
summaised in the most recent Cochrane review (Oude Luttikhuis et al., 2009). Poor 
retention rates have serious implications for the intention to treat analysis and can result in 
the study being underpowered, so every effort was taken to limit attrition. This was done 
by rescheduling of intervention sessions’ date and time to suit the intervention group.  
The treatment intervention was delivered in group discussion fashion, and hence the author 
reminded the parents of their appointments before every session by means of phone calls 
and short messaging services (SMS). Families were expected to attend 12 sessions over 6 
months period (two sessions every month). However, due to poor attendance record after 
the third session, the sessions were condensed to 6 sessions (one session every month) for 
practicality. The author also kept an attendance record for all the sessions.  
 
2.4.11 Outcome measurements 
The primary outcome measure for the study was change in BMI Z score. BMI Z score is 
commonly used in obesity intervention trials as an outcome measure because it is believed 
to be the best measure to assess fat mass change over time (Ford et al., 2010, Hunt et al., 
2007, Cole et al., 2005).  
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Secondary outcome measures consisted of estimated change in body fat, waist 
circumference and blood pressure.   
At Baseline, the author collected blood samples from each eligible subject as part of an 
assessment of cardiometabolic risk factors. The intention was to measure these risk factors 
before and after the intervention (end of trial). However, end of trial assessment of 
cardiometabolic risk factors in obese Kuwaiti adolescents was faced with opposition from 
the head of the laboratory department in the Ministry of Health-Kuwait. Therefore, 
NATTO end of trial outcomes did not include cardiometabolic risk factors profile.   
 
Measurements of height, weight, percentage body fat and waist circumference were taken 
by the team’s two assistant dieticians at baseline (at baseline clinic assessment) and six 
months after the first clinic assessment in the schools. As mentioned, both of the assistant 
dieticians work in a different sector of the FNA, involved in the yearly Kuwait National 
Surveillance System (KNSS)  produced by FNA, hence, the assistant dieticians remained 
blinded to group allocation throughout the study and until after the six-months study data 
were collected.  The team’s assistant dieticians receive yearly training in all the necessary 
measurement techniques from the Food and Nutrition Administration and followed 
standard written protocols for the measurements, as part of their work done in relation to 
the KNSS.  
 
BMI Z score, height, weight, and body fat  
The heights of the subjects were measured using Leicester height measure (Chasmors, 
London, United Kingdom). The subject was measured with socks and shoes removed, 
standing upright and barefoot with feet together in the centre of the base plate. Height (m) 
was measured to the nearest 0.1 cm. 
 
The subject’s weight was measured using Tanita electronic scale model TBF-300 
(Chasmors, London, United Kingdom), with subjects in light clothing without shoes. This 
same machine was used to estimate percentage body fat. Weight (kg) was measured to the 
nearest 0.1 kg.  
 
Bioelectrical impedance is a clinically useful, convenient and relatively cheap method to 
assess body composition, which has become more popular in recent years both in clinical 
settings and research (Hunt et al., 2007, Kyle et al., 2004, Sung et al., 2001). The machine 
measures the resistance (impedance) to a low level electric current travelling through body 
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tissues. Although the estimated body fat produced by the device is specific to the model of 
the BIA used (Kyle et al., 2004), it still provides a useful information on the change in 
percentage body fat over time in response to treatment intervention (Sung et al., 2001).   
 
Values of height and weight were used to calculate BMI (kg/m²) values. BMI Z scores 
were extracted using BMI, decimal age and gender and SAS Programme to calculate z 
score for US CDC (http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm). 
The primary study outcome measure was BMI Z score calculated relative to US CDC 2000 
BMI for age reference data (Kuczmarski et al., 2000). In a study by Al-Isa and Thalib in 
2008 (Al-Isa and Thalib, 2008) to produce a local reference data for BMI of Kuwaiti 
adolescents aged 10 to 14 years, the authors compared local BMI reference percentiles 
with US CDC BMI reference percentiles. The local BMI percentiles cut off points were 
shifted to higher level than that of the US CDC level, possibly due to the high prevalence 
of adolescent obesity in Kuwait that might had contributed to this shift (El-Ghaziri et al., 
2011). Therefore, we decided to use US CDC BMI reference percentiles in NATTO. In 
addition, US CDC BMI cut off point for obesity is strong predictor of cardiometabolic risk 
factors and insulin resistance in young adulthood (Harrington et al., 2013).   
 
Waist circumference  
Waist circumference was measured using a flexible, inelastic tape measure (Supralip® 
160, West-Germany). The waist circumference was measured on the horizontal plane 4 cm 
above the umbilicus with the abdominal muscles relaxed and the subject breathing 
shallowly (Rudolf et al., 2007). Waist circumference is a measure of central fat mass 
(visceral fat) that cotributes to the development of impaired lipid profile, high blood 
pressure and metabolic complications (Haas et al., 2011, Reilly et al., 2010, Hirschler et 
al., 2005, McCarthy et al., 2005). Although not  superior to BMI for the diagnosis of 
obesity (Reilly et al., 2010), we chose to include waist circumference as a secondary 
outcome to be part of the cardiometabolic risk factors (Watts et al., 2008) that were 
supposed to be assessed at baseline and end of trial (section 2.3).    
 
Blood Pressure 
Blood pressure was measured in all participating adolescents during the first clinical 
assessment visit using a desk mercury sphygmomanometer (diplomat-presameter, Reister, 
Germany). The measurement was performed by the author. In daily life, blood pressure 
changes from instant to instant and is influenced by many physiological and environmental 
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factors. The subjects were seated comfortably on a chair for at least 5 minutes prior to 
blood pressure measurement. A set of 2 different size cuffs were present to ensure proper 
selection of the cuff size, ideally covering two thirds of the subject’s upper arm. The blood 
pressure measurement was repeated three time and the average of the three readings was 
recorded (Bird and Michie, 2008, NHBPEP, 2004). Blood pressure is considered one of the 
modifiable cardiovascular risk factors in adults and adolescents (Anyaegbu and 
Dharnidharka, 2014). Obese children and adolescents are more likely to develop 
hypertension than their healthy weight peers (Herouvi et al., 2013). Sometimes with BMI Z 
score reduction of 0.5 improvement in blood pressure profile of obese children and 
adolescents could be reached (Danielsson et al., 2012, Reinehr and Andler, 2004). 
Measuring blood pressure in the present study was intended to be part of the 
cardiometabolic risk factor assessment before and after the intervention. As with waist 
circumference, baseline and end of intervention assessment where obtained but not for the 
blood based other cardiometabolic risk factors.    
 
2.4.12 Data analysis 
Data were analysed using Minitab 16. For the purpose of this thesis, an intention to treat 
analysis was conducted. This refers to the process of analysing data for each subject in the 
groups they were allocated and no subjects were removed from the analyses by the author. 
The analysis used all the available data for each group, regardless of their adherence to the 
protocol, i.e. compliance. If a family failed to attend 50% of the sessions, they were 
considered to be non-completers of treatment. All subjects were analysed within the groups 
to which they were randomly allocated, i.e. intention to treat analyses. A full description of 
the statistical analysis is given in chapter 6.   
 
In summary, the study with the largest sample size was the HRQL study (details in chapter 
4) from which only 82 consented to participate in the NATTO study (details in chapter 6), 
and from those 82 participants, 80 participants consented for blood sample collection 
(details in chapter 5).  
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3. Development and Description of the NATTO 
Treatment Manual 
 
3.1 Introduction 
As described in chapter1, a large body of evidence suggests the need for dietary therapy, 
increased physical activity, and decreased sedentary behaviour through behaviour 
modification techniques for the success of any child or adolescent obesity treatment 
intervention as summarised in the recent systematic reviews and evidence-based guidelines 
(NICE, 2013, SIGN, 2010, Oude Luttikhuis et al., 2009, Hughes and Reilly, 2008, 
McGovern et al., 2008, Barlow, 2007). The NATTO treatment programme was therefore 
based on these principles. Weight management requires conscious effort and readiness to 
change, accompanied by the adequate knowledge and education concerning how to 
improve dietary and physical activity/sedentary behaviours for the improvement of health 
status in the long term. However, the recent systematic reviews and clinical guidelines 
(NICE, 2013, SIGN, 2010, Oude Luttikhuis et al., 2009) fell short of providing the 
mechanisms by which these behaviour modification techniques should be delivered, and 
indicate in general terms that behavioural modification techniques should be used to 
achieve the changes, but do not provide practical details as to how treatment programmes 
should be developed. Well described, evidence-based, simple and readily generalisable 
childhood obesity treatment interventions are still scarce in the literature, and there is no 
consensus on what really works in terms of treating adolescent obesity (Danielsson et al., 
2012, Hughes et al., 2008, Stewart et al., 2005). Furthermore, there is still a gap between 
regions of the world in research done to test the effectiveness of  treatment interventions 
for paediatric obesity (Oude Luttikhuis et al., 2009). As noted in chapter 1, nearly all 
previous paediatric obesity treatment trials were from the USA or Europe. The author’s 
most recent literature search in PubMed in 2013 also found no paediatric obesity treatment 
trials done in the Arabian Gulf region or the Middle East. In addition, if any future obesity 
treatment research is to be built on existing research, it is important to describe what was 
done in the existing research in detail. The present chapter therefore aims to describe the 
NATTO treatment programme in detail. 
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3.2 SCOTT (Scottish Childhood Obesity Treatment Trial) 
The SCOTT study was a randomised controlled trial of a best practice behavioural 
programme for treatment of childhood obesity. It involved 134 obese children of primary 
school age (5-11 years old) randomised to either the intervention group or the standard care 
group in Glasgow and Edinburgh, Scotland (Hughes et al., 2008). The intervention used 
individualised dietetic treatment sessions (8 sessions) over a period of 6 months. The 
intervention was basically a family-centred behavioural change technique influenced by 
the work of Epstein’s group, which used a modified version of the traffic light diet scheme, 
self-monitoring, goal setting and relapse prevention applied to diet, physical activity, and 
sedentary behaviour (Stewart et al., 2005, Epstein, 1996, Epstein et al., 1998). The author 
of this thesis received an intensive five-days training course on the SCOTT programme.  
 
Choosing the SCOTT programme as the basis of the NATTO treatment was based on 
several points. Firstly, it was a family centred intervention focused on changing the 
behaviours recommended as the key targets in recent evidence based management 
guidelines (NICE, 2013, SIGN, 2010, Oude Luttikhuis et al., 2009) for the treatment of 
paediatric obesity (reduction in sedentary behaviour, particularly screen-media use; diet, 
using a modified version of the ‘traffic light diet’ system (Hughes et al., 2008); and 
promotion of physical activity). Second, the intervention incorporated theoretically based 
behaviour change techniques to all three of the targeted behaviours based on the theory of 
planned behaviour and social cognitive behaviour (Hughes et al., 2008): exploration of the 
pros and cons of changes in diet, physical activity, and sedentary behaviour; exploration of 
motivation to change diet, physical activity, and sedentary behaviour; self-monitoring of 
sedentary behaviour (recording of screen time in diaries), diet, and physical activity 
(recording of walking, sport, and physically active play in a diary); identifying the main 
barriers to behaviour change and problem solving in relation to these barriers; goal setting 
in relation to diet, physical activity, and sedentary behaviour; relapse prevention. Thirdly, 
SCOTT programme was available to the author and that was the starting point.    
 
3.3 The rationale for using group setting in NATTO intervention programme 
The development of wide-reaching, effective strategies for the treatment of paediatric 
obesity are necessary. Studies on the effectiveness of group based programmes are 
promising (Garipagaoglu et al., 2009, Weigel et al., 2008, Kalavainen et al., 2007). In 
Garipagaoglu and colleagues study, group treatment was superior to individualised 
standard care in reducing BMI Z score during the intervention period (3 months) and 
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participants maintained that decline at 1 year follow up (Garipagaoglu et al., 2009). Weigel 
et al (2008) tested a 1 year group treatment programme for paediatric obesity (participants’ 
age 7 to 15 years) against outpatient care and showed significant decrease in BMI Z score, 
systolic blood pressure and fat mass in the intervention group (Weigel et al., 2008). Similar 
results were obtained by Kalavainen and colleagues (2007) in a randomised controlled trial 
of a group intervention programme versus routine individual counselling (Kalavainen et 
al., 2007). In another study, de Mello and colleagues suggested that group therapy could be 
an appropriate alternative to individual counselling (de Mello et al., 2004), especially 
because when choosing group treatment the cost-effectiveness is more than that of the 
individualised treatment (Goldfield et al., 2001). In the light of the mentioned advantages, 
we choose group treatment for NATTO for its potential clinical as well as cost-
effectiveness. Some evidence suggests that approaching families in group fashion might 
enhances participation, adherence and facilitate cohesion (Martin et al., 2009).         
  
3.4 Components of the NATTO treatment manual 
3.4.1 The structure of the NATTO treatment programme  
Our NATTO treatment programme focused on family involvement and on bringing about 
long term lifestyle changes. Based on the different content sources mentioned earlier, the 
NATTO treatment programme was a relatively low intensity programme with the aim of 
making it more generalisable and less demanding. It was felt that a one hour session every 
month for the length of the six months treatment programme, one for males and their 
parents, and one for females and their parents, either on the same day or on separate days, 
would provide enough contact time with the participants to deliver the programme and also 
to assess participants’ compliance.  Each session was given by the author and the team’s 
dietician, previously trained as to the mode and method of delivery. The lectures were 
prepared by the author together with the head supervisor Professor John Reilly, and used a 
practical approach. After each session, the groups participated in reviewing the session 
attended and their commitment to the previous session. Any questions, concerns and 
suggestions were welcomed at that stage, from both parents and adolescents. Healthy 
snacks in the form of fruits or vegetables were offered at the end.  
 
The NATTO sessions included nutrition education, physical activity and behaviour 
modification topics delivered by the physician (author) and a dietician. The participants 
were provided with treatment handouts that were modified from SCOTT materials 
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(Stewart et al., 2005) supplemented with additional self-developed material (Appendix1). 
The content of each session in the NATTO treatment programme is outlined in Table 3.1.  
 
The sessions were held in a lecture theatre in Al Faiha polyclinic, an area of central 
location in the capital Kuwait City. Parents and adolescents were reminded of each session 
one week, two days and one day before by SMS sent by the author. Sessions were held 
separately for males and females as mentioned above, to comply with the Kuwaiti culture 
of gender segregation. 
 
3.4.2 Family involvement in the NATTO intervention programme  
There were three lifestyle behaviours that were the main targets for change in the NATTO 
treatment programme. These targets were recommended by recent systematic reviews 
(Oude Luttikhuis et al., 2009, McGovern et al., 2008, Barlow, 2007) and clinical guidelines 
(NICE, 2013, SIGN, 2010) : dietary modification, physical activity and sedentary 
behaviour. Behavioural modifications in the NATTO treatment programme were directed 
mainly at the obese adolescent; however, for any change to take effect it should involve the 
parents for their help and supervision, so treatment efforts in NATTO were meant to 
involve the entire family, as it is strongly recommended by NICE 2013 and SIGN 2010 
guidelines. The work of Golan and colleagues (Golan et al., 1998a, Golan et al., 1998b) is 
of particular interest as they have lead this field and devised a theoretical method for 
childhood obesity treatment emphasising the role of parents as the primary agents for 
change in the treatment process. They concluded that changing the socio-ecological 
context of the family i.e., modifying the home environment, providing healthful role 
modelling, developing family targets related to physical activity and healthful eating, 
targeting family change rather than child-centred change, and adapting health-centred 
rather than weight-centred approach, is most likely to produce a significant and clinically 
meaningful BMI Z score reduction in obese children (Golan and Weizman, 2001).       
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Table 3.1 Components of the NATTO treatment programme  
Session
 
Topic
 
Contents
 
Behaviour change techniques
 
Next appointment
 
1
 
It's your life
 
Obesity complications
 
Goal setting, contracting and rewards,
 
in 2 weeks
 
 
The pros and cons of obesity treatment
 
Self-monitoring
 
 
 
How to start!
 
  
    
2
 
Eat well
 
Energy balance
 
Goal setting, contracting and rewards,
 
in 4 weeks
 
 
Modified traffic light diet
 
Self-monitoring
 
 
 
Food reference guide
 
  
    
3
 
Enjoy living
 
How to increase physical activity
 
Goal setting, contracting and rewards,
 
in 4 weeks
 
 
How to decrease sedentary behaviour
 
Self-monitoring
 
 
    
4
 
Summer fun
 
Tips on meal choices 
 
 
in 4 weeks
 
 
Cooking together healthly
 
  
    
5
 
Take it easy
 
Dealing with tricky situations
 
Problem solving
 
in 4 weeks
 
 
Dealing with relapse
 
relapse prevention
 
 
    
6
 
NATTO forever
 
Family stories
 
Goal setting, contracting and rewards, 
 
 
 
Sharing tips
 
Self-monitoring
 
 
   
 
Long term goals
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3.4.3 Dietary component 
Adapted from the SCOTT novel dietetic treatment, the dietary component in NATTO 
composed mainly of the modified traffic light diet (Stewart et al., 2005). The modified 
traffic light diet is a simplified, less complex version of the traffic light diet proper 
established by Epstein and colleagues(Epstein et al., 1998). It classifies energy dense, high 
fat and high sugar foods in the red zone, fruits and vegetables in the green zone, and starch, 
meat and dairy foods in the amber zone. The anxiety of calorie counting has been omitted 
in this version which puts the parents and their children in a less stressful situation. 
However, the ultimate goal after 6 months of therapy is to restrict the intake of red foods to 
one per day, restrict intake of amber foods to meal times and green foods to be taken freely 
and substituted for red foods. Emphasis was also put on the method of cooking and 
avoidance of frying and using ready-made high fat high sugar content products such as 
sauces and pastes.  These recommendations made up the dietetic part of the group sessions 
to convey the healthy eating message.  Simple dietetic aids, illustrations and practical were 
used in the sessions to demonstrate portion sizes, calorie contents, and fat contents only to 
give an example and to extend the participants’ knowledge on what they are eating without 
rigidly applying this intensive information into their modified dietary habits. Examples of 
healthy local food alternatives to energy dense food choices were also demonstrated. 
 
3.4.4 Sedentary behaviour and physical activity 
Increasing physical activity and decreasing sedentary patterns are an essential part of any 
obesity treatment programme as noted above (Oude Luttikhuis et al., 2009, SIGN, 2010). 
Increasing the level of physical activity in childhood and adolescence increases bone 
density, decreases obesity and decrease the risk of developing of cardiovascular disease 
risk factors (O'Donovan et al., 2010). The current evidence-based guidelines recommend 
that all children and adolescents aged 6 to 17 years accumulate at least 60 minutes of 
moderate to vigorous intensity physical activity per day (SIGN, 2010, O'Donovan et al., 
2010, NICE, 2013, Strong et al., 2005). This involves structured and non-structured 
physical activity. The approach should be incremental allowing for the individual’s 
capacity to perform these activities and to avoid injury. Moderate intensity physical 
activity is when one notices an increase in the heart rate and respiratory rate to 5 or 6 in a 
scale of 1 to 10, and vigorous intensity physical activity is when the individual feels the 
heart and respiratory rates reach up to 7 or 8 (Landry and Driscoll, 2012).  
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Sedentary behaviour or physical inactivity is also targeted as behaviour distinct from 
physical activity. Controlling sedentary behaviour e.g. TV viewing, is sometimes seen as a 
more practical and realistic goal in treating obesity (Landry and Driscoll, 2012, Ortega et 
al., 2008, Reilly and McDowell, 2003) than targeting physical activity. In fact, targeting 
sedentary behaviours have been associated with a significant reduction in overweight and 
can lead to an increase in physical activities (O'Donovan et al., 2010, Epstein et al., 
1995b). For the long term, decreasing sedentary behaviour can be sustained more 
effectively than when targeting an increase in physical activity (Epstein et al., 1998). The 
current recommendations conveys that sedentary behaviour should be reduced to a 
maximum of 2 hours per day (NICE, 2013, SIGN, 2010).        
  
In NATTO we used a culture-sensitive approach in delivering the treatment 
recommendation for reducing sedentary behaviour especially screen time and increasing 
the level of physical activity (e.g. using the stairs and helping in house chores) and indoors 
physical activities and encourage active play. The ultimate goal was to get the participants 
to be active on regular basis in any fun, safe and enjoyable activity. In Kuwait, a lack of 
exercise facilities especially for females is one of the factors attributed to decreased 
physical activity among adolescents (Al-Isa et al., 2011), as well as the weather, which is 
mostly extremely hot most time of the year. In our programme we tried to explore ways for 
the participants to be more physically active in a way that could be sustained for life. Play 
with family members and friends was repeatedly suggested by the participants in each 
session.     
We also emphasised the role of the parents as role models in leading active lifestyle and in 
supporting their children’s participation in enjoyable physical activity.      
 
3.4.5 Behaviour change techniques 
As mentioned above, managing obesity in childhood and adolescent is done through 
changing behaviour towards diet, physical activity and sedentary behaviour usually by 
means of multiple, intertwined methods of changing behaviour, or behaviour change 
techniques (BCT) (NICE, 2013). Using these techniques in childhood and adolescent 
obesity treatment interventions has been proven to be effective in the short and long term 
(Epstein et al., 1994, Wilfley et al., 2007, Golan et al., 1998a, Robinson, 1999). Abraham 
and Michie (2008) developed a taxonomy of 26 conceptually distinct component BCTs, 
which are described using consistent terminology and standard definitions (Abraham and 
Michie, 2008)(Table 3.2). More recently, the original taxonomy (Abraham and Michie, 
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2008) has been revised and extended into a behaviour-specific taxonomy of 40 BCTs for 
physical activity and healthy eating behaviours (CALO-RE) (Michie et al., 2011). The 
CALO-RE taxonomy was developed by three teams of researchers from Coventry, 
Aberdeen and London to provide standard definitions to reliably identify techniques used 
for (1) increasing physical activity and healthy eating primarily in obese adults and (2) 
increasing self-efficacy to promote lifestyle and recreational physical activity. There is still 
uncertainty about how to match BCT to theoretical constructs and more research is needed 
to discover the theoretical basis (Michie et al., 2011), however, having the taxonomy 
implemented in intervention protocols facilitated the scientific investigation of behavioural 
interventions, which would allow for the  replication of effective interventions as well as 
intervention evaluation (Michie et al., 2008).     
 
Our intervention programme employed a number of behaviour change techniques in order 
to help the participants and their parents understand the health consequences of obesity as a 
result of their current lifestyle, encourage them forming goals and specific plans to initiate 
change, help them develop strategies to cope with difficult situations where relapse is 
possible. The behaviour change techniques used in NATTO consisted of goal setting, self-
monitoring,  rewards and contracting, stimulus control, problem-solving and relapse 
prevention (Abraham and Michie, 2008). These techniques are described briefly below.          
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Table 3.2 Definitions of 26 Behaviour Change Techniques and Illustrative Theoretical Frameworks 
Technique Definition 
1. Provide information about behaviour-health link General information about behavioural risk, for example susceptibility to poor  
 
health outcomes or mortality risk in relation to the behaviour 
2. Provide information on consequences information about the benefits and costs of action or inaction, focusing on what  
 
will happen if the person does or does not perform the behaviour 
3. Provide information about others' approval Information about what others think about the person's behaviour and whether 
 
others will approve or disapprove of any proposed behaviour change 
4. Prompt intention information  encouraging the person to decide to act or set a general goal to make a  
 
behavioural resolution 
5. Prompt barrier identification Identify barriers to performing the behaviour and plan ways of overcoming them 
  
6. Provide general encouragement Praising or rewarding the person for effort or performance without this being  
 
contingent on specified behaviours or standards of performance  
7. Set graded tasks Set easy tasks, and increase difficulty until target behaviour is performed 
  
8. Provide instruction Telling the person how to perform a behaviour and/or preparatory behaviours 
  
9. Model or demonstrate the behaviour An expert shows the person how to correctly perform a behaviour, for example, 
 
in class or on video 
10. Prompt specific goal setting Involves detailed planning of what the person will do, including a definition of the  
 
behaviour specifying frequency, intensity, or duration and specification of at least  
 
one context, that is, where, when, how, or with whom 
11. Prompt review of behavioural goals Review and/or reconsideration of previously set goals or intentions 
  
12. Prompt self-monitoring of behaviour The person is asked to keep a record of specified behaviour(s) (e.g., in a diary) 
  
13. Provide feedback on performance Providing data about recorded behaviour or evaluating performance in relation to 
 
to a set standard or others’ performance, i.e., the person received feedback on  
 
their behaviour 
14. Provide contingent rewards Praise, encouragement, or material rewards that are explicitly linked to the  
 
achievement of specified behaviour 
15. Teach to use prompts or cues Teach the person to identify environmental cues that can be used to remind them  
 
to perform a behaviour including times of day or elements of contexts 
16. Agree on behavioural contract Agreement (e.g., signing) of a contract specifying behaviour to be performed so that  
 
there is a written record of the person’s resolution witnessed by another 
17. Prompt practice Prompt the person to rehearse and repeat the behaviour or preparatory behaviours 
  
18. Use follow-up prompts Contacting the person again after the main part of the intervention is complete 
  
19. Provide opportunities for social comparison Facilitate observation of nonexpert others’ performance for example, in a group 
 
class or using video or case study 
20. Plan social support or social change Prompting consideration of how others could change their behaviour to offer the   
 
person help or (instrumental) social support and/or providing social support 
21. Prompt identification as a role model Indicating how the person may be an example to others and influence their  
 
behaviour or provide an opportunity for the person to set a good example 
22. Prompt self-talk Encourage use of self-instruction and self-encouragement (aloud or silently) 
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to support action 
23. Relapse prevention Following initial change, help identify situations likely to result in readopting 
 
risk behaviours or failure to maintain new behaviours and help the person plan to  
 
avoid or manage these situations 
24. Stress management  May involve a variety of specific techniques (e.g., progressive relaxation)  
 
that do not target the behaviour but seek to reduce anxiety and stress 
25. Motivational interviewing  Prompting the person to provide self-motivating statements and evaluations 
 
of their own behaviour to minimize resistance to change 
26. Time management  Helping the person make time for the behaviour (e.g., to fit it into a daily schedule) 
 
Adapted from Abraham and Michie 2008 
 
 
Goal setting 
The adolescent is given the responsibility to identify a certain behaviour or set of 
behaviours that he/she wishes to change. The role of the author was to make sure that this 
goal or goals are SMART, i.e.; Small, Measurable, Achievable, Recorded and Timed 
(Stark, 2003, Stewart et al., 2008b), and personal, i.e.; targeting the participant’s own 
lifestyle behaviour(s) that he/she thinks need to be changed. Although the adolescent chose 
the lifestyle behaviour he/she wished to change, the parent(s) also were asked to provide 
their help and support for their child in order to: identify the targeted behaviour(s) for 
change at a particular time point, keep their child motivated in pursuing change in 
behaviour, identify with their child ways for achieving and maintaining such change in 
behaviour. The participants were asked to set a maximum of three behaviour change goals 
to achieve by the end of the programme.  
 
Self-monitoring 
Self- monitoring involved keeping a record of the participant’s dietary intake and physical 
activity behaviour. In the NATTO treatment programme, we distributed self-monitoring 
diaries aided with dietary and physical activity tips and illustrations (appendix1), to be 
used by all participants for them to reflect on their targeted behaviour(s) and to also record 
any events that either helped them reach and maintain their targeted change in behaviour or 
posed a threat in their process of changing the behaviour. This method enhances attention 
to one’s actions and the surrounding environment (Stark, 2003, Burke et al., 2011).  
Contracting and rewards 
The use of contracting between the participant and the parent with the supervision of the 
author was very essential reinforcement of the goal setting and the self-monitoring steps 
mentioned above. Signing a contract meant that both the parent and the participant agreed 
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on the set goals to be achieved within the decided time frame and that both had the 
responsibility of monitoring the process of achievement. Decision on the reward was based 
on achieving 100% of the set goals and the actual reward was a non-food item, inexpensive 
and preferably involved a family function. At the end of the NATTO intervention 
programme, parents and their children were asked to set new goals and to sign a new 
contract.  
 
Stimulus control 
The context in which the challenging behaviour is occurring is altered using stimulus 
control. Modifying the surrounding environment is a way of controlling the obesity 
augmenting behaviour, and promoting new lifestyle changes that help the participant 
achieve the behavioural goals. Stimulus control and the corresponding environmental 
modifications can be used by parents to reduce the repetitive behaviours that contributed to 
obesity and allows the participants to engage in the new ‘appropriate’ behaviour more 
quickly. For example, reduce buying red foods, or encouraging physical play with family 
members.  
 
Problem solving 
To overcome difficult situation where sticking to goals could be compromised, the 
participants and the parent were encouraged to identify high risk situations and access the 
possible ways to overcome the situation. In NATTO, both parents and their children were 
asked to give examples from their personal experience about situations that could be 
labeled as high risk and also to give more than one solution to the problem at hand.  
 
Relapse prevention 
In order to prevent relapse into the unwanted behaviour, it is crucial to explore the 
participants’ and their parents’ believes regarding obesity and its consequences. Correcting 
or even expanding on the person’s believes towards obesity and its link to the unwanted 
behaviour help the participant cope with relapse situations, and also reflect on their goal 
setting and stimulus control strategies. This also helps the participant to plan ahead for 
difficult situations.    
 
More recent evidence suggests the use of other behaviour change techniques that carry 
more potentially successful outcomes (Martin et al., 2013) (see chapter 7). 
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 3.5 Primary care control treatment  
At the start of this trial, the author and the trial supervisor felt that it was essential to 
compare the NATTO programme to the standard dietetic care that was delivered in Kuwait 
at primary level (see chapter 1). There was no formal training in childhood obesity 
treatment at primary or secondary care levels in Kuwait. The central nutrition clinic offers 
weight management walk in service to the public regardless of age and is considered a 
primary care centre. The patient gets his/her anthropometry measured at first contact, along 
with blood samples for complete blood count (CBC), liver function test (LFT), renal 
function test (RFT), fasting blood glucose (FBG) and lipid profile. The next appointment is 
usually held in 2-3 weeks, where the patient firstly meets the clinic physician for full 
system screening and then sits with the clinic dietician for dietary management. The 
dietary management is composed of a diet sheet/menu and usually the patient is followed 
by the same dietician monthly thereafter. 
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4. Obesity and Health Related Quality of Life 
among Adolescents in Kuwait 
BOODAI, S. A. & REILLY, J. J. 2013. Health related quality of life of obese adolescents in Kuwait. BMC 
Pediatr, 13, 105. Appendix E. 
 
 
4.1 Introduction 
In clinical settings, measures of Health Related Quality of Life (HRQL) are not routinely 
explored using conventional history taking and physical examination. However, poor 
obesity-associated quality of life might lead adolescents and/or their families to seek 
professional treatment of obesity. The effects of obesity in youth on HRQL have been 
characterised mainly from the Western World to date (Griffiths et al., 2010). There is much 
less evidence on the extent to which obesity might impair HRQL in adolescents from non-
western societies(Lin et al., 2013, Lin et al., 2012, Hamzaid et al., 2011, Fazah et al., 2010, 
Chen et al., 2005), but obesity-associated impairment of HRQL has emerged in children, 
adolescents, and young adults in Malaysia, Taiwan, and Lebanon (Lin et al., 2013, 
Hamzaid et al., 2011, Fazah et al., 2010, Chen et al., 2005).  
 
In a recent systematic review (Griffiths et al., 2010) and a recent meta-analysis (Ul-Haq et 
al., 2012) of the association between body mass index (BMI) and health-related quality of 
life among children and adolescents, there were no references to studies done in the 
Arabian Gulf, and all included studies were from the Western world except for 1 study 
done in the Middle East (Israel) (Griffiths et al., 2010, Ul-Haq et al., 2012). It has been 
suggested that the impact of child or adolescent obesity on HRQL is influenced by culture 
(Hamzaid et al., 2011), but since the evidence base on impairment of HRQL in adolescents 
is still very limited in geographical scope the hypothesis that culture influences the obesity 
associated impairment of child or adolescent HRQL has not been tested. For example, it is 
not clear whether obesity impairs the HRQL of adolescents in the Arabian Gulf States. 
Deficits in HRQL may drive healthcare utilization by creating a demand for obesity 
treatment (Hughes et al., 2007, Williams et al., 2005, Schwimmer et al., 2003) and 
understanding the extent of these deficits in non-western societies is important. Thus, the 
conclusions from the literature on obesity effects on HRQL in children and adolescents to 
date cannot necessarily be generalized across the world due to the possibility that 
differences in culture, demography, economy, education and social characteristics might 
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alter any effect which obesity might have on quality of life. Nonetheless, research in this 
area to date so far has showed strong evidence that obesity carries detrimental effects on 
paediatric HRQL including the physical, social and emotional domains of HRQL (Riazi et 
al., 2010, Hughes et al., 2007, Pinhas-Hamiel et al., 2006, Williams et al., 2005, 
Schwimmer et al., 2003, Friedlander et al., 2003, Must and Strauss, 1999, Braet et al., 
1997a). Different tools have been used to assess the impact of obesity on HRQL, the main 
one of which is the Pediatric Quality of Life Inventory version 4.0 (PedsQL™ 4.0). The 
PedsQL™ comprises of parallel scores of child self-report and parent-proxy report, which 
is a very useful tool to assess the burden of obesity on the whole family, and the potentially 
different perspectives of parents and adolescents (Eiser and Morse, 2001) .  
 
So, in order to fill the research gap on the impact of obesity on adolescent HRQL from 
Gulf States and Non Western countries, we conducted this study on a community sample 
of obese Kuwaiti adolescents. The primary purpose of this study was to evaluate the 
association between HRQL and obesity in Kuwaiti adolescents aged 10 to 14 years. The 
hypothesis is that with increased body mass index centile (BMI), HRQL would be 
decreased. Information on the HRQL in this age group, who may be at risk of functional 
limitations and life dissatisfaction, may direct behavioural interventions for improving the 
care of obese children and adolescents. We carried out a formal paired comparison of 
HRQL between obese and healthy weight control adolescents to see if there would be any 
differences. We also wanted to compare the HRQL self-report of adolescents and their 
parent-proxy reports. To our knowledge, this is the first study to evaluate the relationship 
between HRQL and obesity in a paediatric sample in Kuwait and the Arabian Gulf region.   
 
4.2 Literature review on HRQL and paediatric obesity 
Health related quality of life is the individual’s ability to function in relation to his/her 
current state of health. This ability includes physical, mental and social well-being (Tsiros 
et al., 2009). The relationship between HRQL and paediatric obesity has been studied by 
Ul-Haq and colleagues (2012) in their meta-analysis of the association between body mass 
index and health-related quality of life among children and adolescents, assessed using the 
Pediatric Quality of Life Inventory Index (PedsQL™ 4.0) (Ul-Haq et al., 2012): the pooled 
studies came from North America, Europe, Australia and Israel. All studies measured the 
effect of paediatric obesity on the total, psychosocial and physical domains. Pooled 
analysis showed a dose-response type relationship between BMI and the total, 
psychosocial and physical HRQL scores. Obese children and adolescents (ages between 2 
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and 18 years old) had significantly lower total scores HRQL than normal weight and 
overweight peers. The psychosocial and physical domains of the PedsQL™ 4.0 
questionnaire also differed, however the differences in these domains were not statistically 
significant. All of these results considered by Ul Haq et al (Ul-Haq et al., 2012) were 
measured using the self-report forms. 
 
Paediatric obesity remains one of the most common chronic disorders in this age group. 
The health risks associated with obesity go beyond the physical form to involve almost 
always psychological aspects (Griffiths et al., 2010, Must and Strauss, 1999, Braet et al., 
1997a). Numerous researchers have investigated the medical sequelae of paediatric obesity 
thoroughly (Weiss and Kaufman, 2008) and there is long history of research conducted to 
find out the impact obesity has on paediatric physical, functional, emotional and social 
well-being (Braet and Mervielde 1997(Braet et al., 1997a). This is as important an issue as 
exploring the physical-medical complications associated with paediatric obesity. 
Altogether the physical and mental complications are fundamental in forming the shape of 
treatment guidelines indicating the need for supportive interventions, prognostic indicators, 
aid decision making and informing resources allocation and healthcare policy.  
Much of a child’s or adolescent’s life centres around activities with peers and physical 
performance. In adolescence, transition into school structure and peer network dynamics 
can provoke distress even in the absence of negative social experiences (Adolescent health, 
understanding and preventing risk behaviour, 2009). For obese children and adolescents, 
psychosocial development is usually impaired to a varying extent ranging from weight 
status and shape dissatisfaction to depression and other psychosocial disorders (Griffiths et 
al., 2010). The short term psychosocial effects of obesity on children and adolescents 
include social isolation, discrimination and victimisation by peers. In adolescence, if 
obesity persists, which is mostly the case (Kuhl et al., 2012, Guo et al., 1994) it can result 
in negative self-image, and lower self-esteem associated with sadness, loneliness, anxiety 
and high risk behaviour (Pinhas-Hamiel et al., 2006). In the recent systematic review on 
self-esteem and quality of life in obese children and adolescents(Griffiths et al., 2010), 
Griffiths and colleagues showed that the majority of studies conducted using multi-
component assessment, including physical, emotional, social and school performance, had 
strong evidence on an inverse relationship between self-esteem and obesity in that age 
group, where obesity had its greatest impact on the physical appearance, athletic 
performance and social wellbeing. However, the Griffiths et al. (2010) evidence base was 
limited in the number of studies identified (six studies were done on children, 4 studies 
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done on adolescents, and 5 done on children and adolescents, and all from the Western 
World). The Griffiths et al. review found that there was no clear evidence as to whether 
low HRQL in obesity differed between sexes or between different ethnic groups.   
 
 One of the main early studies on impairment of HRQL by obesity in children and 
adolescents was that by Schwimmer et al. (Schwimmer et al., 2003) on a sample of 106 
American children and adolescents aged 5 to 18 years old (57 males). Using the 
PedsQL™4.0 inventory scale, Schwimmer and colleagues found that severely obese 
children and adolescents had significantly lower HRQL scores in all domains and they 
were comparable to scores of children and adolescents with cancer.  
 
Williams et al. in Australia (Williams et al., 2005), also used the PedsQL™4.0 index on a 
community sample of 1456 children and adolescents aged 9 to 12 years old who were 
categorised into three groups; not overweight (n=1099), overweight (n=294) and obese 
(n=63). They demonstrated that HRQL scores decreased dramatically in the obese children 
and adolescents, compared to the overweight and not overweight groups. From Israel, 
Pinhas-Hamiel et al. (Pinhas-Hamiel et al., 2006) compared  results of PedsQL™ 4.0 
scores from a community sample and hospital sample of 88 obese adolescents (aged 11-
14years) and found no significant difference in HRQL scores between treatment-seeking 
sample and community sample, however both groups had significantly lower HRQL scores 
than healthy weight group (n=93), especially in the physical, social and school 
performance domains. These results only highlight the importance of measuring HRQL in 
obese paediatric population, regardless of their treatment seeking status (Tsiros et al., 
2009). 
From the UK, Riazi et al (Riazi et al., 2010) used the PedsQL™ 4.0 inventory scale to 
compare the HRQL of a clinical sample of 96 obese children and adolescents aged 5 to 16 
years old with 444 healthy weight controls with similar age range. Results showed that the 
obese group had significantly lower scores in all domains than the healthy weight controls 
(P ˂0.005).    
 
Some paediatric obesity HQRL studies using the PedsQL™4.0 have investigated the 
difference between child-self report and parent-proxy report scores. In summary, parent-
proxy reports of HRQL tend to be similar  to that of child-self reports in that both scores 
tend to be low in obesity compared to healthy weight controls, but with a larger deficit in 
the obese when studied by self-report (Kuhl et al., 2012, van Grieken et al., 2012, Varni et 
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al., 2007, Hughes et al., 2007, Pinhas-Hamiel et al., 2006, Williams et al., 2005, 
Schwimmer et al., 2003, Wake et al., 2002, Stradmeijer et al., 2000).  
Here, effects of obesity on HRQL might possibly be culture-specific. Hughes et al. 
(Hughes et al., 2007) used the PedsQL™4.0 index to compare child-self report with 
parent-proxy report of a sample of 126 obese 5 to 11 years old children and adolescents 
from Scotland. Parents reported lower scores of all domains of the PedsQL™4.0 than self-
reports and the difference in score was significantly low for the emotional and social 
domains. In contrast, Hamzaid et al. (Hamzaid et al., 2011), in 5 to 11 year old obese 
children and adolescents (n=90) in Malaysia using the PedsQL™4.0 index, observed no 
significant impairment of HRQL when using parent-proxy reports.  
This difference in child’s and parent’s perspectives highlights the importance of seeking 
HRQL score of proxy (parent) raters as well as self-reports to gain access to the amount of 
distress that faces the family as a whole with regards to their child’s obesity (Varni et al., 
2004). In clinical settings, although it is usually assumed that caregivers can provide more 
accurate information about the impact the disease has on the child, it is equally important 
and valid to look into the child’s perspective (Eiser and Morse, 2001). And in a research 
setting, caution should be practiced when utilizing HRQL data from only parent-proxy 
reports or only from child self-report (Ul-Haq et al., 2012, Tsiros et al., 2009).    
 
Box 2. Main findings from the literature reviews on the relationship between 
HRQL and obesity 
• Obesity has a significant negative effect on total score of Peds QL 4.0 in 
obese children and adolescents 
• Obesity has an inverse relationship with self-esteem in obese children and 
adolescents  
• HRQL measured using Peds QL 4.0 was significantly impaired in severe 
childhood and adolescent obesity comparable to scores of children and 
adolescents with cancer 
• Parent-proxy reports of HRQL of their obese children is culture-specific 
• Most of the research on the relationship between obesity and HRQL comes 
from the western world and more research is needed from other parts of 
the world to identify the type of relationship between  paediatric obesity 
and HRQL 
  
 
 
4.3 Other psychological complications of paediatric obesity 
Depression is another form of psychosocial impairment in obese adolescents. There is 
evidence showing that both conditions, i.e. depression and obesity, have a cause and effect 
relationship with each other in that age group (Griffiths et al., 2010, Tsiros et al., 2009). 
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Several studies showed that acquiring depression in adolescence increases the chance of 
obesity even after controlling for confounding factors, especially among girls (Richardson 
et al., 2003, Goodman and Whitaker, 2002).  
 
In social self-perception; the judgment we think others hold on us in relation to our 
appearance or attitude, age plays an important role in the effect of obesity (Strauss and 
Pollack, 2003, Phillips and Hill, 1998). In pre-adolescence, social networking and 
preferences were similar between the obese and the healthy weight, regardless of gender 
(Phillips and Hill, 1998). In 2003, Strauss and Pollack analysed the data of 90,118 students 
from the National Longitudinal Survey of Adolescents health (Richardson et al., 2003) on 
social network mapping and found out that obese adolescents were significantly less likely 
to be chosen as friends than their normal weight peers. This degree of social rejection can 
expand to reach the form of victimisation, where obese children and adolescents are more 
likely to be teased and bullied than their healthy weight peers, and end up with low self-
esteem, dissatisfaction with their physical appearance and athletic performance, and 
possibly eating disorders (Neumark-Sztainer et al., 2002, Kraig and Keel, 2001). 
Correspondingly, greater school connectedness has been associated with better academic 
performance and outcome, and lower levels of involvement in health-risk behaviours 
(Allen et al., 2004) 
 
4.4 Research objectives 
The primary aim of this research was to investigate the HRQL of obese Kuwaiti 
adolescents using PedsQL™4.0 and compare the results with that of HRQL of healthy 
weight adolescents in order to determine whether the obesity associated impairment of 
HRQL described in the literature was present in adolescents in Kuwait. Secondly, we 
wanted to examine differences of HRQL scores between adolescent-self report and parent-
proxy report in the obese group, and also test for gender differences in the effect of obesity 
on HRQL of obese Kuwaiti adolescents. This study, which used the PedsQL™4.0 as its 
measurement tool, was the first of its kind to be conducted in Kuwait and the Arabian Gulf 
region. It would test whether the HRQL of obese Kuwaiti adolescents was impaired in 
relation to the HRQL of matched healthy weight peers.   
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4.5 Methods  
4.5.1 Measurement of HRQL 
Health-related quality of life measures are now frequently needed in clinical trials as 
measures of outcome (Goss and Quittner, 2007). They are subjective measures of one’s 
physical, mental and social well-being in relation to their current state of health. Except in 
very young children or when children are unwell, these measurement tools can be assessed 
by children as young as 5 years of age, otherwise, parent-proxy reports are also available 
(Palermo et al., 2008). Dual reporting where both parents and their children report their 
perceptions is also used to provide an insight into the whole context of family functioning. 
Palermo and Colleagues (Palermo et al., 2008) carried out evidence-based review of tools 
that provide options for either parent or paediatric reports of health-related quality of life. 
There are two types of HRQL measurements; generic and condition-specific instruments. 
The generic or non-categorical type, although less sensitive than the condition-specific 
type, allows for comparison of HRQL of different conditions in a large scale (Palermo et 
al., 2008). The Paediatric Quality of Life Inventory (PedsQL ™ 4.0, MAPI Research 
Institute, Lyon, France) is a generic HRQL questionnaire that also has an age-appropriate 
version and parent-proxy reports (Varni et al., 2001)(See fig 5.1). Using the PedsQL ™ 4.0 
questionnaire, Varni and colleagues found that, obese young patients had lower subjective 
score for their HRQL than patients with cardiac, gastrointestinal, and diabetic conditions. 
This questionnaire is a well-established, valid and reliable tool that can distinguish 
between healthy children and children with acute or chronic conditions and is responsive to 
clinical change over time. It is a multidimensional construct that includes 23 items making 
the physical, emotional, social and school performance domains from which total, 
psychosocial and physical scale scores are derived. The physical functioning domain has 8 
measurement items, the mean of which makes the physical scale score. The emotional 
functioning domain has 5 measurement items, the social functioning domain has 5 
measurement items and the school functioning domain has 5 measurement items (Varni et 
al., 2001). The total score can be derived from the mean of all 23 items. The psychosocial 
scale score can be derived from the mean of items in the emotional, social and school 
performance domains. Three versions of the subjective report scale are available; the 
young children report (age 5 to 7 years) where it has a three-point response scale (0 = not 
at all a problem, 2 = sometimes and 4 = a lot, with each response choice anchored to either 
smiling, middle or frowning face respectively), the children report (age 8 to 12 years) and 
the teenagers report (age 13 to 18 years) where the scale has a five-point response (0 = 
never a problem, 1 = almost never, 2 = sometimes, 3 = often and 4 = almost always). Items 
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are linearly transformed to a 0 to 100 scale, so that the higher the score, the better the 
HRQL. The PedsQL ™ 4.0 inventory is available in English, Arabic and many other 
languages.  
 
4.5.2 Study participants 
The present study sample was recruited from public schools in Kuwait city, the Capital of 
Kuwait. Figure 5.2 outlines the study flow diagram. The Ministry of Education granted us 
the ethical approval to commence the study in intermediate schools in the Capital in order 
to cover the age range selected (10 to 14 years). Gathered from the Ministry of Education’s 
archives, the Capital contains a total of 41 males’ public intermediate schools and 39 
females’ public intermediate schools.   
Phone calls were made to the management of each of these schools to explain the nature of 
the study in order to gain access and recruit the study sample. Only 10 of the public 
intermediate schools gave us appointments and were visited; 3 girls’ schools and 7 boys’ 
schools. Permission was granted by the school principals of only three schools; two male 
and one female school. Screening for height and weight was carried out by two, trained 
dietetic assistants from the Food and Nutrition Administration department of the Ministry 
of Health. Grades from five to nine were selected to cover the age range targeted i.e. 10 to 
14 years. Screening was carried out on a total of 1042 students. After screening, the 
researcher collected the height and weight figures of all pupils, calculated the BMI, and 
plotted the results on the age and gender specific percentile charts. Pupils were categorised 
into healthy weight group, overweight group and obese group according to reference data 
from the US Center for Disease Control (CDC) 2000. Obesity was defined as BMI of ≥ 
95th centile, overweight was defined as BMI ≥ 85th centile and ˂95th centile, and healthy 
weight was defined as BMI ≥ 3rd centile and ˂85th centile, using gender specific, BMI for 
age percentile charts. National (Kuwaiti) reference data for BMI to define weight status in 
that age group was not used. El Ghaziri et al. (2011) proved that using Kuwaiti reference 
data to define weight status in 10 to 14 years old adolescents underestimated the 
prevalence of overweight and had the lowest agreement with known international methods 
namely; Cole-IOTF, CDC 2000, and WHO 2007 (El-Ghaziri et al., 2011).  
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Figure 4. 1 Structure of the multidimentional Peds QL 4.0 generic score scale measuring HRQL in adolescents, 
adopted from Petersen et al., 2009 
 
71 
 
 
 
Figure 4.2 Study flow diagram 
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Only those who were either in the healthy weight or obese categories were selected for the 
study. Verbal check list of the inclusion and exclusion criteria was presented to each class 
before giving out the consent and PedsQL™ 4.0 forms to the selected study sample. 
Participants and their families provided informed written consent. The PedsQL™4.0 
Arabic version was completed independently by adolescents at school and their relative 
parents at home. The study was approved by the Medical Research Committee of the 
Ministry of Health and the Ethical Committee of the Ministry of Education in Kuwait. A 
formal matched pairs were formed between the obese group and the healthy weight group 
according to age and gender. This yielded 98 pairs with 57 paired boys and 41 paired girls, 
with median age of 12.4 years. There were twelve parents’ reports missing. The researcher 
had to pursue the parents, and filled out the Peds™4.0 forms through phone call 
interviews; at the end, these reports were included in the final analysis.  
 
4.5.3 Inclusion and exclusion criteria 
Subjects were included if they fit the eligible age range (10 to 14 years), were either obese, 
as defined by the US CDC 2000 definition of BMI ≥ 95th percentile, or of healthy weight, 
defined as BMI ˂ 85th  and ≥ 3rd percentile. Overweight pupils were excluded from the 
study sample in order to provide a clear contrast in weight status between the two groups 
of interest. Exclusion criteria were as follows: the presence of any chronic disease such as 
diabetes, cardiovascular disease or others; obesity as a result of a known underlying 
organic cause; the presence of a genetic syndrome; untreated hypothyroidism; and the use 
of medication that might interfere with the weight of the subject. The total number of 
pupils who did not fulfill the inclusion criteria was 542, 224 males and 318 females.  
 
4.5.4 Anthropometry 
Subjects were measured in light clothing and without shoes. Height was measured to the 
nearest 0.1 cm using portable 
 stadiometer (Leicester Height Measure, Child Growth Foundation, Leicester, London, 
UK). Weight was measured to the nearest 0.1 kg using scales (Tanita™). BMI was 
calculated as the weight (kg) divided by the height (m²).  
 
4.5.5 Measurement of the HRQL 
The total HRQL score was derived from the mean of all 23 items of the inventory index 
which included the physical functioning domain (8 items), emotional functioning domain 
(5 items), social functioning domain (5 items) and school functioning domain (5 items). As 
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is common in the literature (Varni et al., 2001) psychosocial score was derived from the 
mean of items in the emotional, social, and school functioning domains (See Fig 1.). The 
Physical Score is a separate domain (See Fig.1). The analysis was based on the total, 
psychosocial and physical scores of the obese group, healthy weight group, and parent-
proxy reports. All calculations were done manually by the researcher. All HRQL domains 
were uploaded into excel worksheets, unique for each study group.  
 
4.5.6 Statistical analysis 
Data from obese adolescents were not available, and data from Kuwaiti or other Gulf state 
samples were not available upon which to base a power calculation. In the absence of 
highly relevant local data the present study power was based on data from a previous 
power calculation in a comparison of HRQL in obese and non-obese children in Scotland 
(Hughes et al., 2007). Data from Hughes et al suggested that the sample size required to 
identify a significant difference between the obese group and the healthy weight group 
(within each sex, treating boys and girls separately) was a minimum of around 40-43 pairs 
with 90% power and p = 0.05. All the statistical analyses were performed using Minitab 
16.0. Data were checked for normality by descriptive statistics and histograms with normal 
distribution curves. All scores of the PedsQL™4.0 domains were not normally distributed. 
Matched pairs of obese and healthy weight subjects were selected according to age (age 
within 10 to 14 years) and gender. Wilcoxon signed-rank tests were used to detect 
differences in the scores between the obese and the healthy weight groups. We also used 
Wilcoxon signed-rank test to detect the significance of any difference in scores between 
self-report and parent-proxy report in the obese group. Regression analysis of predictors of 
HRQL was also included.  
 
4.6 Results 
4.6.1 Sample characteristics 
The final study sample consisted of 500 adolescents, all Kuwaiti nationals, 318 boys 
(63.6%) and 182 girls (36.4%) between 10-14 years of age (median age 12.3). From the 
study sample, only 374 parent-proxy reports came back (162 or 43% from the obese group 
and 212 or 57% from the healthy weight group). Data were collected from 224 obese 
adolescents, and 276 healthy weight adolescents.  
 
The ethnic distribution of the whole sample was similar as all participants were Kuwaiti 
Nationals. Formal socioeconomic status definition does not exist (Channanath et al., 2013). 
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Table 4.1 summarises the physical characteristics of the study sample. The normal weight 
group had 176 males of which only 125 parents provided their parent-proxy reports. Also 
included in the group 100 female students of which only 87 parents provided their parent-
proxy reports. On the other hand, the obese group had 142 obese male students and 82 
obese female students of which 91 and 71 parents provided their parent-proxy reports, 
respectively. The median age for the obese group was 12.4 years (IQR 10.4, 14.0) and 
median age for the healthy weight group was 12.3 (IQR 10.1, 14.0). 
 
 
Table 4.1 General characteristics of the obese and healthy weight groups  
  Healthy weight group Obese group 
Variable  n Median IQR n Median IQR 
Age (years) 276 12.3 (10.1, 14.0) 224 12.4 (10.4, 14.0) 
Males 176 12.3 (10.1, 14.0) 142 12.6 (10.8, 14.0) 
Females 100 12.2 (10.0, 14.0) 82 12.4 (10.3, 14.0) 
BMI 276 18.1 (15.0, 21.1)
 
224 28.8 (23.3, 34.3) 
BMI Z score 276 0.1 (-0.6, 0.5)
 
224 2.1 (1.9, 2.3) 
BMI; body mass index 
  
 
4.6.2 HRQL of the obese adolescents 
4.6.2.1 Total Score 
The HRQL data are shown in table 4.2. The total score for the obese self-report ranged 
from 14.1 to 100.0. The median of the total score for the whole sample (n=224) was 84.8 
(IQR 74.2, 95.4). The median of the total score for the obese boys (n=142) was 88.0 (IQR 
78.3, 96.7). The median score for the obese girls (n=82) was 79.3 (IQR 70.4, 91.6). In 
comparison, the total score for the parent-proxy report of the total sample (n=162) ranged 
from 43.8 to 100.0, with a median score of 78.3 (IQR 62.8, 88.0). Median total score for 
parent-proxy reports of the obese boys group (n=91) was 76.1 (IQR 65.2, 86.9) and for the 
obese girls group (n=71) was 81.5 (IQR 60.9, 90.2).  
 
4.6.2.2 Psychosocial Score  
The psychosocial score of the obese sample ranged from11.7 to 100.0. The median was 
85.0 (IQR 75.0, 93.3), median for the obese boys 87.5 (IQR 78.3, 96.7), and for the obese 
girls was 82.5 (IQR 70.0, 91.6). The psychosocial score for the parent-proxy report ranged 
from 30.0 to 100.0. The median score for the obese group 76.7 (IQR 63.3, 88.3), for the 
obese boys was 87.5 (IQR 78.3, 96.7), and for the obese girls 82.5 (IQR 70.0, 91.6). 
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4.6.2.3 Physical Score 
The physical score of the obese sample ranged from 18.8 to 100.0. The median score for 
the whole sample was 87.5 (IQR 75.0, 100.0), for the obese boys 90.6 (IQR 78.1, 100.0), 
for the obese girls 81.3 (IQR 68.0, 96.9). 
The physical score for the parent-proxy report ranged from 6.3 to 100.0. The median for 
the total sample was 82.9 (IQR 59.4, 93.8), for the obese boys 84.4(IQR 62.5, 93.8), and 
the obese girls 81.3 (IQR 50.0, 93.8). 
 
4.6.3 HRQL of healthy weight adolescents 
4.6.3.1 Total Score 
Here, the self-report and parent-proxy scores for the total, psychosocial and physical scores 
are summarised in table 4.3. The sample included 276 healthy weight adolescents, of 
which there were 176 healthy weight boys and 100 healthy weight girls. A total of 212 
parent-proxy reports were obtained, of which 125 from healthy weight adolescents’ boys’ 
parents reports and 87 from healthy weight adolescents’ girls’ parents reports. The total 
score of the healthy weight adolescents self-reports ranged from 18.5 to 100.0, median was 
89.1 (IQR 76.4, 96.7), 92.4 (IQR 78.3, 97.8) for the boys, and 86.4 (IQR 75.0, 95.6) for the 
girls. Median score for the parent-proxy report was 79.3 (IQR 62.0, 91.3), for the healthy 
weight boys’ parent-proxy reports 82.6 (IQR 69.1, 91.3), and girls’ parent-proxy reports 
69.6 (IQR 55.4, 87.0).  
 
4.6.3.2 Psychosocial Score 
The psychosocial score for the healthy weight controls ranged from 6.7 to 100.0, median 
was 88.3 (IQR 76.7, 96.7), median for the boys 90.0 (IQR 76.7, 98.3), and for the girls 
86.7 (IQR 73.3, 96.7). In comparison, the psychosocial score for the healthy weight parent-
proxy report of the whole sample ranged from 20.0 to 100.0, median for the parent-proxy 
report 76.7 (IQR 63.3, 90.0), for the boys’ 78.3 (IQR 66.7, 91.7) and for the girls’ 70.0 
(IQR 58.3, 86.7). 
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Table 4.2 Health-related quality of life scores, median (IQR) from self-report and parent-proxy report of the obese group 
Variable  Boys
 
Girls
 
Total
 
Self-report
 
n=142
 
n=82
 
n=224
 
Physical score 90.6 (78.1, 100.0)
 
81.3 (68.0, 96.9)
 
87.5 (75.0, 100.0)
 
Psychosocial score 87.5 (78.3, 96.7)
 
82.5 (70.0, 91.6)
 
85.0 (75.0, 93.3)
 
Total score 88.0 (78.3, 96.7)
 
79.3 (70.4, 91.6)
 
84.8 (74.2, 95.4)
 
   
Parent-proxy report
 
n=91
 
n=71
 
n=162
 
Physical score  84.4 (62.5, 93.8)
 
81.3 (50.0, 93.8)
 
82.9 (59.4, 93.8)
 
Psychosocial score 76.7 (66.7, 86.7)
 
80.0 (61.7, 91.6)
 
76.7 (63.3, 88.3)
 
Total score 76.1 (65.2, 86.9)
 
81.5 (60.9, 90.2)
 
78.3 (62.8, 88.0)
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4.6.3.3 Physical Score 
 The physical score of the healthy weight group self-reports ranged from 18.8 to 100.0. 
Median score for the total healthy weight sample was 93.7 (IQR 81.2, 100.0), for boys 96.9 
(IQR 84.4, 100.0), and for girls was 87.5 (IQR 77.2, 96.9).  
The physical score for the parent-proxy reports ranged from 6.3 to 100.0, median 87.5 
(IQR 62.5, 96.9), for the boys’ 90.6 (IQR 71.9, 96.9) and for the girls’ 75.0 (IQR 50.0, 
93.7).  
 
4.6.4 Matched paired comparison of HRQL between the obese vs healthy weight 
(control) group (n=98 matched pairs) 
4.6.4.1 Self-Reports 
Formal matched pairs were formed between obese and normal weight groups based on age 
and gender as shown in table 4.4. There were no statistically significant differences in 
HRQL between the obese and normal weight adolescents self-reports, using the total score 
and psychosocial score scales. The median of the total score of the obese group was 84.8 
and for the healthy weight group was 88.0 (95% CI -0.5, 7.1; p 0.08). The median of the 
psychosocial subscale for the obese group was 85.0 and for the healthy weight group was 
88.3 (95% CI -1.6, 7.5; p 0.2). However, the difference in the physical score between the 
obese group and the healthy weight group was statistically significant with median score 
for the obese group at 87.5 and median score for the healthy weight group at 90.6 (95% CI 
1.5, 9.4; p 0.01).    
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Table 4.3 Health-related quality of life scores, median (IQR) from self-report and parent-proxy report of the healthy weight group 
Variable 
 
Boys
 
Girls
 
Total
 
Child self-report
 
n=176
 
n=100
 
n=276
 
Physical score 96.9 (84.4, 100.0) 87.5 (77.2, 96.9) 93.7 (81.2, 100.0) 
Psychosocial score 90.0 (76.7, 98.3) 86.7 (73.3, 96.7) 88.3 (76.7, 96.7) 
Total score 92.4 (78.3, 97.8) 86.4 (75.0, 95.6) 89.1 (76.4, 96.7) 
   
Parent-proxy report
 
n=125
 
n=87
 
n=212
 
Physical score  90.6 (71.9, 96.9) 75.0 (50.0, 93.7) 87.5 (62.5, 96.9) 
Psychosocial score 78.3 (66.7, 91.7) 70.0 (58.3, 86.7) 76.7 (63.3, 90.0) 
Total score 82.6 (69.1, 91.3) 69.6 (55.4, 87.0) 79.3 (62.0, 91.3) 
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Table 4.4 Paired comparisons of health related quality of life (HRQL) for the healthy-weight group vs obese group, median (IQR) 
  Healthy-weight group  Obese group 95% CI p-value   
Variable
 
n=98 n=98       
Self-report
 
Median (IQR) Median (IQR) 
Physical score 90.6 (81.3, 100.0) 87.5 (68.8, 100.0) 1.5, 9.4 0.01 
Psychosocial score 88.3 (76.7, 95.0) 85.0 (73.3, 93.7) -1.6, 7.5 0.2 
Total score 88.0 (78.0, 95.7) 84.8 (70.7, 95.7) -0.5, 7.1 0.08 
Parent-proxy report
 
Physical score 86.0 (56.3, 96.9) 81.3 (62.5, 93.8) -4.7, 6.3 0.7 
Psychosocial score 76.7 (65.0, 90.0) 76.7 (61.7, 90.0) -3.4, 5.8 0.7 
Total score 79.3 (59.8, 91.3) 78.8 (63.6, 88.0) -2.8, 6.0 0.5   
Healthy-weight and obese group median age 12.4 (2.1); median BMI Z score for the healthy-weight group 0.1 (1.1);  
median BMI Z score for the obese group 2.1 (0.4). All pairs were taken from the same school year 
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4.6.4.2 Parent-proxy reports 
As shown in table 4.4 there were no statistically significant differences in parent-proxy 
reports between the obese group and healthy weight group. In total score, the median for 
the obese group was 81.3 and for the healthy weight group was 86.0 (95% CI -2.8, 6.0; p 
0.5). The median of the psychosocial score in the obese group was 76.7 and for the healthy 
weight group was 76.7 (95% CI -3.4, 5.8; p 0.7). And the median for the physical score in 
the obese group was 81.3 versus 86.0 in the healthy weight group (95% CI -4.7, 6.3, p 0.7). 
 
4.6.5 Matched paired comparison of HRQL between obese males vs healthy weight 
males (n=57 matched pairs) 
4.6.5.1 Self-reports 
Separate analysis was carried out as shown in table 4.5, to compare self-report and parent-
proxy reports between the obese males and the healthy weight males. The median of the 
total score for the healthy weight males self-reports was 88.0, and for the obese males was 
89.1 (95% CI -3.3, 5.4, p 0.5). For the psychosocial score, the median for the healthy 
weight males was 88.3 and for the obese males was 88.3 (95% CI -3.4, 5.9, p 0.6). 
Similarly, the difference in the median of the physical score between the healthy weight 
males and obese males was not statistically significant; median for the healthy weight 
males was 93.8 and for obese males was 93.8 (95% CI -1.6, 6.3, p 0.2).  
 
4.6.5.2 Parent-proxy reports 
The median of the total score for the obese group was 76.1, and for the healthy weight 
group was 84.8 (95% CI 0.0. 10.9, P 0.05), the difference of which is statistically 
significant. The median of the psychosocial score for the obese group was 75.0 and for the 
healthy weight group was 80.0 (95% CI -1.6, 10.8; P 0.14). The median of the physical 
score for the obese group was 81.2 and for the healthy weight group was 93.7 (95% CI 0.0-
11.0; P 0.07).   
 
4.6.6 Matched paired comparison of HRQL between obese females vs healthy weight 
females (n=41 matched pairs) 
4.6.6.1 Self-reports 
The data of the female matched pairs are presented in table 4.6. The median of the total 
score for the obese group was 75.0 and for the healthy weight group was 88.0, statistically 
significant difference (95% CI 0.5, 13.0, p 0.04). In the psychosocial score, there was no 
significant difference between the obese group (median 80.0) and healthy weight group 
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(median 86.7) where the 95% CI was -0.8, 13.4 and p value of 0.09. However, the 
difference in the physical score between the obese group (median 78.1) and healthy weight 
group (median 87.5) was statistically significant where the 95% CI was 3.1, 14.1 and p 
value was 0.01.  
 
4.6.6.2 Parent-proxy reports 
None of the differences in the scores between obese group and healthy weight groups were 
statistically significant as shown in table 4.6. In the total score, median for the obese group 
was 82.6 and for the healthy weight group was 62.0 (95% CI -14.1, 3.2; p 0.2). For the 
psychosocial score, the median of the obese group was 80.0 and for the healthy weight 
group was 66.7 (95% CI -11.6, 3.4; p 0.3). For the physical score, the median for the obese 
group was 81.3 and for the healthy weight group 62.5 (95% CI -20.4, 3.1; p 0.2). 
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Table 4.5 Paired comparison of health related quality of life (HRQL) for healthy weight boys group vs obese boys group 
  Healthy weight boys
 
Obese boys 95% CI p-value 
Variables n= 57
 
n= 57     
Child-self report
 
Median (IQR)
 
Median (IQR) 
Physical score 93.8 (84.4-100.0)
 
93.8 (79.7-100.0) -1.6, 6.3 0.2 
Psychosocial score 88.3 (75.0-95.9)
 
88.3 (77.5-95.0) -3.4, 5.9 0.6 
Total score 88.0 (76.7-96.7)
 
89.1 (78.8-95.7) -3.3, 5.4 0.5 
 
Parent-proxy report
 
 
Physical score 93.7 (68.8-98.5)
 
81.2 (64.1-93.7) 0.0, 11.0 0.07 
Psychosocial score 80.0 (66.7-92.5)
 
75.0 (60.9-88.3) -1.6, 10.8 0.1 
Total score 84.8 (70.7-93.0)
 
76.1 (64.1-88.0) 0.0, 10.9 0.05 
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Table 4.6 Paired comparison of health related quality of life (HRQL) for healthy weight girls group vs obese girls group 
  Healthy weight girls
 
Obese girls 95% CI p-value 
Variables n= 41
 
n= 41     
Self-report
 
Median (IQR)
 
Median (IQR) 
Physical score 87.5 (79.7-98.5)
 
78.1 (65.6-92.2) 3.1, 14.1 0.01 
Psychosocial score 86.7 (77.5-95.0)
 
80.0 (67.5-92.5) -0.8, 13.4 0.09 
Total score 88.0 (78.3-94.1)
 
75.0 (68.0-95.1) 0.5, 13.0 0.04 
 
Parent-proxy report
 
 
Physical score 62.5 (46.9-90.6)
 
81.3 (56.3-96.9) -20.40, 3.1 0.2 
Psychosocial score 66.7 (60.9-85.0)
 
80.0 (61.7-91.7) -11.6, 3.4 0.3 
Total score 62.0 (54.9-85.9)
 
82.6 (61.9-90.8) -14.1, 3.2 0.2 
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4.6.7 Differences between self-reports and parent-proxy reports for the obese 
adolescents 
Table 4.7 summarises the data of the obese adolescent self and parent-proxy reports. The 
median age of the sample was 12.3 (IQR 11.3 – 13.4, n=162). There were 91 males for the 
paired comparison (median age 12.4, IQR 11.4 – 13.4) and 71 females for the paired 
comparison (median age 12.2, IQR 11.1 – 13.2). All the differences in median of the total, 
psychosocial and physical scores between obese adolescents’ self-report and parent-proxy 
reports were statistically significant (p ˂ 0.001). The differences in in median between 
male-self report and parent-proxy report of the total, psychosocial and physical scores were 
all statistically significant (p ˂ 0.001), so was the difference in the median of the female-
self report and parent-proxy report for the physical score (p 0.03). However, the difference 
in the median of the total score and the psychosocial score between the female-self report 
and parent-proxy report were not statistically significant (p 0.06, 0.1, respectively). 
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Table 4.7 Comparison between HRQL score of self-report and parent-proxy report for the obese group 
  Self-report Parent-proxy report 95% CI p- value 
Median (IQR) Median (IQR) 
Males (n=91)
 
 
Total score 89.1 (79.3-96.7) 76.1 (65.2, 86.9) 6.5 - 13.6 ˂ 0.001 
Psychosocial score 88.3 (78.3-96.7) 76.7 (66.7, 86.7) 6.7 - 14.2 ˂ 0.001 
Physical score 90.6 (78.1-100.0) 84.4 (62.5, 93.8) 3.2 - 12.6 ˂ 0.001 
 
Females (n=71)
 
 
Total score 81.5 (70.7-92.4) 81.5 (60.9, 90.2) -0.1 - 9.8 0.06 
Psychosocial score 83.3 (71.7-91.7) 80.0 (61.7, 91.6) -0.9 - 9.1 0.1 
Physical score 84.4 (65.6-96.9) 81.3 (50.0, 93.8) 0.0 - 12.5 0.03 
 
Total  (n=162)
 
 
Total score 86.5 (73.9-95.6) 78.3 (62.8, 88.0) 4.9 - 10.9 ˂ 0.001 
Psychosocial score 86.7 (75.0-93.7) 76.7 (63.3, 88.3) 4.2 - 10.8 ˂ 0.001 
Physical score 87.5 (75.0-100.0) 82.9 (59.4, 93.8) 3.2 - 11.0 ˂ 0.001 
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4.6.8 Regression analysis of predictors of HRQL 
Age, gender and weight status were considered as potential factors which might influence 
HRQL in the present study and so were included in regression analysis which aimed to 
determine if any influence of obesity on HRQL was independent of age and sex 
(summarised in  4.8).  
 
Table 4.8 Regression analysis of predictors of HRQL (p) 
Variable Self-report Total score   Parent-report Total score   
        
Age 0.1 ˂ 0.001 
Gender 0.02 ˂ 0.001 
weight status 0.1 0.6 
          
 
 
From adolescent perspective, age and weight status had no significant predictive 
association with HRQL in the scale chosen for the analysis i.e. the total score (p 0.1 for 
both factors), however, gender showed some association but was statistically insignificant 
(p 0.02).  
In the parent-report analysis, age and gender had significant association with HRQL total 
score, and obesity had no association (p 0.6).   
 
4.7 Discussion 
Impact of obesity on HRQL- Main findings and study implications 
The present study found few significant differences in HRQL domains between obese 
Kuwaiti adolescents and healthy weight Kuwaiti adolescents when paired comparisons 
were made between the obese versus healthy weight groups. The only statistically 
significant difference found in the paired comparisons was in the physical score, though 
the total score difference approached significance, though the regression analysis did 
suggest that obesity was not associated with impairment of HRQL, at least in the total 
score. Differences between the obese and the healthy weight groups in HRQL were 
generally smaller than might have been expected from the literature on Western samples of 
obese children and adolescents (discussed in more detail below) 
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In the present study, gender was an important factor, as obese females’ HRQL scores were 
generally lower than those of obese males, and in the paired comparisons between obese 
and non-obese groups differences which were significant emerged in the girls which were 
not present in the boys(Table 4. 4,4.5, and 4.6). In the regression analyses both female sex 
and obesity tended to predict lower HRQL and so it seems that HRQL was lower in girls 
than boys in the present study, and was more impaired in the obese girls than in obese 
boys.  
 
A summary of the main findings of this study is as follows: 
A. Formal matched pairs were formed between the obese and healthy weight 
adolescents on a total of 98 pairs with median age 12.3 years.  
B. The difference in physical score between the pairs was statistically significant p 
0.007. 
C. The difference in the total score approached significance due to the effect of the 
difference in the physical score between groups (p 0.08). 
D. No differences were found in parent-proxy reports between the obese and healthy 
weight groups. 
E. Obese boys had similar scores in the physical, psychosocial, and total scores to the 
healthy weight boys (n= 57). 
F. Obese girls had statistically significant difference in the total and physical scores 
and a trend of lower psychological score (p 0.04, 0.006 and 0.09, respectively). 
G. Differences between parent-proxy reports and obese adolescents’ self-report in 
total, psychosocial and physical scores were statistically significant (p ˂ 0.001). 
       
Impact of obesity on HRQL- Comparisons with other studies 
For the purpose of this thesis, it is essential to compare studies coming from different parts 
of the world which investigated the effect of paediatric obesity on HRQL using the 
PedsQL™4.0 questionnaire with our study. As mentioned in the introduction; research in 
this area was carried out primarily from the Western world and more recently the Far East 
and found that obesity had negative impact on paediatric HRQL (Ul-Haq et al., 2012, 
Griffiths et al., 2010, Hamzaid et al., 2011, Hughes et al., 2007). So in order to appreciate 
the magnitude of our findings, comparison with other research findings from different parts 
of the world should be carried out. Hughes et al. (Hughes et al., 2007) compared the HRQL 
between obese and healthy weight children aged 5 to 11 years in Scotland. Using 
PedsQL™4.0 self-report questionnaire, Hughes et al. found that HRQL was impaired in 
obese children compared to healthy weight peers. They also found that this impairment 
was much more marked when assessed by parents than by child self-report. In contrast, 
Hamzaid et al. (Hamzaid et al., 2011) in the MASCOT study (Malaysian Childhood 
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Obesity Treatment Trial); found that impairment of HRQL in obesity was much more 
marked when using child-self report rather than parent-proxy report. Table 4.9 displays the 
median and IQR of the physical score, psychosocial score and total score of the present 
study, SCOTT and MASCOT. The median of obese Kuwaiti adolescent-self report in the 
physical, psychosocial and total scores were higher than child-self reports in MASCOT 
and SCOTT.   
 
One previous study of HRQL in adolescents and young adults in Kuwait: Al-Fayez and 
Ohaeri (Al-Fayez and Ohaeri, 2011) used a different instrument to measure HRQL and 
included older participants than those recruited to the present study, 14-23 y olds. In the 
study by Al-Fayez and Ohaeri (Al-Fayez and Ohaeri, 2011) HRQL scores were lower than 
in samples from western countries, lower in females than males, but the influence of 
obesity on HRQL was not considered. The reasons why HRQL is lower in girls than boys 
was not the main focus of the present study, but was consistent with the findings of Al-
Fayez and Ohaeri (Al-Fayez and Ohaeri, 2011).    
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Table 4.9 Health-related quality of life scores, median (IQR) from obese child-self report of Kuwaiti adolescents (10 to 14 years), Malaysian children (9.6 to 10.5 years) 
and Scottish children (5 to 11 years) 
Variable    Child self-report   Parent-proxy report   
Kuwait(Boodai and Reilly, 2013)   n=162 n=162   
Physical score 87.5 (75.0-100) 82.9 (59.4-93.8) 
Psychosocial score 86.7 (75.0-93.7) 76.7 (63.3-88.3) 
Total score 86.5 (73.9-95.6) 78.3 (62.8-88.0) 
Malaysia (MASCOT)(Hamzaid et al., 2011) n=90 n=90 
Physical score  82.9 (65.7-90.6) 67.2 (59.4-81.3) 
Psychosocial score 62.5 (53.3-75.4) 62.5 (53.3-75.4) 
Total score 76.1 (64.1-84.8) 65.2 (57.3-76.1) 
Scotland (SCOTT)(Hughes et al., 2007) n=126 n=126 
Physical score 75.0 (61.7-84.4) 71.8 (59.4-81.2) 
Psychosocial score 73.3 (61.3-83.3) 65.0 (54.8-76.7) 
Total score 73.7 (62.4-82.8) 65.6 (56.7-77.8) 
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Median HRQL scores in the Kuwaiti parent-proxy reports in the present study were higher 
than that of parent-proxy reports in the studies in Scotland and Malaysia (Hamzaid et al 
2011, Hughes et al. 2007). This basic comparison raises the question of whether HRQL of 
obese Kuwaiti adolescents, while there was evidence that it was impaired in the present 
study, was impaired to the extent that this was a problem. Another way of looking at it is 
whether the HRQL scores of the present study samples were at the low end or below the 
low end of the normal range, but no thresholds or ‘normal range’ for diagnosis of low 
HRQL exists at present  
 
Differences between adolescent-self report and parent-proxy report-main findings and 
study implications 
The present study showed that parent-reported HRQL was significantly lower than 
adolescent-reported HRQL in all measured domains. This discrepancy in scores does not 
mean exaggerated parents’ perception of their child obesity, nor does it suggest the 
invalidity of the adolescents’ perception of their disease. It might simply reflect how 
parents see their child’s obesity problem as having greater implications for their physical 
functioning and social wellbeing than the adolescents perceive (Eiser and Morse, 2001).  
Beside the present study, many paediatric obesity studies find that parent-proxy reports of 
HRQL to be lower than paediatric-self reports (Hughes et al., 2007, Pinhas-Hamiel et al., 
2006, Schwimmer et al., 2003). However, other studies have found smaller or no 
significant differences between parent and child/adolescent self-reports (Hamzaid et al., 
2011, Williams et al., 2005). It has been suggested that these differences between 
paediatric and parent perceptions of the paediatric HRQL in relation to obesity emphasises 
the importance of using both paediatric-self reports and parent-proxy reports when 
assessing HRQL of obese children and adolescents (Ingerski et al., 2007). It has also been 
suggested that these differences could have been the driving force for parents to seek 
professional help for their children’s obesity (Tsiros et al., 2009) and this help should be 
offered for the whole family, not only the obese child.  
 
4.7.1 Strengths, limitations and future research 
The present study is the first to date describing HRQL in a community sample of obese 
Kuwaiti adolescents. It was done on a 224 obese Kuwaiti adolescents and compared their 
HRQL score with 276 healthy weight peers, which provided adequate power. The use of a 
valid and reliable HRQL measurement tool (PedsQL ™ 4.0) on such a large and 
homogenous sample also adds to the strengths of the present study. However, possible 
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confounding factors like race and socioeconomic status could not be accounted for in this 
study. In Kuwait, no official definition of social class is present. Also, no consensus exists 
within the research community on how to define social class in this state with one of the 
highest per capita incomes in the world. One other limitation is the possibility of sampling 
error; it is not clear how representative the sample selected is and a study with a 
representative sample would have been ideal. 
 
On the other hand, further studies in other samples with other age range and other settings 
are required in order to reach consensus regarding HRQL and obesity in Kuwaiti paediatric 
population, so that for example any effects of obesity on HRQL in children (rather than 
adolescents) can be determined, and also determine any effects of obesity on clinical 
sample of obese children/adolescents.  
 
4.8 Conclusion 
The present study suggests that quality of life might not be impaired very dramatically in a 
community sample of obese Kuwaiti adolescents. Any obesity-related HRQL impairment 
may be more marked in girls than boys and may be more marked when parent-proxy 
reports are used than when self-reports are used. However, it also recommends the need for 
more educational and informative community programmes to increase population’s 
perception on the impact of obesity on health in general and quality of life in specific. As 
for treatment objectives, it recommends that intervention programmes for the treatment of 
adolescents’ obesity in Kuwait should be directed at both adolescents and their parents. 
This resilience in adolescents’ HRQL should be considered when constructing treatment 
protocols.  
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5. Cardiometabolic Risk Factors in a Sample of 
Obese Kuwaiti Adolescents 
BOODAI, S. A., CHERRY, L., SATTAR, N. & REILLY, J. J. In press-a. Prevalence of cardiometabolic risk 
factors and metabolic syndrome in obese Kuwaiti adolescents. Diabetes Metab Syndr Obes. Appendix F. 
 
5.1 Introduction 
Childhood and adolescent obesity increase the risk of both current and future health 
disorders as noted in chapter 1 (Reilly, 2006, Dietz, 1998). Childhood and adolescent 
obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, 
dyslipidaemia, inflammation, liver disease and compromised vascular function (Franks et 
al., 2010, Lenz and Diamond, 2008, Freedman et al., 2001, Kolterman et al., 1981). As 
with obesity, these impairments could track into young adulthood which increases the risk 
of cardiometabolic diseases and even certain types of cancer independent of adult weight 
(Beauloye et al., 2007, Reilly et al., 2003). This is an important public health issue which 
reflects the need for policy for early detection, timely treatment, and development of 
prevention and treatment interventions for this specific group.   
Therefore, this chapter focuses on the assessment of these cardiometabolic risk factors in a 
reasonably homogenous sample of obese Kuwaiti adolescents undergoing educational 
group therapy for the treatment of their obesity (NATTO, as described in chapter 6).  
 
The detrimental effects of adolescent obesity on subsequent risk of cardiovascular disease 
are partly mediated by the presence of cardiometabolic risk factors (Juonala et al., 2011). 
Cardiovascular disease is the leading cause of morbidity and mortality worldwide with an 
estimate of 17.3 million deaths in 2008 and by 2030 this number could reach up to 23.3 
million (Alwan, 2011). It is widely believed that atherosclerosis begins in childhood and 
progresses into adulthood (Strong et al., 1992, Zieske et al., 2002). Results from the 
Bogalusa Heart Study, a prospective study  in the USA following children for 
cardiovascular risk factors since 1972, showed that as the number of cardiovascular disease 
risk factors increase in childhood, so does the severity of both coronary and aortic 
atherosclerosis in young adulthood (Freedman et al., 2001). In the Netherlands, 2/3 of the 
severely obese children and adolescents had more than one cardiovascular disease risk 
factor in one study (van Emmerik et al., 2012). In Germany and Switzerland around 50% 
of obese children have at least one cardiometabolic risk factor (l'Allemand-Jander, 2010). 
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These cardiometabolic risk factors exert their effects on endothelial function and structure 
resulting in endothelial dysfunction, carotid intimal thickness and increased arterial 
stiffness (Beauloye et al., 2007, Skilton and Celermajer, 2006, Balagopal et al., 2005, 
Iannuzzi et al., 2004). Thus the presence of these cardiometabolic risk factors does not 
necessarily suggest morbidity at a young age, but can predict the early development of 
cardiovascular disease which will be manifest later in life.  
 
The presence of obesity in childhood and adolescent is also related to the development of 
fatty liver or steatosis, which is the most common liver abnormality in this age group 
(Schwimmer et al., 2006). Steatosis can exist with or without elevated liver enzymes 
(aminotrasferases) (Strauss et al., 2000). For the long term, the ramifications of having 
persistently elevated liver enzymes and steatosis are very important and could lead 
eventually to the development of cirrhosis (Weiss and Kaufman, 2008, Schwimmer et al., 
2006).   
 
In the present study we carried out assessments of obesity-related cardiometabolic risk 
factors that could impair vascular health and liver function. These included lipid profile 
(Cholesterol, LDL, VLDL, HDL, TG), IL-6, ICAM, CRP, adiponectin, liver function tests 
(ALT, AST, gGT) and insulin resistance (described in detail in the next section). To date, 
there are no published studies on the prevalence of these risk factors among Kuwaiti 
adolescents.  
 
The main original intention of the present study was to measure these cardiometabolic risk 
factors before and after initiation of a family-based obesity treatment intervention 
(NATTO, described in chapter 3) and to test whether these risk factors changed during the 
course of weight management. This plan had a potential value in directing and shaping 
future treatment interventions done in Kuwait. Finding the prevalence of cardiometabolic 
risk factors in a sample of obese Kuwaiti adolescents could potentially persuade families to 
take part in future treatment trials, if they knew that some of these risk factors could be 
present in their children and pose a threat to their health. Finding that cardiometabolic risk 
factors change positively during weight management would probably encourage future 
obesity treatment efforts in Kuwait. 
 
In fact, the assessment of cardiometabolic risk factors in the present study was cut short, 
and only baseline measures were taken due to difficulties faced with the authorising body 
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in the Ministry of Health-Kuwait (see discussion). However, having baseline data on 
cardiometabolic risk factors still provided valuable information on the extent of these risk 
factors in a group of obese Kuwaiti adolescents, and might be a useful tool to engage 
families in treatment interventions in future (chapter 6). So in the end the main aim of the 
present study was to establish the prevalence of novel (adiponectin has not been measured 
in obese Kuwaiti adolescents before) and traditional cardiometabolic risk factors in obese 
Kuwaiti adolescents, in order to establish whether such measures might be useful to 
encourage greater engagement with obesity treatment in future adolescent obesity 
treatment trials in Kuwait. 
 
5.2 Methods  
5.2.1 The cardiometabolic risk factors  
5.2.1.1 Dyslipidaemia 
Cholesterol, VLDL, LDL, HDL and TG 
Cholesterol is a steroid that is synthesised in many types of tissue, but particularly in the 
liver and the intestinal wall (Harvey and Ferrier, 2011). Approximately three quarters of 
cholesterol is newly synthesised and a quarter originates from dietary intake. It is a 
structural component of all cell membranes, modulating their fluidity, and, in specialised 
tissues, cholesterol is a precursor of bile acids, steroid hormones, and vitamin D (Harvey 
and Ferrier, 2011).   
 
Very low density lipoproteins (VLDL) are composed mainly of endogenous 
triacylglycerols (TAG) and are produced in the liver. Their function is to carry TAG from 
the liver to the peripheral tissue (Harvey and Ferrier, 2011).  
 
Low density lipoproteins (LDL) are derived from VLDL by the action of lipoprotein lipase 
in the plasma. They are rich in cholesterol and cholesterol esters.  The primary function of 
LDL particles is to provide cholesterol to peripheral cells or return it to the liver (Harvey 
and Ferrier, 2011).     
 
High density lipoproteins (HDL) are responsible for the reverse transport of cholesterol 
from the peripheral tissue to the liver (Harvey and Ferrier, 2011). Here, cholesterol is 
transformed into bile acids ready for excretion into the small intestine via the biliary tract 
(Harvey and Ferrier, 2011).  
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Dyslipidaemia occurs when there is impairment in the lipid profile of an individual 
characterised by the presence of one or more of the following: elevated total cholesterol, 
elevated LDL, elevated TG, low concentration of HDL.  The association between 
dyslipidaemia and atherosclerosis is well established and is considered the primary risk 
factor for its development (Herouvi et al., 2013). Atherosclerotic lesions cause structural 
damage through accumulation of fatty streaks in the arterial wall obstructing the lumen and 
reducing the blood flow to varying degrees. This can lead to the development of coronary 
artery disease, stroke, aortic aneurysm, and peripheral vascular disease (Baker et al., 2008, 
Gielen and Hambrecht, 2004, Strong et al., 1992). However, the diagnosis and treatment of 
dyslipidaemia can reverse these conditions (Herouvi et al., 2013, Beauloye et al., 2007, 
Zieske et al., 2002, Strong et al., 1992, Holman et al., 1958).  
 
There has been pathological evidence of atherosclerosis in adolescents and young adults 
with obesity. According to the Pathobiological Determinants of Atherosclerosis in Youth 
(PDAY) study (McMahan et al., 2006, McGill et al., 2002), the prevalence of 
atherosclerotic lesions in coronary arteries of humans aged 15 to 35 is higher in males and 
increases with BMI and panniculus adiposus thickness (abdominal subcutaneous fat). The 
typical dyslipidaemic pattern in obese children and adolescents is characterised by elevated 
total cholesterol, elevated TG, top normal to mildly elevated LDL and decreased HDL, 
compared to healthy weight controls  (Friedland et al., 2002, Kwiterovich, 2008), and this 
profile could track into adulthood. In fact, results from the Bogalusa Heart Study showed 
that obese adolescents who continue to be obese adults have a 2.4, 3.0 and 8.0 times higher 
chance of having abnormal LDL, TG and HDL levels, respectively, than those who were 
and remained lean (Srinivasan et al., 1996). Juonala and colleagues (Juonala et al., 2011) 
had collected data from large prospective studies namely the Bogalusa Heart study (USA), 
the Muscatine study (USA), the Childhood Determinants of Adult Health study (Australia) 
and the Cardiovascular Risk in Young Finns Study (YFS, Finland) with sample size of 
6328 subjects that were followed from childhood for an average of 23 years. Obesity was 
defined using the International Obesity Task Force definition for children and BMI cutoff 
of 30 for adults. Obese adults who were obese children, as compared to healthy weight 
adults who had their weight in the healthy range during childhood, had a 1.8 increased risk 
of elevated LDL, 2.1 increased risk of decreased HDL level, 3.0 fold increased risk of 
elevated TG (p≤0.002 for all comparisons). In a sample of 26,000 6 to 18 year old obese 
children and adolescents from Germany and Switzerland,  32% had one or more lipid 
profile abnormality (l'Allemand-Jander, 2010).    
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5.2.1.2 Inflammatory markers 
It is well established that obesity is associated with a state of chronic low grade 
inflammation (Yudkin et al., 1999, Gustafson et al., 2007), in children and adolescents 
(Ford et al., 2004, Warnberg et al., 2004, Visser et al., 2001).  
 
Adipose tissue serves as an organ for lipid storage and also plays a major endocrine role in 
secreting various adipokines like leptin and adiponectin as well as other immune related 
mediators involved in inflammation. These mediators include pro-inflammatory cytokines 
such as interleukin-6 (IL-6), which in turn activate the synthesis of hepatic acute phase 
inflammatory proteins such as C-reactive protein (CRP), and therefore adipose tissue has a 
key role in the mechanism of low grade chronic inflammatory state associated with obesity 
(Trayhurn and Wood, 2004).   
 
The pathophysiological process of the development of atherosclerotic lesions involves 
local inflammation as a promoter of fatty deposits and plaque formation (Lind, 2003). 
One of these inflammatory promoters is CRP. CRP is a protein synthesised in the liver and 
plays a major role for complement system activation as part of the body defence 
mechanism against infections. Elevated CRP level is considered an independent pro-
atherogenic factor due to its roles in stimulating endothelial production of adhesion 
molecules, mediating the attraction of monocytes in the area of the atherosclerotic lesions, 
mediating the uptake of LDL into macrophages which is novel mechanism for foam cell 
formation prior to fatty deposition (Jarvisalo et al., 2002). Therefore, CRP measurements 
are useful for the detection and monitoring of the inflammatory status of the body.  
 
CRP levels have been shown to be higher in obese than in healthy weight adults and 
children (Trayhurn and Wood, 2004, Jarvisalo et al., 2002, Visser et al., 2001, Yudkin et 
al., 1999). This may be related to the overexpression of the cytokine interleukin-6 (IL-6) 
from the excessive adipose tissue and its release to the circulation where it is considered 
the primary promoter of the synthesis of CRP by the liver (Visser et al., 2001).  
 
IL-6 is a cytokine secreted by activated macrophages and lymphocytes. However, third of 
the total secreted levels of IL-6 comes from adipose tissue, particularly visceral adipose 
tissue (Yudkin et al., 2000). There are other cytokines released by adipose tissue such as 
tumour-necrosis factor α (TNF-α). IL-6 was found to be significantly elevated in obese 
adolescents compared to healthy weight controls (Makni et al., 2013). 
 97 
 
Priming the endothelial cells for the atherosclerotic plaque formation depends on the 
release of cell adhesion molecules expressed on the surface of endothelial cells. These 
adhesion molecules facilitate the binding of monocytes and lymphocytes to the 
endothelium in the early stages of atherosclerosis development. Of these adhesion 
molecules are the vascular cell adhesion molecule (VCAM) and intracellular adhesion 
molecule (ICAM). Circulating levels of these adhesion molecules are considered predictors 
for acute vascular events (Lind, 2003). Obesity in adults (Straczkowski et al., 2002) and 
children (Martos et al., 2009) has been associated with higher levels of circulating 
endothelial adhesion molecules such as ICAM. The hypothesis behind this association is 
related to the release of CRP (see earlier) and of angiotensinogen and angiotensinogen 
converting enzyme by adipocytes, a system that contribute of the vasoconstriction and also 
stimulates the production of ICAM from the dysfunctional endothelium (Herouvi et al., 
2013, Gustafson et al., 2007).  
 
5.2.1.3 Anti-inflammatory markers in adipose tissue 
Adiponectin is an adipokine (a protein synthesised only in adipose tissue) which has an 
anti-inflammatory action. It inhibits phagocytosis, inhibits TNF-α production by 
macrophages, plays a key role in modulating insulin sensitivity as well as having anti-
atherogenic activity (Trayhurn and Wood, 2004). Its secretion is markedly reduced in 
obesity, insulin resistance and type 2 diabetes (Gustafson et al., 2007). In obese children 
and adolescents, adiponectin levels are low and this is associated with elevated 
inflammatory markers, mainly CRP (Winer et al., 2006). From the Bogalusa Heart Study, 
in a sample of 835 24 to 42 year old adults, the mean adiponectin levels were lower for 
every 1 mm of childhood skinfold thickness (Toprak et al., 2011). It has been suggested 
that adiponectin could be used as a marker for metabolic syndrome in children and 
adolescents (Winer et al., 2006). Reductions in the BMI of obese children and adolescents 
could increase adiponectin and HDL levels (Herouvi et al., 2013).   
 
5.2.1.4 The metabolic syndrome (MS) 
A clustering of cardiovascular disease risk factors in adults was first described by Reaven 
in 1988 (Reaven, 1988) and was termed by the Metabolic Syndrome (MS), Syndrome X, 
or Insulin Resistance Syndrome. It is characterised by the presence of central obesity, 
hypertension, dyslipidaemia with high TG concentrations and low HDL concentrations, 
and hyperglycaemia (Sovio et al., 2013, Gustafson et al., 2007). The diagnosis in adults is 
made when three out of these five criteria is present (Alberti et al., 2009). Such a clinical 
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profile predisposes the individual to develop atherosclerotic cardiovascular disease 
(ACVD) and type 2 diabetes mellitus. Mortality from ACVD is nearly doubled in 
individuals suffering from MS compared to the normal population and these individuals 
have 3 to 4 times increased risk of developing ACVD (Haffner, 1999).  
 
The definition of MS in children and adolescents is not yet standardised, but the need to 
identify children and adolescents with increased risk of developing cardiovascular disease 
and diabetes type 2 remains extremely important (Reinehr et al., 2007). Several studies 
have found clustering of components of MS  in the paediatric population. For example; 
paediatric obesity and hypertension (Salman et al., 2010, Angelopoulos et al., 2006); 
paediatric obesity and glucose intolerance or type 2 diabetes (Sinha et al., 2002); paediatric 
obesity and dyslipidaemia (Korsten-Reck et al., 2008), Paediatric obesity, insulin 
resistance and dyslipidaemia (Sinaiko et al., 2005). Identifying children and adolescents 
with components of MS could help prevent future adult risk of cardiovascular disease and 
diabetes. In a prospective 25 year-long study, the Princeton Lipid Research Clinics Follow-
up Study showed that 4% adolescents (n=771, mean age 12. 9 years) had ≥ 3 components 
of MS, 77% of which were obese, and at follow-up, 27.2% of the 771 cohort had MS as 
adults (mean age 38 years) 6 of them had CHD (Morrison et al., 2007). Morrison and 
colleagues recommend early intervention to treat and prevent paediatric obesity to 
overcome the future clinical complications in adults (Morrison et al., 2007). However, the 
tracking pattern of MS criteria from childhood to adulthood according to a joint statement 
from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the 
Young Committee of the Council on Cardiovascular Disease in the Young; Council on 
Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism is 
unstable especially among adolescents and they have called for the assessment of 
cardiometabolic risk factors instead of having to assess the presence of MS especially in 
the clinical context (Steinberger et al., 2009). Furthermore, the definitions of MS in 
paediatrics were traditionally either based on adult cut off points or use a single set of cut 
points for all ages. To resolve this issue, the International Diabetes Federation in 2007 
published a set of paediatric MS criteria based on percentile definitions intended to be 
standard across the age range 6 to 16 (Zimmet et al., 2007). Subsequently, the application 
of the IDF definition has not been uniform across researchers and thus the prevalence of 
paediatric MS remains variable as a result of lack of a universal definition and variation in 
the definition used (Steinberger et al., 2009). Reinehr and colleagues (2007) compared the 
prevalence of MS among 1205 Caucasian overweight 4 to 16 year old Germans using eight 
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proposed definitions (Reinehr et al., 2007). The prevalence of MS varied significantly 
(p˂0.001) and ranged from 6 to 39% depending on the definition used. These definitions 
included Weiss et al. (Weiss et al., 2004), Viner et al. (Viner et al., 2005), de Ferranti et al. 
(de Ferranti et al., 2004), Cook et al. (Cook et al., 2003), the WHO (Alberti and Zimmet, 
1998), The National Cholesterol Education Program Adult Treatment Panel (ATP III) 
(2001), the European Group for the Study of Insulin Resistance (EGIR) (Balkau and 
Charles, 1999), and the IDF (Zimmet et al., 2007).    
 
5.2.1.5 Insulin resistance 
Insulin resistance, both in diabetic and nondiabetic individuals, is often associated with 
obesity, especially central obesity (Yudkin, 2003). The level of resistance occurs in both 
liver and skeletal muscles. This obesity-associated insulin resistance has been attributed to 
the presence of free fatty acids (FFAs), released through lipolysis of TG, which impairs 
insulin action in both hepatocytes and myocytes. Furthermore, many inflammatory 
cytokines released from adipocytes, such as TNF-α and IL-6, have inhibitory effect on 
insulin signalling and glucose uptake (Yudkin, 2003). Insulin resistance leads to a state of 
hyperinsulinaemia in order to produce a euglycaemic state, exhausting pancreatic β-bells 
and eventually leading to type 2 diabetes mellitus (Keskin et al., 2005).    
Quantifying insulin resistance is of great importance for clinical and epidemiological 
purposes. Methods of varying degrees of complexity exist for each of these purposes. One 
simple widely used surrogate index is the homeostatis model assessment (HOMA), which 
depends on blood insulin and glucose concentrations under fasting conditions using the 
equation; (fasting glucose x fasting insulin)/22.5 (Muniyappa et al., 2008).    
 
5.2.1.6 Non-alcoholic fatty liver disease (NAFLD) 
This is a broad term describing hepatic histological changes ranging from non-specific 
steatosis or fatty change to non-alcoholic steatohepatitis (NASH) which is a condition of 
having more than 5% of hepatocytes containing fat, degenerative changes and fibrosis. The 
diagnosis is made when ultrasound test shows fatty changes in the liver or with histological 
assessment (Welsh et al., 2013). There is no standard cut off value for serum ALT and 
AST but the most commonly used cut off point is a serum level of >40 U/L (Sohn et al., 
2013, Schwimmer et al., 2005) and >35 U/L for gamma-glutamyl transpeptidase (GGT; a 
biliary system enzyme) (Strauss et al., 2000).The condition is strongly associated with 
obesity and insulin resistance and is one of the most common liver disease worldwide 
(Koebnick et al., 2009, Schwimmer et al., 2008, Younossi et al., 2002) and is the most 
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common liver disease seen in paediatrics (Koebnick et al., 2009, Schwimmer et al., 2006). 
In Europe, NAFLD was present in 11 to 29% of overweight and obese children in two 
large studies, predominantly in boys (Wiegand et al., 2010, Reinehr and Toschke, 2009). 
Obese children diagnosed with NAFLD might also have cardiovascular disease risk factors 
including dyslipidaemia and hypertension (Schwimmer et al., 2008). More recently in USA 
the prevalence of NAFLD affects nearly 11% of the total population of the adolescents, a 
figure that has doubled over the past 20 years, with significant contribution of obesity as a 
risk factor (Welsh et al., 2013). However, data demonstrate that not all overweight and 
obese children and adolescents even with biopsy-proven NAFLD have raised levels of 
liver enzymes (Fracanzani et al., 2008). 
 
5.2.2 Study participants 
Participants in the present study were invited from among participants in the NATTO 
study (n=82, see chapter 2), a treatment intervention for adolescent obesity in Kuwait 
described earlier in the thesis (chapter 2). Eighty participants aged 10 to 14 years (40 
males) consented and underwent a baseline clinical examination, prior to the start of the 
NATTO study in 2009 and were diagnosed with obesity (BMI ≥ 95th percentile for age and 
sex according to US CDC reference data). The participants had no other morbidities and 
were willing to provide blood samples for the current study.  
 
5.2.3 Blood sampling 
Data were collected on the 80 obese adolescents (age 10-14 years) who participated in the 
National Adolescent Treatment Trial for Obesity (NATTO) RCT in 2009. Participants and 
their parents signed an informed consent form. The study was approved by the Ethics 
Committee for Medical Research-Ministry of Health-Kuwait.  
 
Participants underwent clinical examination including anthropometric assessment by the 
author. Blood sample collection was carried out by the author and it took place at 8 am in 
the outpatient clinic after an overnight fast (8-12 hours). The fasting state was verbally 
confirmed by the participants before sampling. Venous blood was obtained. Blood samples 
were collected directly in a 10-ml tubes containing EDTA as an anticoagulant. Blood 
samples were then immediately placed in ice and centrifuged (GS-6KR, Beckman 
Instruments, Inc, California, USA) within 15-30 minutes of collection for 15 minutes at 
3000 rpm and 4°C. EDTA plasma was pipetted into 5 aliqouts of 0.5 ml Eppendorf tubes 
(Treff Lab, Switzerland) and frozen immediately at 70°C for subsequent analysis.   
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5.2.4 Blood sample analysis 
Cholesterol, TG, HDL, sensitive CRP, ALT, AST and gGT assays were performed by Dr 
Lynne Cherry of the Metabolic Medicine Group of the Cardiovascular and Medical 
Sciences division based at the BHF-GCRC Building at University of Glasgow using a 
C311 Roche analyser. Sensitive CRP immunotubidimetric assays with cholesterol, TG, 
HDL, ALT, AST, and GGT being enzymatic colorimetic. Kits were supplied by Roche 
Diagnostic Gmbh. 
VLDL and LDL results were calculated using the Friedwald equation:  
LDL (mmol/L) = total cholesterol – (HDL + TG / 2.19) 
VLDL (mmol/L) = total cholesterol – LDL – HDL 
The manufacturer and supplier of these kits is Roche Diagnostics Gmbh, D-68298 
Mannhein, Distribution in USA: Roche Diagnostics Corporation, Indianapolis, IN, USA.  
IL-6, ICAM, adiponectin and insulin analysis (ELISAS) was carried out by Dr Lynne 
Cherry of the Metabolic Medicine Group of the Cardiovascular and Medical Sciences 
division based at the BHF-GCRC Building at University of Glasgow. Kits supplied by 
R&D Systems Europe Ltd. (19 Barton Lane, Abingdon Science Park, Abingdon, OX 14 
3NB, United Kingdom) and Mercodia AB. A Multiskan Ascent Plate reader and Ascent 
Software were used for calculation of results. Human IL-6 HS, cat nos HS600B. Human 
adiponectin, cat nos DRP300. Human ICAM, cat nos DCD540. Multiskan Ascent Plate 
reader and software supplied by Thermolife Sciences, Unit 5, The Ringway centre, Edison 
Road, Basingstoke, Hampshire, RG21 6YH, United Kingdom. Mercodia Ultrasensitive 
Insulin ELISA, cat nos 10-1132-01 (Mercodia AB, Sylveniusgatan 8A, SE-754 50 
Uppsala, Sweden).  
 
 5.2.5 The cut off points and definitions for the cardiometabolic risk factors     
Table 5.1 shows the cut off points for the cardiometabolic risk factors measured. The 
cardiometabolic risk factors included fasting blood glucose (FBG), Fasting insulin, 
homeostatic model assessment for insulin resistance (HOMA-IR), systolic and diastolic 
blood pressure, lipid profile (cholesterol, HDL, LDL, and TG), Liver function tests (ALT, 
AST, GGT), and inflammatory markers (CRP, IL-6, ICAM, and adiponectin).  
There are two commonly used cut off points for Fasting blood glucose(FBG, mmol/L),  the 
WHO normal cut off ˂ 6.1 mmol/L (WHO, 2006) and the American Diabetes Association 
normal cut off ˂ 5.6 mmol/L (Genuth et al., 2003). However, in Kuwait the official 
criterion used for diagnosing and classifying diabetes mellitus is the WHO criterion 
(Ahmed et al., 2013) and so that was used in the present study.  
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The resistance of the body to the action of insulin due to obesity results in overproduction 
of this hormone by the pancreas. Ideally, hyperinsulinaemia is defined if insulin level 
exceeds the normal value according to the pubertal stage due to the impact of physiological 
insulin resistance of puberty (Alberti and Zimmet, 1998). However, Tanner staging was 
not assessed during the clinical examination in the present study for social and cultural 
reasons, thus standard values of normal, borderline and high fasting insulin levels proposed 
by American Heart Association scientific statement was chosen (Williams et al., 2002) 
(table 5.1).  
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Table 5.1 Cut off points of blood parameters   
  Normal Borderline high High Reference 
TC, mmol/L ˂ 4.40 4.40 - 5.15 ≥ 5.18 
(NECP Panel, 1992) 
LDL, mmol/L ˂ 2.85 2.85 - 3.34 ≥ 3.37 
HDL, mmol/L > 1.66 1.55-0.91 (Borderline-low) ≥ 0.91 (low) 
TG, mmol/L 
   
2-9 y ˂ 0.85 0.85 - 1.12 ≥ 1.13 
10-19 y ˂ 1.02 1.02 - 1.46 ≥ 1.47 
FBG, mmol/L ˂ 6.10 6.10 - 6.90 (IFG) ≥ 7.00 (DM) (WHO, 2006) 
ALT, mmol/L ≤ 40.00 
 
> 40.00 (Siest et al., 1975, 
AST, mmol/L ≤ 40.00 
 
> 40.00 Strauss et al., 2000, 
GGT, mmol/L ≤ 35.00 
 
> 35.00 Schwimmer et al. 2005) 
Fasting insulin, mU/L ˂ 15.00 15.00 - 20.00 > 20.00 (Williams et al., 2002) 
CRP, mg/L ˂ 1.00 1.00 - 3.00 > 3.00 (Pearson et al., 2003) 
IL-6, pg/ml 1.00 - 3.90 
 
> 3.90 (Makni et al., 2013) 
ICAM, ng/ml 
   
(Andrys et al. 2000) 6-10 y 206.80 - 486.80 
 
> 486.80 
11-15 y 184.10 - 354.00 
 
> 354.00 
Adiponectin, µg/ml > 10.00 
 
< 5.00 (low) (Goksen et al., 2013) 
HOMA-IR 
  
> 3.16 (Keskin et al., 2005) 
Systolic/diastolic blood pressure ˂ 90th percenSle ≥ 90th and ˂ 95th percenSle ≥ 95th percentile (NHBPEP, 2004) 
TC; total cholesterol, LDL; low density lipoprotein, HDL; high density lipoprotein, TG; triglycerides, FBG; fasting blood glucose, ALT; alanine aminotrasferase,  AST; aspartate aminotransferase, 
GGT;  gamma glutamyl transpeptidase, CRP; C-reactive protein, IL-6; interleukin 6, ICAM; intracellular adhesion molecule, HOMA-IR; homeostatic model assessment for insulin resistance ,  
IFG; impaired fasting glucose, mmol/L; millimole per litre, mU/L; milliunit per litre, mg/L; milligram per litre, pg/ml; picogram per millilitre, ng/ml; nanogram per millilitre, µg/ml; microgram per  
millilitre. 
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HOMA-IR for the participants was measured using the equation mentioned in section 
6.1.1.5 above. The equation was based on the method developed by Matthews et al. (1985). 
HOMA-IR is a proxy for insulin resistance and is widely used in clinical settings and 
research with high reliability in determining insulin resistance (Keskin et al., 2005).There 
is still a debate about the appropriate cut off point for HOMA-IR with proposed values of ≥ 
2.5 (Sharma et al., 2011, Madeira et al., 2008), ≥ 1.77 (Arshi et al., 2010) and > 3.16 
(Keskin et al., 2005). Keskin et al. (2005) assessed insulin resistance in obese and 
nonobese adolescents (mean age 12.8 years) using three different methods namely HOMA-
IR, fasting glucose/insulin ratio (FGIR) and quantitative insulin sensitivity check index 
(QUICKI). Keskin and colleagues found out that HOMA-IR was the most sensitive and 
most specific of the three methods and the cut off point for insulin resistance diagnosis was 
3.16. Sharma et al. (2011) based their HOMA-IR cut off point calculations on a sample of 
obese and nonobese children (mean age 6.5 years), and Arshi et al. (2010) had their cut off 
value for HOMA-IR based on samples of asthmatic children. Therefore, the definition of 
insulin resistance in this thesis will depend on values of HOMA-IR > 3.16 (Keskin et al., 
2005).  
Assessment of lipid profile for the participants included fasting TG, fasting cholesterol, 
fasting LDL, and fasting HDL (table 5.1). Jolliffe et al. (2006) developed age and gender 
specific percentiles for lipoproteins and cholesterol starting from age 12 to 20 years. 
However, our participants were aged 10 to 14 years and it was not possible to use the these 
lipoprotein percentiles for the whole sample, therefore the reference values for these 
parameters were taken from the National Cholesterol Education Program with fixed cut off 
points for normal, borderline and high values regardless of gender and age (NECP Panel 
(1992).   
Liver function tests were obtained in all participants and included ALT, AST and gGT. 
The upper limit for ALT and AST in adults differ between populations and differences 
exist between males and females (Sohn et al., 2013). However, in studies examining the 
prevalence of abnormal ALT, AST and gGT in adolescents, the most commonly used cut 
off points were > 40 U/L, > 40 U/L and > 35 U/L, respectively (Siest et al., 1975, Strauss 
et al., 2000, Schwimmer et al., 2005), therefore , these were the values that we used as cut 
off points in our study. 
Markers of inflammation were assessed in all participants. Acute phase protein  CRP 
(CRP) was measured and is considered a primary warning of atherosclerosis in the 
paediatric population as well as an indicator of the chronic inflammatory state associated 
with obesity (Pearson et al., 2003). Generally, normal and abnormal levels of CRP were 
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developed for the adult population (Pearson et al., 2003, Jaye and Waites, 1997), and some 
studies tested for normal range in healthy adults to be from 0.08 to 6.1 mg/L (Macy et al., 
1997). In our study we used the cut off points set by the American Heart Association and 
Centre for Disease Control and Prevention (Pearson et al., 2003) (see table 5.1).  
The inflammatory cytokine IL-6 has an age-related variability with peak physiological 
elevation around age 4 and 15 years in relation  to cartilage and bone development (Sack et 
al., 1998). In the literature, precise reference range for IL-6 vary greatly depending on the 
age and gender of the participants tested (Warnberg et al., 2004, Sack et al., 1998, 
Yamamura et al., 1998). However, several papers included values that have been 
extrapolated for healthy subjects within the study population (Sekiyama et al., 1994, 
Yamamura et al., 1998, Warnberg et al., 2004). As mentioned earlier, IL-6 level increases 
with obesity, and since our study population only included obese adolescents, we used the 
reference range of the control group (healthy controls n=37) from a study by Makni et al. 
(2013) where they examined the prevalence of a number of cardiometabolic risk factors in 
obese and non-obese Tunisian adolescents (mean age of the control group 13.7 years). The 
cut off point for abnormal value in the present study was > 3.9pg/ml. 
Inflammatory plasma soluble adhesion molecules ICAM were also measured in all of the 
participants for its relation to the chronic inflammatory state associated with obesity as 
mentioned before. The literature shows that their reference value is age related and when 
applying the cut off point for our study we chose a study done in the Czech Republic by 
Andrys et al. (2000) to establish reference range for serum soluble adhesion molecules in 
healthy children and adolescents aged 6 to 15 years defined by values between the 5th and 
95th percentiles for each inflammatory marker. The normal cut off range for 6 to 10 years 
old was 206.8-486.8 ng/ml, and for 11 to 15 years old was 184.1 to 355.0 ng/ml (Andrys et 
al., 2000).  
The anti-inflammatory adipokine adiponectin was measured in all participants in the 
fasting state. It is normally present in  plasma concentrations of 2-20 µg/ml(Oh et al., 
2007). Most studies comparing adiponectin concentration in obese adolescents to its 
concentration in healthy controls referred to” low levels”  when adiponectin concentration 
was ˂ 5 µg/ml as compared to its concentration in healthy control subjects at > 10 µg/ml 
(Goksen et al., 2013, Tascilar et al., 2011, Alikasifoglu et al., 2009). Therefore, in the 
present study we used the same cut off points.  
 
Hypertension was defined as a systolic and or diastolic blood pressure at or above the 95th 
percentile or higher for age, sex and height measured on 3 separate occasions (NHBPEP, 
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2004). In order to fulfil the 3 separate occasions condition of the definition, blood pressure 
was measured before clinical consultation started, during the consultation and at the 
beginning of the physical examination of the clinical assessment interview.                 
 
5.2.6 Metabolic syndrome definitions 
Metabolic syndrome was defined according to both the International Diabetes Federation 
(IDF) (Zimmet et al., 2007) and the National Cholesterol Education Programme Adult 
Treatment Panel III (ATP III) (Panel, 2001). Choosing these two definitions was based on 
the fact that both definitions share the same five parameters used in the diagnosis of MS 
namely: high waist circumference, high TG, low HDL, high blood pressure and high FBG 
(table 5.2). However, the IDF definition requires the presence of high waist circumference 
plus two or more of the 5 parameters and ATP III definition requires the presence of three 
or more of the 5 parameters. Table 5.2 shows the cut-off points for MS diagnosis by both 
IDF and ATP III.  
 
Table 5.2 Cut off points of the International Diabetes Federation (IDF) and Third Adult Treatment Panel (ATP III) criteria 
Factors IDF criteria¹ ATP III criteria² 
  
  
Waist circumference (cm) ≥ 90th percentile or adult cut-off if lower ≥ 90th percentile 
TG (mmol/L) ≥ 1.7 ≥ 1.24 
HDL (mmol/L) ˂ 1.03 ≤ 1.03 
Blood pressure (mmHg) ≥ 130/85 ≥ 90th percentile 
Glucose (mmol/L) ≥ 5.6 ≥ 6.1 
¹IDF criteria for metabolic syndrome is the presence of high waist circumference plus two or more of the listed factors  
²ATP III criteria is the presence of three or more of the listed criteria 
 
5.3 Results 
5.3.1 Characteristics of study participants  
Table 5.3 shows the mean and SD of all measured parameters for the participants (n=80), 
for the boys (n=40), and for the girls (n=40). The mean age was 12.3 years (SD 1.1). These 
are the same participants as studied in the NATTO trial described in chapter 2, but the 
cardiometabolic risk factor data are based on baseline, pre-intervention blood samples.  
All participants were obese and had their BMI ≥95th percentile for age and sex according to 
US CDC reference population (Kuczmarski et al., 2000).  
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5.3.2 Blood pressure 
Twenty six out of the 80 participants (32.5%) had systolic and/or blood pressure at or 
above the 95th percentile for age, sex and height.  
 
5.3.3 Fasting blood glucose, insulin, and HOMA-IR 
Hyperglycaemia and hyperinsulinaemia was present in 2.5% (2/80) and 43.8% (35/80) of 
participants, respectively. Insulin resistance as defined by HOMA-IR value > 3.16 (Keskin 
et al., 2005) was found in 67.5% (54/80) of participants. 
 
5.3.4 Lipid profile 
Out of the 80 participants, 27.5% (22/80) had high TG level, 33.8% (27/80) had high total 
cholesterol level, 20% (16/80) had low HDL level, and 35% had high LDL level. 
 
5.3.5 Liver function tests  
Liver function tests showed high ALT in 26.3% (21/80) of participants, high AST in 
88.8% (71/80) of participants, and high GGT level in 17.5% (14/80) of participants. 
 
5.3.6 Inflammatory markers 
Inflammatory markers included CRP, IL-6, ICAM and adiponectin as noted above. CRP 
level was high in 42.5% (34/80) of participants, IL-6 level was high in 7.5% (6/80) of 
participants, ICAM level was high in 66.3% (53/80) of participants and adiponectin level 
was normal in all participants. 
 
5.3.7 Metabolic syndrome 
Table 5.4 shows the results of waist circumference (WC), TG, HDL, FBG, systolic blood 
pressure and diastolic blood pressure using IDF and ATP III criteria. Seventeen of the 80 
participants (21.3%) met the diagnosis of MS by the IDF definition and 24 of the 80 
participants (30%) met the diagnosis of MS by the ATP III definition.    
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Table 5.3 Descriptive parameters of the adolescents according to gender, Mean (SD) 
Variables All Participants (n=80)  Boys (n=40) Girls (n=40) Number of participants with abnormality (%) 
      
 
Borderline High 
Age, years 12.3 (1.1) 12.4 (1.2) 12.3 (1.1) na na 
BMI Z score 2.2 (0.3) 2.2 (0.3) 2.2 (0.3) na na 
Waist circumference, cm 93.3 (12.2) 96.6 (12.4) 90.0 (11.2) 
  
Systolic blood pressure, mmHg 122 (11) 125 (11) 119 (9) na 24 (30.0%) 
Diastolic blood pressure, mmHg 77 (8) 78 (8) 77 (7) na 14 (17.5) 
Total cholesterol, mmol/L 4.7 (0.9) 4.7 (1.0) 4.7 (0.8) 25 (31.5%) 27 (33.8%) 
LDL, mmol/L 3.0 (0.8) 3.0 (0.9) 3.0 (0.7) 20 (25%) 28 (35.0%) 
TG, mmol/L 1.3 (0.5) 1.3 (0.5) 1.3 (0.5) 26 (32.5%) 22 (27.5%) 
HDL, mmol/L 1.1 (0.2) 1.1 (0.2) 1.1 (0.3) 60 (75%) low 16 (20.0%) 
FBG, mmol/L 4.7 (0.8) 4.8 (0.9) 4.5 (0.6) na 2 (2.5%) 
Fasting insulin, µU/L 26.7 (23.8) 26.4 (25.8) 27.0 (22.0) 21 (26.5%) 35 (43.8%) 
HOMA-IR 6.0 (7.3) 6.4 (9.2) 5.5 (5.0) na 54 (67.5%) 
ALT , U/L 34.2 (23.6) 42.2 (21.3) 26.1 (23.4) na 21 (26.3%) 
AST, U/L 58.1 (19.3) 63.3 (15.6) 52.8 (21.4) na 71 (88.8%) 
GGT, U/L 27.0 (12.6) 31.4 (13.9) 22.7 (9.6) na 14 (17.5%) 
CRP, mg/L 4.2 (5.1) 5.0 (4.6) 3.5 (5.5) 31 (38.5%) 34 (42.5%) 
IL-6, pg/mL 2.0 (1.8) 1.9 (1.5) 2.0 (2.1) na 6 (7.5%) 
ICAM, ng/mL 461.3 (158.5) 493.2 (158.0) 429.4 (154.6) na 53 (66.3%) 
Adiponectin, ng/mL 50.7 (25.0) 47.0 (21.5) 54.4 (27.9) na none  
LDL; low density lipoprotein, TG; triglycerides, HDL; high density lipoprotein, FBG; fasting blood glucose, ALT; alanine aminotransferase, AST; aspartate amino transferase 
GGT; gamma glutamyl transpeptidase, CRP; C-reactive protein, IL-6; interleukin-6, ICAM; intracellular adhesion molecule, na; not applicable 
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Table 5.4 Metabolic syndrome prevalence using International Diabetes Federation (IDF) and Third 
 Adult Treatment Panel (ATP III) criteria in the participants  
Anthropometric and biochemical variables Mean (SD) IDF ATP III 
Waist circumference (cm) 93.3 (12.2) 66 (82.5%) 66 (82.5%) 
TG (mmol/L) 1.3 (0.5) 12 (15%) 37 (46.5%) 
HDL (mmol/L) 1.1 (0.2) 26 (32.5) 26 (32.5%) 
FBG (mmol/L) 4.7 (0.8) 4 (5%) 2 (2.5%) 
Systolic blood pressure 122 (11) 
9 (11.5%) 11 (13.5%) 
Diastolic blood pressure 77 (8) 
MS prevalence   17 (21.3%) 24 (30%) 
TG; triglycerides, HDL; high density lipoprotein, FBG; fasting blood glucose. 
 
 5.4 Discussion 
The current study is the first to estimate the prevalence of cardiometabolic risk factors and 
MS, using IDF and ATP III criteria, in a group of obese Kuwaiti adolescents. 
The main findings of this study were the high prevalence of multiple cardiometabolic risk 
factors; out of the sixteen risk factors measured, eight were high in ≥ 30% of the 
participants (table 5.3). The cardiometabolic risk factors with highest prevalence of 
abnormal values included AST (88.7% of the sample), HOMA-IR (67.5% of the sample), 
ICAM (66.5% of the sample), fasting insulin (43.5% of the sample), CRP (42.5% of the 
sample), LDL (35.0% of the sample), cholesterol (33.5% of the sample), and systolic blood 
pressure (30.0% of the sample); 96.3% (77/80) of participants had at least one impaired 
cardiometabolic risk factor as well as obesity.  
 
In clinical terms, most of the participants in our study had impaired lipid profile, insulin 
resistance, impaired liver function tests and chronic inflammatory process with high risk of 
atherosclerosis.  
 
As demonstrated in chapter 6, most of the participating families had poor attendance at 
treatment intervention and to the control primary care condition. Therefore, findings from 
the present study, had they been available at the time the trial started, may have had an 
impact on compliance with the intervention, or at least on attendance. It might have been 
possible to use the cardiometabolic risk factor results to demonstrate to the adolescents and 
their families that their obesity was a medical problem which was affecting them, and so 
possibly persuade them to engage more with treatment. Moreover, all of the measured 
parameters in the present study, except for adiponectin, are readily accessible by 
physicians working in the Ministry of Health-Kuwait in the clinical setting, and are widely 
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available in many other parts of the world, so their measurement could be part of any 
treatment protocol for adolescent obesity in the future. 
            
Risk factors for cardiovascular disease and type 2 diabetes mellitus have extended their 
roots to reach children and adolescents (Poyrazoglu et al., 2014, Herouvi et al., 2013, 
Beauloye et al., 2007, Weiss and Caprio, 2005, Reilly et al., 2003, Visser et al., 2001, 
Srinivasan et al., 1996, Strong et al., 1992). There are a number of studies that 
demonstrated this from the local and the international communities. Locally, Al-Isa et al. 
(2010c) have examined the prevalence of multiple circulating inflammatory biomarkers 
namely; CRP, ICAM, vascular cell adhesion molecule (VCAM), and HOMA-IR. They 
aimed at setting reference ranges of these markers in a group of 774 Kuwaiti adolescents 
aged 10 to 19 years. They also set the age 14 as the cut off point for puberty, due to social 
and cultural obstacles faced in Tanner staging their study sample. However, the sample 
included lean, overweight and obese boys and girls, classified according to the IOTF 
classification of obesity (El-Ghaziri et al., 2011, Cole et al., 2000), and knowing that 
obesity is an independent risk factor for cardiovascular disease, we rejected the use of their 
proposed reference ranges of the inflammatory biomarkers examined in our study. 
Moreover, taking reference ranges from a random sample in a population of high 
prevalence of paediatric obesity (El-Ghaziri et al., 2011) is most likely to be false positive. 
Having said that, the reference range for CRP in Al-Isa et al. (Al-Isa et al., 2010c) study 
was lower than what we used as cut off value in the present study. Using Al-Isa and 
colleagues proposed reference ranges in the present study increased the prevalence of 
participants with abnormal CRP from 42.5% (34/80) to 86.3% (69/80), decreased the 
prevalence of participants with abnormal fasting insulin from 43.8% (35/80) to 16.3% 
(13/80), and decreased the prevalence of participants with abnormal HOMA-IR from 
67.5% (54/80) to 11.3% (9/80). The prevalence of participants with abnormal ICAM 
stayed the same (66.3%, 53/80).      
 On the other hand, they (Al-Isa et al., 2010c) concluded that ICAM, VCAM, CRP, and 
insulin resistance represented by HOMA-IR increase with increasing BMI and with age (˂ 
14 or ≥ 14).  
 
In a study from Iran (Kelishadi et al., 2013) on 5,528 adolescents aged 10 to 18 years 
assessing the relationship between multiple cardiometabolic risk factors (total cholesterol, 
TG, LDL, HDL, blood pressure and FBG) with BMI, low physical activity and unhealthy 
diet. BMI had the greatest direct effect on total cholesterol, LDL, TG, FBG and blood 
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pressure and an inverse relationship with HDL, more than that contributed by inactivity 
and unhealthy diet. Kelishadi et al. (2013) called for immediate interventions to tackle 
paediatric obesity and its associated cardiometabolic risk factors in order to prevent future 
risk of MS and chronic non-communicable diseases in Iran.             
Kardas et al. (2013) compared the level of cholesterol, LDL, TG, HDL, FBG, blood 
pressure, vitamin D and adiponectin between obese (n=63) and nonobese (n=51) Turkish 
adolescents aged 10 to 16 years. Obesity was defined as BMI >90th percentile for age and 
gender specific Turkish reference population. Cholesterol, LDL, TG, FBG, blood pressure 
were significantly higher in the obese group compared to the nonobese group. Adiponectin, 
vitamin D, and HDL were significantly lower in the obese group compared to the nonobese 
group. Mean adiponectin value for the obese group was 3.3 (± 0.89) ng/ml and in the non-
obese group the mean value was 6.0 (±1.4) ng/ml.  
In the Netherlands, inpatient children and adolescents (n=80, aged between 8 to 19 years) 
diagnosed with severe obesity were evaluated for the presence of multiple cardiometabolic 
risk factors namely blood pressure, fasting insulin, FBG, HOMA-IR, cholesterol, LDL, 
TG, HDL and CRP (Makkes et al., 2013), as part of an inpatient treatment trial for their 
obesity. Data from the study (Makkes et al., 2013) showed that 80% of the participants had 
at least one impaired cardiometabolic risk factor as well as severe obesity. In comparison 
with our study, 90% of our participants had at least one impairment with regards to the 
same cardiometabolic risk factors assessed. 
 
Aminotransferases are proxy markers for NAFLD. Our study showed that ALT and AST 
were elevated in 26% and 71% of participants, respectively. In a study done in Germany 
on 224 healthy, overweight and obese 1 to 12 years old children and adolescents, elevated 
liver enzymes (ALT, AST, GGT) were present in 29% of overweight and obese 
participants (Engelmann et al., 2014). An expert committee recommendation regarding the 
prevention, assessment, and treatment of child and adolescent overweight and obesity 
suggests biannual screening for liver disease with serum ALT and AST starting at age 10 
years in obese children and adolescents (Barlow, 2007). However, no recommendation for 
NAFLD screening has been made by gastroenterology societies that jointly claimed more 
firm evidence is required before making any official recommendation (Chalasani et al., 
2012).  
 
We also noted in our main findings of the present study that the prevalence of metabolic 
syndrome was high, as almost third of the participants had MS, and prevalence varied 
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depending on the definition used. When using the IDF criteria (Zimmet et al., 2007) for 
definition of MS, 21.3% of our participants had MS, and 30% had MS according to the 
ATP III definition (Panel, 2001). In a study done in Kuwait on apparently healthy female 
adolescents (n= 431, age 10 to 19 years) to assess the prevalence of MS using the same 
definitions that we applied to our study, it was found that MS was present in 9.1% by ATP 
III definition and 14.8% had MS when IDF definition was used (Al-Isa et al., 2010a). In 
Saudi Arabia, the prevalence of MS using the IDF definition was high (18%) among 180 
obese 9 to 12 year olds  (Abdel-Megeid and Alfawaz, 2012). Also using the IDF definition 
in Lebanese adolescents, Nasreddine et al. (2012) found that 21.2% of the 104 obese 
adolescents (mean age 16 ±1.3 years) had MS, 3.8 % of the 78 overweight adolescents 
(mean age 16.4 ±1.4 years) had MS, and 1.2% of the 81 healthy-weight adolescents (mean 
age 16.8 ±1.3 years) had MS. In Iran, according to ATP III definition, MS has been found 
in 3.3% of Iranian adolescents (n=450, 15 to 18 years old) (Mehrkash et al., 2012). In a 
sample of 321 overweight, obese and extremely obese adolescents from Brazil (obesity 
defined using the CDC 2000 definition (Kuczmarski et al., 2000), MS was found in around 
18% of the 10 to 16 year old adolescents using the IDF definition (Rizzo et al., 2013). 
Similarly in the USA (Weiss et al., 2004), it was found that > 50% of obese children and 
adolescents (n=439, 4 to 20 years old) had MS according to definitions modified from ATP 
III and WHO (Alberti and Zimmet, 1998).  
 
Our participants were generally a fairly homogenous group of Kuwaiti adolescents, living 
in Kuwait City and recruited from 3 state schools, who were examined for the presence of 
cardiometabolic risk factors including metabolic syndrome. The use of traditional markers 
for cardiovascular disease i.e. lipid profile and blood pressure, multiple markers for 
inflammation i.e. CRP, IL-6 and ICAM, and for the first time adiponectin in a sample of 
Kuwaiti adolescents, assessment of insulin resistance as well as liver function, all add to 
the novelty of our study.   
However, our study had a number of limitations. First, at general examination, Tanner 
staging of puberty was not possible to conduct due to social/ cultural and practical reasons. 
The clinical examination room assigned for the team was under-equipped (Appendix 3) 
with no available privacy screen therefore undressing the participants was not possible. As 
mentioned earlier this study was intended to be a baseline blood assessment in a RCT of 
treatment intervention for adolescent obesity in Kuwait (chapter 6), with an end of trial 
blood assessment to follow (after 6 months, at the end of the intervention). However, only 
a baseline assessment of cardiometabolic risk factors was possible. The Director of the 
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Laboratory Department in the Ministry of Health in Kuwait (i.e. the direct authorising 
personnel) refused to give the author access to the lab after 6 months and so blood based 
measures at the 6 month follow up were not possible (chapter 7). A similar obstacle was 
faced with schools’ head principals in another follow up study of our quality of life 
assessment in obese and nonobese Kuwaiti adolescents (chapter 4). Having no follow-up 
data limited our analyses, and highlights the lack of interest in research within some 
authorities in Kuwait.  
 
Nonetheless, we believe that our study highlights the importance of assessing multiple 
cardiometabolic risk factors in obese adolescents in Kuwait at a larger scale. Also we 
signify the importance of addressing the possible presence of these cardiometabolic risk 
factors and MS in obese Kuwaiti adolescents when conducting future treatment 
interventions – the relatively high prevalence of abnormal values for cardiometabolic risk 
factors could be a useful aid to engage more families into participating in treatment, and 
might also increase the level of commitment to participation by those who do take part 
(chapter 6).  
 
5.5 Conclusions 
The present study suggests that a number of cardiometabolic risk factors and metabolic 
syndrome are prevalent in obese Kuwaiti adolescents. This observation might provide 
impetus to future strategies to treat paediatric obesity, and to prevent or delay the 
appearance of cardiovascular disease and diabetes mellitus in the future adult generation. 
The observation might also be used to encourage greater engagement with treatment 
among families, and might also help persuade some of the authorities in Kuwait that such 
studies are valuable and necessary.                
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6. Results of the National Adolescent Treatment 
Trial (NATTO) Randomised Controlled Trial 
BOODAI, S. A., MCCOLL, J. H. & REILLY, J. J. In press. Randomised controlled trial of a good practice 
approach to treatment of adolescent obesity in Kuwait: National Adolescent Treatment Trial for Obesity in 
Kuwait (NATTO): Project design and results. Trials. Appendix F. 
 
6.1 Introduction 
This chapter outlines the results of the NATTO study (Boodai et al., 2014b) which 
assessed the feasibility and efficacy of a trial of a family based behavioural treatment 
programme for obese adolescents in Kuwait compared to primary care in respect to 
primary and secondary outcomes. The rationale for this study was described fully in 
chapter 1, the trial design and methodology were described fully in chapter 2, and the 
intervention manual was described fully in chapter 3.  
Despite the high prevalence of childhood and adolescent obesity and its associated medical 
and psychological consequence, treatment interventions have only been modestly 
successful in creating change in the targeted behaviours and typically show short term 
effects (Oude Luttikhuis et al., 2009). Moreover, the recent Cochrane review (Oude 
Luttikhuis et al., 2009) found only 29 eligible trials of adolescent obesity treatment, and 
none of these were from the Arab world (16 from North America, 7 from Europe and 
Australia; 3 from Far East Asia; 2 from Israel). At present the availability of treatment for 
obese adolescents in Kuwait is negligible.  
 
The primary aim of the present study was therefore to test the hypothesis that a ‘good 
practice’ intervention for the treatment of adolescent obesity in Kuwait would have a 
greater effect on primary and secondary outcomes than allocation to a control group. The 
secondary aims were to test the feasibility of conducting such a trial in Kuwait, and the 
feasibility of using a good practice intervention and referral to primary care as a control 
condition, with a view to developing improved obesity treatment RCT in Kuwait and the 
other Gulf States. 
 
6.2 Methods 
6.2.1 Power calculations 
Data analysis was carried out using Minitab 16. The author carried out the analysis 
presented in this chapter with the advice of Professor John McColl, Department of 
Statistics, University of Glasgow.  
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As discussed in chapter 2, the primary outcome measure for the study was change in BMI 
Z score from baseline to six months and the study had been powered for 30 participants in 
each arm at 6 months with change in BMI Z score of -0.25 between groups with 90% 
power at 0.05 significance. 
 
6.2.2 Study participants 
Participating subjects had to meet the inclusion criteria. These criteria were discussed in 
detail in chapter 2 and included, age 10-14 years, Obese (BMI ≥95th percentile relative to 
US reference data), have at least one parent willing to participate in the trial.  
A total number of 224 obese adolescents were assessed for eligibility for the present study; 
82 consented and were recruited into the study; 41 participants were randomised to the 
primary care control group (boys 51%) and 41 to the intervention programme (boys 51%). 
Of the 82 participants entered at baseline, 63 (77%) participants (31 from the intervention 
group and 32 from the control group) were available for the six month follow-up. The 
expected drop out rate as decided in SCOTT’s power calculation was 36% at 6 months. 
The actual drop-out rate at 6 months was 23%. Figure 4.1 shows the CONSORT 2010 
(Moher et al., 2012) flow diagram of the participants throughout the study. 
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Assessed for eligibility (n= 224) 
Excluded (n= 142) 
♦   Not meeting inclusion criteria (n=6 ) 
♦   Declined to participate (n= 127 ) 
♦   Other reasons (n= 9 ) 
Analysed (n= 31)  
♦ Excluded from analysis (n=10, could not be 
contacted)  
Lost to follow-up (n=10, could not be contacted)  
Discontinued intervention (n= 29 attended ˂ 4 
sessions) 
Allocated to intervention (n= 41) 
♦ Received allocated intervention : 
        7 participants attended 6 sessions 
4 participants attended 5 sessions 
1 participant attended 4 sessions 
3 participants attended 3 sessions 
9 participants attended 2 sessions 
15 participants attended 1 session 
♦ Did not receive allocated intervention (n=2, DNA ) 
Lost to follow-up (n=9, could not be contacted) 
Discontinued intervention (n= 41) 
Allocated to primary care control (n=41) 
♦ Received allocated intervention (n= 0 ) 
♦ Did not receive allocated intervention (n= 41, 
did not attend, DNA ) 
Analysed (n= 32)  
♦ Excluded from (n=9, could not be contacted) 
Allocation 
Analysis 
Follow-Up 
Randomized (n= 82) 
Enrollment 
  
Figure 6.1 CONSORT 2010 flow diagram for NATTO 
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6.2.3 Data analysis 
Primary and secondary outcome measures were tested for normality by comparing the 
means and medians and using Ryan Joiner Normality Tests (a normal distribution was 
assumed if p ≥ 0.05). Appendix 2 shows the normal distribution curves for the physical, 
psychological and total scores. Most outcome measures were normally distributed. 
Therefore, all data within this chapter are reported as mean and standard deviation; the 
parametric tests (paired t-test and 2- sample t-test) were used. Changes in variables from 
baseline to six months follow up for each participant within the group were tested using 
paired t-test. Changes in outcome variables between groups, i.e. intervention and control 
groups were examined using 2- sample t-test. A p value of ˂ 0.05 was taken to indicate 
statistical significance.  
 
As described in chapter 2, intention to treat (ITT) analysis was used- this involved 
including all subjects for whom data were available regardless of their attendance. Missing 
data were excluded from the analysis.  
 
The baseline characteristics of participants include age, gender, and anthropometry. 
Reporting of baseline demographic profiles and other characteristics of each group in 
NATTO study is a requirement of the CONSORT statement of RCT (Moher et al., 2012). 
Socioeconomic status of participants is also a requirement, and in the UK for example, a 
relatively precise definition of social class based on the general social standing of the 
occupation of the person suggested by the Registrar General is widely used (Coombs et al., 
2013). In Kuwait however, there is no official definition of socioeconomic status (Shah et 
al., 1999). Also, there is no consensus among researchers in Kuwait on how to define 
social class in this community (Shah et al., 1999). On the other hand, the Capital; where 
the trial is conducted, is considered the most highly developed residential area in Kuwait 
and Kuwaiti nationals have a high standard living. There are other means to measure 
socioeconomic status (SES) such as parents’ education, occupation, income, and type of 
housing, but the author did not carry out this survey as all participants were selected from 
schools in the Capital and further inquiry into the SES was judged to be time consuming 
and not feasible.  
 
Eight participants (19%) from the intervention group (n=41) attended 100% of the 
treatment sessions; that is 6 sessions. None of the control group attended any of the 
primary care appointments; only four parents arranged for appointments, however, none of 
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these actually attended any sessions in primary care. As a result of low compliance with 
the intervention, per protocol analysis for BMI Z score was not performed. 
 
6.3 Results 
6.3.1 Subject recruitment and group allocation 
A total n of 224 obese adolescents were assessed for eligibility for the present study as 
described earlier (See Fig. 4.1); 142 families were excluded due to the following reasons: 
A. 6 families did not meet the inclusion criteria due to medical history. 
B. 127 families with eligible adolescents refused to participate due to lack of interest 
and time. 
C. 9 families failed to attend the baseline assessment clinic appointment and were 
not enrolled in the study. 
Therefore the final sample size consisted of 82 families, which represented 37% of 
inquiries from the eligible families; 41 participants were randomised to the control group 
(primary care) and 41 to treatment group (intervention). 
 
Of the 82 participants entered at baseline, 63 (77%) of participants (32 from the control 
group and 31 from the intervention group) attended the six month follow up. 
The expected drop out rate from power calculation was 30%, however, the actual drop-out 
rate for the present study at six months was 23%. 
 
6.3.2 Adherence to treatment intervention 
Programme session attendance was used as a proxy measure for adherence to the study 
protocol. Better attendance to treatment sessions has been associated with improved 
clinical outcomes and prevention or reduction of complications (Wadden et al., 2005, Chao 
et al., 2000). Of the 41 intervention group participants, 12 (29%) participants attended 4 
out of the 6 treatment sessions and 29 (71%) participants attended less than 4 treatment 
sessions.  
 
6.3.3 Characteristics of participants at baseline 
The baseline characteristics of the two study groups were similar and these are shown in 
table 4.1. There were 21 boys and 20 girls in both the intervention group and the control 
group. There were no significant differences between the groups for age, blood pressure, 
and anthropometric measures (table 6.1).   
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Table 6.1 Baseline characteristics of the study participants 
Variable 
Intervention group Control group p value¹ Whole sample  
(n=41) (n=41)   (n=82) 
Age (years) 12.4 (1.2) 12.4 (1.2) 0.9 12.4(1.2) 
Male / Female 21 / 20 21 / 20 
 
42 / 40 
BMI Z score 2.2 (0.3) 2.2 (0.3) 0.2 2.2 (0.3) 
% Body Fat 43.3 (7.3) 44.7 (6.9) 0.4 44.0 (7.1) 
Systolic BP (mm Hg) 122.0 (12.3) 122.0 (8.2) 0.9 122.2 (10.4) 
Diastolic BP (mm Hg) 76.0 (8.5) 79.1 (6.4) 0.1 77.5 (7.6) 
Waist circumference (cm) 93.0 (12.7) 94.0 (11.6) 0.7 93.5 (12.1) 
Data are mean (SD), BP = blood pressure, ¹2-sample t-test 
 
6.3.4 Primary outcome- change in BMI Z score 
 Changes within groups 
The primary outcome of the NATTO study was change in BMI Z score from baseline to 
six months. Table 6.2 shows the changes in BMI Z score from baseline to six months 
(mean and SD, paired t-test). The analysis included all subjects with available measures at 
six months post baseline (intervention group n=31, control group n=32). There was no 
statistically significant difference within each group for BMI Z score at any measurement 
point.  
 
Table 6.2 Change in BMI Z score within group over time, Mean (SD) 
Group (n) Baseline Six months p value¹ 
 
Intervention (31) 
2.2 (0.3) 2.2 (0.3) 0.5 
    
Control (32) 2.2 (0.3) 2.2 (0.3) 0.3 
        
¹Paired t-test by group 
 
Differences in change in anthropometry between groups 
As mentioned earlier, the aim of the NATTO study was to test for changes in BMI Z score 
from baseline to six months and the study had been powered on a change in BMI Z score 
of -0.25 at six months. Table 6.3 shows the change in BMI Z score from baseline to six 
months (2-sample t-test) compared between the intervention group and the control group. 
The analysis was conducted for all subjects with available measures at six months post 
baseline (intervention group n=31, control group n=32). There was no significant 
difference in the between group change in BMI Z score at six months. 
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Therefore, our hypothesis that the office-based intervention would be more successful in 
reducing BMI Z score than the control group was rejected.  
 
Table 6.3 Change in BMI Z score between groups over time, Mean (SD) 
Period Intervention group Control group Between group  p value¹ 
n=31 n=32 change *(95% CI) 
 
from 0 to 
  0.0 (0.1) 0.0 (0.2)     0.0(-0.1; 0.1)   0.6 
6 months 
 
* 95% Confidence Interval, ¹ 2-sample t-test 
 
6.3.5 Secondary outcomes 
6.3.5.1 Changes in percentage body fat (%BF) 
Changes within groups 
Percentage body fat decreased significantly within each group over the six month period of 
the trial (p ˂ 0.001, respectively) (table 6.4). 
 
Table 6.4 Change in percentage body fat within group over time, Mean (SD) 
Group (n) Baseline Six months p value¹ 
Intervention (31) 43.8 (7.0) 41.0 (6.0) ˂0.001 
    
Control (32) 44.2 (7.5) 40.9 (7.3) ˂0.001 
        
¹Paired t-test by group 
 
Changes between groups 
Although each group (intervention n=31 and control n=32) had a statistically significant 
drop in percentage body fat over six months, the difference between groups as tested by 2-
sample t-test was statistically insignificant (p  0.6) (table 6.5). 
 
 
Table 6.5 Change in percentage body fat between groups over time, Mean (SD) 
Period Intervention group Control group Between group p value¹ 
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n=31 n=32 change *(95% CI) 
 
From 0 to  
-2.8 (3.7) -3.4 (4.1) -0.5 (-2.5; 1.4) 0.6 
6 months 
* 95% Confidence Interval, ¹2-sample t-test 
 
6.3.5.2 Changes in blood pressure 
Changes within groups 
Examination of change in systolic blood pressure from baseline to six months within each 
group via paired t-test revealed no significant differences in the means (table 6.6). 
 
Table 6.6 Systolic blood pressure (mmHg) within group over time, Mean   (SD) 
Group (n) Baseline Six months p value¹ 
Intervention (31) 122.0 (13.0) 122.0 (10.0) 0.8 
    
Control (32) 122.0 (8.0) 123.0 (7.0) 0.5 
        
¹Paired t-test by group 
  
There was a statistically significant increase in diastolic blood pressure within the 
intervention group (p 0.01) at six months. Difference in diastolic blood pressure at six 
months post baseline for the control group was not statistically significant (p 0.3) (table 
6.7). 
 
Table 6.7 Diastolic blood pressure (mmHg) within group over time, Mean (SD) 
Group (n) Baseline Six months p value¹ 
Intervention (31) 76.0 (9.0) 79.0 (7.0) 0.01 
    
Control (32) 79.0 (7.0) 80.0 (5.0) 0.3 
        
¹Paired t-test by group 
 
 
 
Changes between groups 
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Table 6.8 shows the mean and SD of changes in systolic blood pressure between the 
intervention group (n=31) and the control group (n=32) from point 0 to six months. Using 
2-sample t-test, the analysis showed that there was no significant difference change in 
systolic blood pressure over time between the intervention and the control groups (p  0.9).  
 
Table 6.8 Change in systolic blood pressure (mmHg) between groups over time, Mean (SD) 
Period Intervention group Control group Between group p value¹ 
  n=31 n=32 change *(95% CI)   
From 0 to  
0.4 (6.7) 0.6 (4.8) 0.3 (-2.7; 3.2) 0.9 
6 months 
* 95% Confidence Interval, ¹2-sample t-test 
 
Table 6.9 shows the difference in diastolic blood pressure from baseline to six months 
between the intervention group (n=31) and the control group (n=32) which was statistically 
insignificant. 
 
Table 6.9 Change in diastolic blood pressure between groups over time, Mean (SD) 
Period Intervention group Control group Between group p value¹ 
  n=31 n=32 change *(95% CI) 
 
From 0 to 
2.9 (6.2) 1.1 (5.8) -1.8 (-4.8; 1.3) 0.2 
6 months 
* 95% Confidence Interval, ¹2-sample t-test 
 
6.3.5.3 Changes in waist circumference 
Changes within groups 
Both the intervention group and the control group had a statistically significant increase in 
waist circumference measurement from baseline to six months (table 6.10). 
 
 
 
 
 
 
Table 6.10 Waist circumference (cm) by group over time, Mean (SD) 
Group (n) Baseline Six months p value¹ 
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Intervention (31) 94.0 (13.7) 98.9 (14.6) ˂0.001 
    
Control (32) 92.3 (11.1) 95.7 (12.5) ˂0.001 
        
¹Paired t-test by group 
 
 
Changes between groups 
There was no significant difference between the groups for change in waist circumference 
(p 0.3) (table 6.11).  
 
Table 6.11 Change in waist circumference (cm) between groups over time, Mean (SD) 
Period Intervention group Control group Between group p value¹ 
  n=31 n=32 change *(95% CI) 
 
From 0 to 
4.9 (5.8) 3.5 (5.7) -1.4 (-4.3; 1.5) 0.3 
6 months 
* 95% Confidence Interval, ¹2-sample t-test 
 
6.4 Discussion 
6.4.1 Summary of main findings 
While it seems that no previous adolescent obesity treatment trials have been published 
from Kuwait or other Gulf States, the present study suggests that conducting randomised 
controlled trials of adolescent obesity treatment interventions in Kuwait is feasible. 
Feasibility examines the practicality of conducting research in terms of recruitment and 
retention. The study power calculation showed that approximately 30 participants were 
required in each arm at six months and in reality 31 participants from the intervention 
group and 32 participants from the control group attended the six months assessment. 
Retention level was acceptable and strikingly similar to that reported in other adolescent 
obesity treatment trials which took place over a similar time scale (Oude Luttikhuis et al., 
2009). Luttikhuis and colleagues in the recent Cochrane review described drop-out in 
adolescent obesity treatment trials ranging from 0 to 43% at the end of intervention.  
 
The primary outcome in the present study was BMI Z score and based on the SCOTT 
study power calculation we hypothesised that the intervention programme might be 
efficacious in reducing BMI Z score by approximately 0.25 over six months in the 
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intervention group to no change in the control group, and it is quite a small difference in 
BMI Z score as discussed below. Both paired t-tests and 2-sample t-tests revealed no 
significant difference in changes in BMI Z score within each group and between groups. 
The present study therefore failed to show that an office-based good practice obesity 
treatment programme could improve the primary treatment outcome.  
 
Although mean BMI Z scores were essentially unchanged from baseline to six months in 
both groups, weight increased significantly in both groups (p˂0.00 for both groups) with 
no significant difference in weight change between the groups (p 0.6).  
 
Weight maintenance is widely recommended as an important aim of childhood and 
adolescent obesity treatment (SIGN, 2010, NICE, 2013). In the present study, 16% (6 out 
of 31) of those in the intervention group maintained or lost weight from baseline to six 
months. On the other hand, 15% (5 out of 32) of the participants in the control group had 
maintained or lost weight during the six month trial. This also indicates that the 
intervention programme was not superior to no-treatment option, and that treatment 
achieved relatively little in relation to treatment targets. In a recent review with meta-
analysis on the effectiveness of lifestyle interventions in child and adolescent obesity (Ho 
et al., 2012) Ho and colleagues reported 18 out of 22 included studies to have positive 
effect on weight loss. In this analysis the included studies were of lifestyle interventions 
versus a no treatment or wait-list control group and the effect size varied by age of 
participants and length of study. Ho and colleagues also conducted a meta-analysis on 7 
studies that reported BMI Z score as a primary outcome. Pooled BMI Z score reduction 
was 0.1 greater for lifestyle intervention compared with the control condition.  
What represents a clinically meaningful reduction in BMI Z score with obesity treatment is 
unclear as noted by the SIGN guidelines in 2010 (SIGN, 2010) and this question has been 
debated in some studies (Kolsgaard et al., 2011, Reinehr et al., 2006, Reinehr and Andler, 
2004). There is no agreed cut off point for the degree of reduction in BMI Z score which is 
desirable or the timescale over which the reduction in BMI Z score should be achieved, but 
improvements in cardiovascular disease risk factors have been associated with a reduction 
of 0.1 to 0.5 following treatment interventions (Kolsgaard et al., 2011, Reinehr et al., 
2006). Unfortunately, in the present study, reductions of ≥ 0.1 of BMI Z score over six 
months were achieved by only 25% (8 out of 31) of the intervention group and 21% (7 out 
of 32) of the control group. 
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Accompanying the weight increase in both arms of the trial from baseline to six months 
was a significant increase in waist circumference in each group with no between-group 
differences. Waist circumference measurements were taken as indices of fat distribution, 
although the clinical meaning of this measurement in paediatric population  is still unclear 
(Rudolf et al., 2007). The significant decrease in % body fat within the intervention and the 
control group at six months could be explained of being a result of linear growth.  Details 
entered into impedance software for the end of trial assessment were different from 
baseline with regards to age and height. Height for both groups increased significantly at 6 
months. The Tanita BIA software uses age, height and gender based proprietary formula to 
make the body fat estimate. However, the use of % body fat along with BMI Z score 
changes from baseline to end point of longitudinal studies can be useful tool in detecting 
group differences in fatness changes (Basterfield et al., 2012)  
 
On a positive note, the present study intervention appeared to have had no negative impact 
on height or systolic blood pressure from baseline to six months. However, the classical 
approach for an intervention to have a negative impact on growth or general homeostasis 
of the body is usually with more intensive dietary management involving for example 
calorie restriction with subsequent nutrient restriction that could at the end result in greater 
weight reduction (SIGN, 2010, Rivera et al., 2003).  
 
An evidence-based fourth report from the National High Blood Pressure Education 
Program (NHBPEP) working group on children and adolescents (2004) defines adolescent 
prehypertension as ≥120/80 mmHg and recommends rechecking blood pressure in 6 
months with weight management counselling if overweight or obese. The issue of 
measurement error is acceptable in group level comparisons (e.g. intervention group vs 
control group) than for changes within individuals. 
The mean systolic blood pressure at baseline for the whole sample was 122 mmHg (SD 10) 
and for diastolic blood pressure was 77 mmHg (SD 8). At 6 months assessment, the 
intervention group had a mean blood pressure of 122/79 mmHg (SD 10/7) where they has 
a statistically significant increase in their diastolic blood pressure (p 0.01) and the control 
group had their mean blood pressure at 123/80 (SD 7/5). It is evident that the whole sample 
had prehypertension from the beginning and it stayed with them through to the end of trial. 
Our intervention did not provide treatment for the intervention group and although 
diastolic blood pressure increased significantly, it remained within normal range and it is 
the systolic blood pressure that defined prehypertension for the whole sample.   
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6.4.2 Intervention feasibility 
The NATTO intervention programme was designed to involve parents and their obese 
adolescents as recommended by evidence-based guidelines (SIGN, 2010, NICE, 2013). In 
the present study, consented parents and their adolescents were perceived to be motivated 
to participate. However, the trial records showed that attendance in both the intervention 
arm and the control arm were poor.  
The intervention programme was originally designed to a total of 12 sessions arranged as 
one session every two weeks for 6 months. In the first session 36 families out of the 41 
families attended. Two weeks after the author had to cancel the session due to cancellation 
by almost all families. This scenario was repeated for the session that followed and the 
author had to condense the sessions to 6 instead of 12 and to take place every month 
instead of every two weeks. Attendance was still poor and only 12 (29%) of participants 
attended 4 out of the 6 sessions.  
Reasons behind poor attendance are largely anecdotal and not based on formal qualitative 
evaluation. The recent MRC Framework on developing and evaluating complex 
interventions (Craig et al., 2008) recommends that in order to explore reasons behind failed 
intervention attendance, qualitative studies should be run in conjunction with the 
intervention trial, but this was not possible for the present study due to lack of resources. 
The main reasons conveyed by parents for not attending were related to school work or 
simply forgetfulness, although the original study programme (12 sessions) and the 
amended programme (6 sessions) were provided to parents, and reminders were also 
provided for each upcoming session by means of phone calls and SMS. This suggests that 
reasons for not attending were not directly related to the study programme itself. Time and 
location were not among the list of reasons for non-attendance as described in a US weight 
management study (Barlow and Ohlemeyer, 2006). A recent review on the reasons behind 
high attrition rate in paediatric weight management studies suggested specific stigma 
describing the main characteristics of the participants with high attrition rate and these 
include: severe obesity; the presence of comorbidities; racial/ethnic minorities; poor or 
single-parent households (Skelton and Beech, 2011)  none of which existed in the present 
study participants. 
  
A better understanding of the obstacles, if any, behind parents’ non-adherence to treatment 
sessions requires further exploration using qualitative methods, and goes beyond the scope 
of the present study. 
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The intervention programme was tested against the standard care which is an 
individualised clinic appointment with subsequent follow up. However, only four parents 
attempted to arrange primary care appointments and none of the participants in the control 
group attended any standard care sessions, as evident from the clinic formal records. 
Subsequently, the intervention programme was in effect tested against a no treatment 
control.  
 
6.4.3 Declining interest in intervention 
A total of 136 eligible families did not consent to participate in the study due to various 
reasons. The main reason given by the families was concern for their child’s academic 
performance. Other anecdotal reasons for declining to participate were lack of interest and 
time, and unawareness of parents regarding their child’s weight status. Some parents have 
actually challenged the author arguing that the children’s weight was simply a result of 
puberty. Parental unawareness of their offspring overweight and obesity has been reported 
internationally (Parry et al., 2008)  and in Kuwait (Al-Qaoud et al., 2010).   
 
6.4.4 Comparisons with other studies 
SCOTT was an RCT based in Scotland and targeted 5 to 11 year olds by means of 
generaliseable best practice individualised family centred behavioural intervention and 
since NATTO intervention was based on the SCOTT trial, a brief comparison with the 
outcomes of SCOTT is appropriate. Table 6.12 shows a comparison between SCOTT study 
results and NATTO.  
The change in BMI Z score, physical activity levels and quality of life over time in the 
Hughes et al (Hughes et al., 2008) were reported as median (IQR), so the author used the 
mean (SD) results from Stewart thesis (Stewart, 2008). Also, Hughes et al (2008) reported 
results at 6 months end of treatment and at 12 month follow-up, but in the present study we 
only reported results at 6 months end of treatment.  
Both studies show similar results in primary outcome at 6 months for the intervention 
groups and the control groups.   
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Table 6.12 Comparison of the present NATTO study with SCOTT study 
  NATTO SCOTT 
Participants 10 to 14 years old, Kuwait 5 to 11 years old, Scotland 
 
n=82 (42 males) randomised; n=134 (59 males) randomised; 
 
n=41 intervention group (IG) n=69 Intervention group  
 
IG 6 months n=31 IG 6 months n=48, 12 months n=45 
 
CG (control group) 6 months n=32 CG 6 months n=49, 12 months n=41 
 
No 12 months follow up 
 
   
Primary outcome Changes in BMI Z score at 6 months end Changes in BMI Z score at 6 months end  
 
of treatment of treatment 
   
Secondary outcomes % body fat (%BF), Waist circumference  Total activity + time in sedentary   
 
(WC), blood pressure (BP) at 6 months  behaviour, light intensity + ¹MVPA 
 
(end of treatment) at 6 months (end of treatment), 
  
measure of quality of life at 6 months 
  
(end of treatment) 
   
Primary outcome IG 0.0 (0.1) IG -0.1 (0.2) 
at 6 months CG 0.0 (0.2) CG -0.1 (0.2) 
 
Mean (SD) Mean (SD) 
   
Secondary outcomes %BF IG -2.9 (3.7) Total activity (accelerometry ²cpm); 
at 6 months CG -3.4 (4.1) IG 18 (163) 
 
WC IG 4.9 (5.8) CG -98 (165) 
 
CG 3.5 (5.7) Sedentary behaviour;  
 
Systolic BP IG 0.4 (6.7) IG 0.1 (5.6) 
 
CG 0.6 (4.8) CG 3.8 (5.3) 
 
Diastolic BP IG 2.9 (6.2) Light intensity ; 
 
CG 1.1 (5.8) IG -0.6 (4.6) 
 
Mean (SD) CG -3.3 (4.1) 
  
MVPA; 
  
IG 0.5 (2.1) 
  
CG -0.4 (1.8) 
  
Quality of life, Total child report   
  
IG 3.7 (12.6) 
  
CG 6.9 (13.5) 
  
Total parent report 
  
IG 3.3 (9.1) 
  
CG 5.2 (9.8) 
    Mean (SD) 
¹MVPA; moderate-vigorous physical activity, ²cpm; count per minute, IG; intervention group, CG; control group 
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Several studies have tested intervention techniques for the treatment of adolescent obesity 
which ranged from exercise classes, education classes, dietary modification, inpatient 
therapy, cognitive behavioural therapy, to drug therapy (Oude Luttikhuis et al., 2009). Few 
group based educational programmes for the treatment of adolescent obesity were included 
in the most recent Cochrane review for obesity treatment in children and adolescents 
(Rodearmel et al., 2007, Nemet et al., 2005, Israel et al., 1994, Mellin et al., 1987). 
Rodearmel et al. (2007) America on the Move (AOM) intervention is an example of 
examining how providing minimum information regarding diet and physical activity could 
aid weight loss. It involved meeting the families during the intervention period of 6 months 
to alter two behaviours related to diet (replacing sugar with sweetener) and physical 
activity (walk additional 2000 steps per day using pedometer). Participants (n=218 age 7 to 
14) were randomised to either the AOM group or the self-monitoring group (SM). AOM 
group received nutrition education and support around replacing dietary sugar and 
increasing their level of physical activity while the SM group were asked only to wear 
pedometers and record physical activity with no further guidance. The treatment sessions 
were held once per month for 6 months for the AOM group. Both groups had a statistically 
significant reduction in BMI Z scores at 6 months; however the difference between the 
groups was not significant. Another study (Nemet et al., 2005) was conducted in Israel and 
involved randomising 54 families (participants age 6 to 16 years) to either the intervention 
group or the routine care group. The intervention consisted of four evening lectures on 
childhood obesity, general nutrition, in addition to a balanced hypocaloric diet and twice 
weekly exercise programme. The study was held for 3 months and outcomes were 
measured at end of the intervention and again in 12 months. Outcomes measured included 
height, weight, BMI, skin-fold thickness and lipid profile. There was significant decrease 
in body weight, BMI and percentage body fat, cholesterol and LDL at 3 months and 12 
months for the intervention group while the routine care group gained weight at 3 months 
and 12 months.  
Another study from the USA conducted over 2 decades ago by Israel et al (1994) and 
included in the Cochrane review (Oude Luttikhuis et al., 2009, Israel et al., 1994). It tested 
behavioural treatment programme of obesity in which either parents had the primary 
responsibility to follow the programme (control group) or enhanced child involvement 
(ECI) condition (intervention group) which basically means giving the children some 
responsibility for self-management. Thirty four families were randomised and the age 
range of the children was 8 to 13 years. The programme lasted for approximately 6 months 
and involved weekly group discussions, homework assignments regarding stimulus 
 130 
 
control, physical activity, food intake and rewards. End of treatment outcomes were 
percentage overweight (based on weight for age, height and sex), triceps skin-fold 
thickness and measures of self-regulation and self-control. There was significant reduction 
of %overweight in both the intervention and the control group. Mellin and colleagues 
(Mellin et al., 1987).  
 
Recent paediatric obesity treatment studies also focus on cardiometabolic as well as weight 
management. A more recent systematic review and meta-analysis on the use of lifestyle 
interventions to treat childhood and adolescent obesity and/or improve the cardiometabolic 
outcomes conducted by Ho et al (2012). The systematic review included 38 RCTs that 
compared lifestyle interventions to no treatment/ wait list, usual care or written educational 
materials controls. The dietary component of the lifestyle interventions included traffic 
light diet or modified traffic light diet, or calorie restriction. Nineteen studies incorporated 
physical activity sessions. The results showed a statistically significant reduction in BMI Z 
score (-0.1, 95% CI -0.18 to -0.02) and when the intervention was longer than 6 months 
duration, greater weight loss was observed. There was also a significant improvement in 
LDL, TG, Fasting insulin and blood pressure. In our study, cardiometabolic risk factors 
were obtained at baseline, and there was an end of trial measurement to be made. However, 
due to bureaucratic complexity, end of trial measurement of cardiometabolic risk factors 
were not possible. 
 
In 2013 Sbruzzi and colleagues published a systematic review and meta-analysis on the use 
of educational programmes with behavioural, nutritional and physical activity components, 
for the prevention and treatment of paediatric obesity (Sbruzzi et al., 2013). Eight studies 
were treatment trials and the outcomes included waist circumference, BMI and BMI Z 
score. The review showed that educational treatment interventions for at least 6 months 
resulted in significant reduction in waist circumference, BMI, BMI Z scores and diastolic 
blood pressure. 
 
El-Sabban and Badr (2011) tested the nutrition knowledge of slightly older group than our 
sample (age 15 to 21 years 1,037 Kuwait University student) with regards to general 
nutrition, nutrition-related health problems and different groups of nutrients. The scores 
were poor, fair or good. The overall nutrition knowledge of the sample was rated as fair. 
One of our objectives in our study was to build up nutrition knowledge among the 
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intervention group in an attempt to correct the deficit in nutrition and health relationship 
that is evident from the El-Sabban and Badr study. 
 
6.4.5 Study strengths and limitations 
The principal strengths of the present study were: the high level evidence obtained, with 
adherence to the CONSORT statement on conduct and reporting of RCT (Moher et al., 
2012); the fact that the trial was powered adequately, in contrast to a number of previous 
trials in this area (Oude Luttikhuis et al., 2009); development and testing of a potentially 
generalisable intervention; completing a challenging adolescent obesity treatment RCT 
(Warren et al., 2007) in the novel setting of a Gulf State.   
At baseline, there were no significant differences between the study groups in terms of 
anthropometric measures, weight status, and blood pressure (table 6.1). This suggests that 
randomisation was successful in avoiding any discrepancies between groups at baseline.  
 
The present study also had a number of weaknesses. Longer-term obesity treatment trials 
are desirable, and a 6 month follow up is considered the minimum desirable in the most 
recent Cochrane review of paediatric obesity treatment RCT (Oude Luttikhuis et al., 2009).  
An assessment of parent and adolescent perspectives on the treatment programme would 
have been desirable in order to both understand the current intervention better and to 
inform future treatment interventions (Craig et al., 2008, Stewart et al., 2008a, Murtagh et 
al., 2006). The intervention was designed to modify dietary, physical activity and sedentary 
behaviours, however, and the measured outcomes did not include an assessment of these 
behavioural measures. We did not have the time or human or equipment resource to make 
that assessment, however, weight and adiposity measure changes might give an indication 
as to whether any such behavioural change took place, though they could not identify what 
the behavioural changes were.   
 
6.4.6 Study implications and suggestions for further research 
This study addresses the need for serious efforts to address what seems to be the gap 
between treatment interventions and families. This patient-intervention interface needs 
further evaluation to identify reasons behind adherence and attrition. Qualitative studies 
should therefore be conducted in parallel with treatment intervention studies to help with 
quality control of the intervention tested and also help shape future treatment policy.   
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Future intervention trials in Kuwait might find it useful to focus treatment at other 
population subgroups (e.g. younger or older participants, or to tailor treatment to boys or to 
girls) or in other settings (e.g. a hospital or school based programme), but this was not 
possible in the present study due to resource limitations. Moreover, future studies should 
aim to assess behavioural changes in diet, physical activity and inactivity as part of the 
study’s outcome. 
 
6.5 Conclusions 
The present study is the first reported intervention for the treatment of adolescent obesity 
in Kuwait. The study suggests that an adolescent treatment trial is feasible, but the 
intervention used seemed much less feasible and had no benefits in terms of clinically 
relevant reductions in BMI or other weight status measures. With the persistence of 
adolescent obesity, more randomised controlled trials of treatment interventions should be 
conducted in accordance with the high standards of the CONSORT statement with the 
support of the Kuwaiti authorities, parents and schools.   
 133 
 
7. General Discussion 
 
The current thesis set out to examine the feasibility and efficacy of an adolescent obesity 
treatment intervention in Kuwait. It also sought to explore the health related quality of life 
in obese adolescents and the prevalence of cardiometabolic risk factors, and whether these 
health related quality of life and cardiometabolic risk factors would change after 
completion of the treatment intervention.  
 
There is general agreement in the literature that there is a lack of evidence from obesity 
treatment trials of adolescents, especially from the non-western world (Ho et al., 2012, 
SIGN, 2010, Oude Luttikhuis et al., 2009, NICE, 2013), and more recent evidence suggests 
that adolescents may be more resistant to obesity treatment than children (Danielsson et al., 
2012). Danielsson and colleagues (2012) investigated the response of obese children and 
adolescents to 3 years of behavioural treatment intervention for obesity.  From the 643 
patients in their cohort, 20% of the adolescents of the age range 10 -13 years had what was 
considered to be a clinically significant reduction in BMI Z score of ≥ 0.5, while 58% of 
children at the age range 6-9 had reduction in BMI Z score of ≥ 0.5. Therefore, obese 
adolescents might be a particularly challenging group to treat, even outside Kuwait.  
 
Childhood is a vital period to deliver obesity prevention strategies and possibly treatment 
strategies for those who are already obese with promising, clinically meaningful reduction 
in BMI Z score (Danielsson et al., 2012, Matson and Fallon, 2012, Baidal and Taveras, 
2012). However, adolescent obesity treatment is also crucial to address in order to prevent 
an upcoming generation of obese adults with multiple comorbidities.      
 
Paediatric obesity is a multifaceted public health problem which requires urget prevention 
and treatment strategies (Avis et al., 2014). Effective treatment strategies are probably 
population specific to some extent, and require a testing process to come up with the most 
successful, population specific treatment option (Reinehr and Wabitsch, 2011).  
 
The original thesis plan, which aimed to explore the feasibility and efficacy of adolescent 
obesity family-based treatment intervention on BMI Z score, health related quality of life 
and cardiometabolic risk factors in Kuwait, started from Glasgow with the agreement of 
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the Higher Degree Committee of the University of Glasgow to conduct the treatment trial 
in Kuwait for a 12 month period (Glasgow PhD degrees permit a maximum of 12 months 
to be spent outside of Glasgow). The next stage started in Kuwait with the approval of the 
Medical Research Committee of the Ministry of Health to conduct the trial in Kuwait with 
the collection of baseline measurements that included anthropometric, health related 
quality of life assessment and blood samples, and the collection of end of trial 
measurements of the same parameters.  
 
The original plan was cut short and the thesis plans were modified to describe an obese 
adolescent treatment intervention in Kuwait (NATTO treatment manual chapter 3), the 
results of the NATTO study in relation to primary outcome which was BMI Z score and 
secondary outcomes which were percentage body fat, blood pressure and waist 
circumference (chapter 6), health related quality of life of a sample of obese Kuwaiti 
adolescents compared to healthy weight peers and compared to their parent-proxy reports 
(chapter 4), and the prevalence of cardiometabolic risk factors in a sample of obese 
Kuwaiti adolescents (chapter 5).  
 
The modification of the original plan was mostly due to the bureaucratic system in Kuwait 
which hindred the gathering of end of trial assessment of cardiometabolic risk factors and 
health related quality of life data, combined with the university limitation on the amount of 
time which could be spent outside of Kuwait. Our original ethical approval included 
baseline and end of trial assessment of primary outcome (BMI Z score) and secondary 
outcomes (percentage body fat, cardiometabolic risk factors and health related quality of 
life assessment). However, at the schools that agreed to participate in the study, school 
principals refused to allow the author assessment of participants heath related quality of 
life by means of Peds QL 4.0 questionnaire due to the schools’ time restraints and only 
assessment of the participants weight, height and blood pressure was permitted at follow 
up. University of Glasgow PhD regulations, as noted above, meant that the author only had 
12 months in Kuwait for the trial conduct and completion and starting a fresh process of 
ethical approval was out of the question. The author was faced also with refusal for end of 
trial blood samples collection. The head of laboratory department approval was needed to 
appoint the author a nurse and an equipped room. He specifically asked for a new ethical 
approval and a letter from the supervisor Professor John Reilly addressed to him directly to 
give permission to the author collecting end of trial blood samples. Sadly, the importance 
of the research was not on the agenda discussed with the school principals or the head of 
 135 
 
the lab department and it didn’t matter that the original ethical approval was valid. From all 
of the above, the author had to consider each study as separate namely; health related 
quality of life of obese adolescents in Kuwait (chapter 4) (Boodai and Reilly, 2013), 
prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti 
adolescents (chapter 5) (Boodai et al., 2014a) and National Adolescent Treatment Trial for 
Obesity in Kuwait (NATTO, chapter 6) (Boodai et al., 2014b).  
 
This final chapter considers the main findings of the thesis studies, and highlights the 
implications of these findings in adolescent obesity treatment interventions in the future, 
with particular emphasis on Kuwait and the Gulf states. It also highlights the limitations of 
the thesis studies and future directions to minimise these limitations. 
 
7.1 Reaffirmation of the main thesis findings 
Chapter 6 in this thesis discussed the results of a family based obesity treatment RCT for 
Kuwaiti adolescents in terms of feasibility and some evidence of efficacy (Boodai et al., 
2014b). The power calculations were based on the SCOTT trial (Hughes et al., 2008). 
Random school selection was not possible and only schools who agreed to participate were 
selected. Participants in the study were fairly homogenous in that all attended state schools 
and all were Kuwaiti nationals. The chapter concluded that performing RCT for the 
treatment of adolescent obesity in Kuwait is feasible. The feasibility was judged in terms 
of collecting baseline and end of trial measurements of primary and secondary outcomes. 
Efficacy of the treatment intervention was also tested and the chapter showed that the 
intervention had no effect on primary (BMI Z score) or secondary outcomes (percentage 
body fat, waist circumference, and blood pressure). The study was a wellconducted RCT, 
which followed the CONSORT guidelines (Moher et al., 2012), and in all areas of 
scientific research negative results should be of as much importance as positive ones. The 
intervention programme was intended to be reproducible, high intensity programme in 
comparison to typical dietitic care within the primary care system of Kuwait. Intensity of 
the sessions had to be reduced due to participants’ incompliance. The health system in 
Kuwait is still lacking an integrated mutidisciplinary service for the treatment of paediatric 
obesity, in particular clinical psychologist services. Therefore the typical dietitic approach 
in treating paediatric obesity has no reference to behaviour modification techniques applied 
in the NATTO study. The need for more intensive and longer treatment programmes may 
well have the influence on the success of clinical management of paediatric obesity.   In 
the most recent systematic review and meta-analysis of comprehensive behavioural 
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interventions for treating paediatric obesity, the authors concluded that using behavioural 
techniques in improving dietary habits, physical activity and sedentary behaviour could 
reach an overall average reduction of 0.47 in BMI Z score corresponding to a medium 
effect size (Janicke et al., 2014). The length of follow up in the selected studies ranged 
from 10 to 24 months, where improvement in weight outcomes were maintained provided 
that greater session intensity and treatment duration were present (Janicke et al., 2014). 
The degree of parents involvement had no effect on weight changes of their offspring, but 
their adherence to the behavioural techniques had great effect on their offspring’s weight 
outcome (Janicke et al., 2014). During the conduct of the NATTO trial, the author had to 
decrease the intensity of the treatment intervention due to participants’ lack of compliance 
as described in chapter 6. Moreover, it was not possible to collect follow up data beyond 6 
months due to time restraints in Kuwait as the Higher Degree Committee in the University 
of Glasgow only allowed the author 12 months of research. Preparation,  recruitment and 
baseline data collection started in September 2009, as mentioned in chapter 2. The start of 
the NATTO study was in January of 2010 and the last group session was in May 2010. The 
2010 school year ended in June 2010, therefore end of trial measurements were carried out 
in June 2010. The mentioned timeline was very limiting to the research team and is one of 
the major limitations of the NATTO study.  
An add on qualitative study is critical in assessing what the participants’ likes and dislikes 
about the intervention and assessing their needs and support from outside the family with 
their suggestions for how the intervention could be improved in the future. The impact of 
cultural differences is very crucial, and interventions worked in one setting may not be as 
effective elsewhere. Therefore, part of the study design should also include pre-trial 
evaluation to let the participating subjects be part of the decision making of  how to 
implement the intervention in question, within the evidence-base frame.  
No measurement of in changes dietary intake/habits was undertaken. Such measurements 
may have given a valuable insight into the types of changes undertaken by the adolescents 
and their families. It was also unfortunate that data on physical and sedentary behaviours 
was not included in the results. Dietary habits and physical activity level would have been 
useful and which might have changed even in the absence of major changes in 
anthropometry.   
 
Chapter 4 discussed the results of a comparison of health related quality of life between 
obese Kuwaiti adolescents and healthy weight peers and between obese Kuwaiti 
adolescents and their parents’ perception of their health related quality of life (Boodai and 
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Reilly, 2013). The assessment tool for HRQL was the Peds QL 4.0 questionnaire (Varni et 
al., 2003). Decreased health related quality of life has been considered the norm in obese 
children and adolescents (Pulgaron, 2013, Ul-Haq et al., 2012, Al-Akour et al., 2012, 
Hamzaid et al., 2011, Griffiths et al., 2010, Riazi et al., 2010, Varni et al., 2007, Hughes et 
al., 2007), but in the study described in chapter 4 the HRQL of obese Kuwaiti participants 
did not differ much from that of the healthy weight peers except for the physical domain of 
the Peds QL 4.0 questionnaire (Boodai and Reilly, 2013). This result could contribute to 
the low attendance and compliance of participants at the NATTO study, pointing to their 
relatively undisrupted HRQL. This chapter gives an obvious message to researchers and 
health professionals that culture is an important factor in determining health effects of 
obesity, particularly mental health and well being, and international results from western 
countries might not be applicable in Kuwait. 
 
Finally, chapter 5 was based on baseline measurements of cardiometabolic risk factors in 
80 obese Kuwaiti adolescents participating in NATTO. The chapter also discussed the 
prevalence of metabolic syndrome using the IDF and the ATP III criteria (Zimmet et al., 
2007, Panel, 2001). Seventy seven out of the 80 obese participants (96.3%) had at least one 
cardiometabolic risk factor. Almost a third of participants had MS. The chapter pointed out 
that if these results had been available for participants in the NATTO trial, attendance 
might had been better at the intervention sessions, assuming that concern over 
cardiometabolic risk factors could be used to motivate attendance. The chapter re-
emphasises the importance of finding a treatment intervention for adolescent obesity, since 
multiple cardiometabolic risk factors increase the risk for later cardiometabolic disease. 
 
7.2 Implications of thesis findings and future research suggestions 
This thesis tried to explore the feasibility of conducting adolescent obesity treatment RCT 
in Kuwait. The literature still lacks any evidence of paediatric obesity treatment 
intervention trials from Kuwait and the Gulf region (Musaiger, 2012). Conducting an 
obesity treatment RCT in Kuwait was feasible as shown in the present study, but only with 
difficulty. Lack of resources, lack of support from the Kuwaiti authorities, lack of time in 
Kuwait, and lack of engagement with treatment all restricted our research plans. Our 
findings emphasise the urgent need for local paediatric obesity treatment approaches. 
  
If we or other researchers attempt to conduct a ‘NATTO 2’ adolescent obesity treatment 
trial in the future, an alternative approach is required, a more ‘bottom-up’ approach 
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following the recommendations in the UK MRC statement on the development and 
evaluation of complex interventions, which was published only after the NATTO study 
was conceived in 2007/2008 (Craig et al., 2008). This would include a pilot study before 
the conduction of the RCT. An exploratory trial is indicated by the UK MRC Framework 
in order to check for the feasibility of the intervention tested within the context in which 
the intervention is being undertaken.A qualitative arm of the study which attempts to 
understand adolescent and parent perspectives, and to use this understanding to design a 
more acceptable, family tailored treatment protocol, and to identify the key barriers in 
changing their dietary and physical activity habits and in engaging more with the treatment  
(Craig et al., 2008). The fact that there was no statistically significant difference between 
the groups in reduction of BMI Z score would suggest that the intervention group still 
required to make further lifestyle changes. It is possible that in the intervention programme 
employed in the present study there were too many new concepts and strategies 
implemented compared to the standard treatment. The traffic light diet scheme was used 
and a variety of behavioural change techniques were employed. All of these were a 
substantial change from the typical dietetic care, therefore make comparison of differences 
complex. 
 More money, support and manpower will also be needed for future research of this kind- 
the data collection phase of the present study was supported by the resources of the author 
and a small bench fee to meet study running costs. Follow up in future treatment RCT 
should ideally be as long as possible and  no less than 12 months from baseline. Another 
possible scenario is to conduct future ‘NATTO 2’ in schools rather than primary care 
clinics. Schools hold great promise in delivering treatment intervention with potential 
success (Almas et al., 2013, Sahota et al., 2001a), though in the present study some 
problems in dealing with schools in Kuwait have been noted.  
 
Individual-level theories, community-level theories, interpersonal communication, 
printed materials, interactive computer technologies, and media campaigns these represent 
but a few of the tools available for the health professionals for designing, implementing, 
and evaluating health behavior change programs. Typically, a problem affecting a 
particular population has been identified, and the health professional must do something to 
fix the problem, whether it is high rates of obesity among children and adolescents in a 
community or inappropriate use of emergency departments for nonurgent care. If the 
NATTO study being done again, the use of the health programme planning which is a 
model for cost-benefit evaluation framework proposed by Green and Kreuter, would be 
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helpful in the study design. It involved the processes of health problem diagnosis, careful 
planning and continuous evaluation of the intervention proposed to hopefully create a 
successful intervention (Crosby and Noar, 2011, Green and Kreuter, 2005). At planning 
phase, researchers should expand their understanding of the community in which they are 
working by conducting multiple data collection activities that involve observations, 
surveys, focus groups with members of the community and concept mapping. Concept 
mapping is the term used to allow participants to generate a large number of ideas that are 
then subjected to quantitative analysis. Final agreement is reached on the concept maps 
that best reflect the participants’ views. The second phase involves the essessment of the 
problem at hand using national datasets, which in Kuwait are readily available from the 
KNSS mentioned in chapter 1. This phase also involves the behavioural assessment at 
three key levels. The first one concerns the individual’s behaviour contributing to the 
health problem, the second level concerns the behaviour of others who can directly affect 
the behaviour of the individual with the health problem, and the third level is the action of 
decision makers whose decisions affect the social or physical environment that influences 
the individuals with the health problem. After selecting the relevant behavioral and 
environmental factors for the intervention,selection of behavioural modification techniques 
should be in place to initiate the intervention designed. After implementing the 
intervention, a plan for data collection should be in place for process evaluation, and the 
intervention outcomes (Green and Kreuter, 2005).  
  
The application of the health programme planning model and the UK MRC framework 
would have been more reliable in designing the NATTO trial, and helped in  exploring the 
reasons behind lack of family engagement in the intervention , and participants suggestions 
for how the intervention could be improved in the future.    
 
It is also possible that health care professionals lack the knowledge necessary to address 
paediatric obesity and treat it (Findholt et al., 2013), therefore, further research is needed to 
examine the foundations of the health care system involved in dealing with obese 
paediatric population in terms of assessment, internal nutrition knowledge, and 
management. Parents and health professionals need to be educated that childhood obesity 
is associated with medical comorbidities and is not simply a social or cosmetic concern 
(van Emmerik et al., 2012, Reilly and Kelly, 2011). 
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Currently, there is no clear assessment of behaviour modification techniques that are most 
effective in the treatment of paediatric obesity (Martin et al., 2013). Martin and 
colleagues(2013) assessed studies that have used behaviour change techniques to promote 
healthy eating and increase physical activity for paediatric obesity prevention and 
treatment. The effectiveness of interventions is probably being opposed by the inclusion of 
BCTs that are ineffective in achieving clinically meaningful reductions in BMI, and this 
may explain why such interventions fare so poorly in achieving (and maintaining) larger 
reductions in BMI over time. Potentially effective behaviour modification techniques were 
identified, however, more research is needed to identify targeted treatment interventions 
(Martin et al., 2013). Identifying the active components of interventions aiming to manage 
obesity in adolescents is very crucial and different from those used in the treatment of 
obesity in children.  Possibly with ‘NATTO 2’, application of these potentially effective 
behaviour change techniques could result in better treatment outcomes.  
 
The health related quality of life study in chapter 4 could be expanded in the future to 
involve more participants, with the involvement of private as well as public schools. 
Another future approach might be to use a disease-specific QoL instrument, rather than a 
generic instrument, since disease specific instruments might reveal small QoL deficits not 
revealed by generic instruments. For example, the Impact of Weight on Quality of Life 
(IWQOL-Kids) questionnaire is a new disease specific valid and reliable tool used to 
assess weight-related quality of life of obese adolescents (Modi and Zeller, 2011). In 
future, the IWQOL-Kids questionnaire could be translated to Arabic and used to assess 
weight related quality of life in obese Kuwaiti adolescents. It is designed to be used by 
adolescents, contains 27 items with each item begins with the phrase ‘because of my 
weight ..’, and is sensitive to differences between overweight and obese groups, and 
between clinical and community samples (Modi and Zeller, 2011).  
 
For further research in the assessment cardiometabolic risk factors in obese Kuwaiti 
adolescents, it would be of great value if results be available at the preparatory stage of 
treatment RCT before group allocation, as these might provide a form of ‘wake up call’ for 
families participating in the trial. Attendance of both control and intervention groups could 
possibly be encouraged and retainability improved. Moreover, having baseline and end of 
trial assessment of cardiometabolic risk factors adds clinical value to the assessment of the 
efficacy of the tested intervention.  
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To sum up, we still have some way to go in understanding the environmental, cultural  and 
other influences on the development of obesity in children and adolescents, and developing 
effective interventions that change obesity related behaviours. If we continue the 
preventive and treatment research in parallel, across the biological, behavioural and 
environmental disciplines, then we will make small changes, which taken together, will 
lead to social and societal change that will optimally result in a reversal of the obesity 
epidemic in the coming decades. 
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Appendix A 
 
 
  
 
 
WELCOME……. 
 
Dear parents and children; 
 
Firstly I would like to welcome you all into the first childhood obesity treatment trial to be conducted in 
Kuwait. It is also my pleasure to thank you for your valued participation in this trial that if proved to be a 
success, hopefully will be the first step into producing  guidelines towards proper management of 
childhood obesity. If however the results are not encouraging; this will mark our next step into finding 
other useful tools to tackle childhood obesity in Kuwait.  
 
 
 
 
Background: 
 
Childhood and adolescence obesity in Kuwait is reaching escalating levels. It has detrimental effects on 
child’s physical and psychological health. Unfortunately, there is no consensus on the most appropriate 
treatment method. Evidence is urgently needed to come up with population specific and effective 
treatment programmes. This study examines the effect of group therapy programme in treating obesity in 
a cohort of 10 to 14 year old adolescents. We will examine the effects of treatment on weight, body mass 
index, psychological health and cardiovascular disease risk factors. 
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Information about the study: 
 
The research is conducted by Dr Shurooq Boodai, a Medical Registrar in Central Nutrition Clinic Food 
and Nutrition Administration, Ministry of Health. She is currently a PhD student at University of 
Glasgow, UK. The research is basically the pivot of her research degree and is taking place under 
supervision of Professor John Joseph Reilly-University of Glasgow.  
As stated in the informed consent form, participation in this study is completely optional with no 
obligatory effects taking place at any point during the trial. 
The trial outline has been reviewed and approved by the Ethical Committee for Medical Research-
Ministry of Health-Kuwait.   
 
 
Mapping the study: 
 
After recruiting the appropriate number of adolescents into the study, a computer generated programme 
will divide the cohort into two groups; the intervention group who will receive the hypothesized group 
therapy, and the control group who will receive the welcome pack and will be given an appointment at the 
end of trial for end of trial assessment. There will be equal chance of enrollment into either group. At this 
point both groups and parents will be asked to answer a mini quality of life questionnaire.   
Before group assignment, there will be given an appointment to attend the first one to one interview with 
the researcher. Here, a thorough medical history and examination will take place and blood samples will 
be collected. Weight and height will be measured and plotted on percentile charts. 
The treatment sessions for the intervention group will take place thereafter in a lecture hall of Al Faiha’a 
polyclinic. They will be held every month for a period of 6 months. Each session will run for 60 minutes 
and another 15 minutes will be assigned for questions. Refreshments will be served at the end of each 
session.  
At the sixth month all groups will be an end of trial reassessment of weight, height and another set of 
blood samples. Also, a mini quality of life questionnaire will be distributed.  
Analysis of results and comparison of inter and intra group findings will take place in University of 
Glasgow.  
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The Treatment sessions aiding material 
 
Session One 
 
 
 
 
 
 
 
 188 
 
 
 
 
 
 
 
 
 189 
 
 
 
 
 
 
 
 
 
 190 
 
 
Session Two 
 
 
 
 
 
 191 
 
 
 
 
 
 
 
 
 192 
 
 
 
 
 
 
 
 
 193 
 
 
Session Three 
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This session included rope jumping, and hula hoop exercise. 
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Session Five 
 
This session was a practical involving healthy snack making.  
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Appendix B 
 
Normal Distribution curve for physical score in Peds QL 4.0  
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Normal Distribution curve for psychosocial score in Peds QL 4.0 
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Normal distribution curve for total score in Peds QL 4.0 
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Appendix C 
 
 
The Nutrition Clinic for baseline measurements. 
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Appendix D 
 
 
PedsQL™ Administration GuidelinesSM       
 
The following guidelines are intended for use by individuals trained in the administration of standardized 
questionnaires.  The PedsQL™ administrator is crucial in developing rapport with the respondents, 
emphasizing the importance of the questionnaire, addressing concerns, and ensuring that the PedsQL™ is 
completed accurately and confidentially.   
 
General Protocol 
 
1. Create a procedure for assigning identification numbers that will allow for parent/child  
comparisons as well as comparisons of baseline/follow-up data. 
2. If feasible, the PedsQL™ should be completed before the respondents complete any other health data 
forms and before they see their physician or healthcare provider. 
3. The parent/child should first complete the PedsQL™ Generic Core Scales and then complete any 
additional PedsQL™ Module. 
4. Parents, Children (8-12) and Teens (13-18) may self-administer the PedsQL™ after introductory 
instructions from the administrator.  If the administrator determines that the child or teen is unable to 
self-administer the PedsQL (e.g., due to illness, fatigue, reading difficulties), the PedsQL should 
be read aloud to the child or teen.  For the Young Child (5-7), the PedsQL™ should be administered 
by reading the instructions and each item to the young child word for word.  At the beginning of each 
subscale repeat the recall interval instructions (one month or 7 days) to remind the young child to 
respond only for that specific recall interval.  Use the separate page with the three faces response 
choices to help the young child understand how to answer.  When reading items aloud to a child, 
intonation should be kept neutral to avoid suggesting an answer. 
5. If a child has difficulty understanding the age-appropriate PedsQL, the preceding age group version 
may be administered to the child (e.g., administering the Young Child (5-7) Self-Report version with 
the three faces response choices to an 8 year old).  However, if a child presents with severe cognitive 
impairments (as determined by the administrator), the PedsQL may not be appropriate for that 
child.  In such cases, only the Parent-Proxy Report should be administered to the child’s parent. 
6. The parent and child must complete the questionnaires independently of one another. Discourage the 
parent, child, or other family members from consulting with one another during the completion of the 
questionnaire.  Let them know that they can feel free to discuss their answers following completion of 
the questionnaires, but that it is important to get both the parent’s and the child’s individual 
perspectives.  If you are administering the questionnaire to the child, the child should be facing away 
from the parent. 
7. If the child or parent has a question about what an item means or how they should answer it, do not 
interpret the question for them.  Repeat the item to them verbatim.  Ask them to answer the item 
according to what they think the question means.  If they have trouble deciding on an answer, ask 
them to choose the response that comes closest to how they feel. The child and/or the parent has the 
option of not answering a question if they truly do not understand the question.  
8. If a parent/child asks you to interpret the responses, tell her/him that you are not trained 
to interpret or provide a score for the answers given.  If the PedsQL™ is being used for a clinical 
study, let the parent/child know that their answers will be combined with other participants’ answers 
and analyzed as a group rather than as individual respondents. 
9.   Document all reasons for refusals and non-completions of the PedsQL™. 
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Administering the PedsQL™ 
 
1. The following scripts have been developed as a guide to introduce the PedsQL™ to the child and 
his/her parent(s).  Modify the language to a style that is most appropriate for you and the respondent. 
 
For the child: 
 
The PedsQL™ asks you questions about how you feel and what you think about your health.  It is 
not a test, and there are no right or wrong answers.  It takes about 5 minutes to complete.   If you 
have any questions, please let me know. 
 
For the parent: 
 
The PedsQL™ is a questionnaire that assesses health-related quality of life in children and 
adolescents.  It contains questions about your child’s physical, emotional, social, and school 
functioning in the past one month (or for the Acute version, in the past 7 days).   
 
The PedsQL™ is brief and typically takes less than 5 minutes to complete.  It is not a test, and 
there are no right or wrong answers.  Please be sure to read the instructions carefully and choose 
the response that is the closest to how you truly feel.  Please do not compare your answers with 
your child's responses.  We are interested in your and your child’s individual perspectives.  
However, feel free to discuss the questionnaire with your child after you have both completed it 
and returned it to me.  If you have any questions, please let me know. 
 
2. Provide the respondent with a pen or pencil and a solid writing surface.  If a table is not available, the 
participant should be provided with an item such as a clipboard.  Remain nearby should questions or 
concerns arise. 
3. When the parent/child returns the PedsQL™, look it over and check to see that all answers have been 
completed.  Verify that no item has more than one response.  If any responses are incomplete, 
illegible, or there are multiple responses for an item, please ask the parent or child to indicate their 
response.   
4. Ask the participants if they had any difficulties completing the questionnaire or if they have any other 
comments regarding the questionnaire.  Document any important feedback. 
5. Thank the parent and child for taking the time to complete the questionnaire.  If the study design 
involves following up with these respondents, let them know that they may be asked to complete the 
PedsQL™ again at another time.  Indicate when they can expect to be contacted again if known. 
 
 
 
  Christelle Berne  
Mapi Research Institute 
27, rue de la Villette 
69003 Lyon 
France  
Tel: +33 (0) 472 13 66 67
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0 وا.BJ ا%را	 0 1 2 3 4
 4 اBR	>  ا%ر Q(ري 0>  0 1 2 3 4
 5 اBR	>  ا%ر 
Mھب ا; اQ@; او ا5	>  0 1 2 3 4
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 1 ا	 ا+o    0^   ا&J 0 1 2 3 4
 2 ا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 3 اQر+ اQط ا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 1 اG)س 0Y(ف أو ا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 2 اG)س 0&iن أو اq)ط 0 1 2 3 4
 3 اG)س 0R`>  0 1 2 3 4
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 1 ا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ض 0 1 2 3 4
 5 ا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 3   اA> اQر+ اQط ا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ر"  0 1 2 3 4
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